Commission
File Number
|
Exact Name of Registrant as Specified in its Charter,
Principal Office Address and Telephone Number
|
State of
Incorporation or
Organization
|
I.R.S. Employer
Identification No.
|
001-38646
|
Dow Inc.
|
Delaware
|
30-1128146
|
|
2211 H.H. Dow Way, Midland, MI 48674
|
|
|
|
(989) 636-1000
|
|
|
|
|
|
|
001-03433
|
The Dow Chemical Company
|
Delaware
|
38-1285128
|
|
2211 H.H. Dow Way, Midland, MI 48674
|
|
|
|
(989) 636-1000
|
|
|
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Registrant
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
Dow Inc.
|
Common Stock, par value $0.01 per share
|
DOW
|
New York Stock Exchange
|
The Dow Chemical Company
|
4.625% Notes due October 1, 2044
|
DOW/44
|
New York Stock Exchange
|
Exhibit No.
|
Exhibit Description
|
|
|
Subsidiaries of The Dow Chemical Company.
|
|
|
|
Consent of Independent Registered Public Accounting Firm for Dow Inc.
|
|
|
|
Consent of Independent Registered Public Accounting Firm for The Dow Chemical Company.
|
|
|
|
Ankura Consulting Group, LLC's Consent.
|
|
|
|
As Recasted Part I, Item 1. Business, Item 1A. Risk Factors, Item 2. Properties and Item 3. Legal Proceedings. As Recasted Part II, Item 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities, Item 6. Selected Financial Data, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations, Item 7A. Quantitative and Qualitative Disclosures About Market Risk and Item 8. Financial Statements and Supplementary Data. As Recasted Part IV, Item 15. Exhibits, Financial Statement Schedules.
|
|
|
|
101.INS
|
XBRL Instance Document.
|
|
|
101.SCH
|
XBRL Taxonomy Extension Schema Document.
|
|
|
101.CAL
|
XBRL Taxonomy Extension Calculation Linkbase Document.
|
|
|
101.DEF
|
XBRL Taxonomy Extension Definition Linkbase Document.
|
|
|
101.LAB
|
XBRL Taxonomy Extension Label Linkbase Document.
|
|
|
101.PRE
|
XBRL Taxonomy Extension Presentation Linkbase Document.
|
|
/s/ RONALD C. EDMONDS
|
Ronald C. Edmonds
|
Controller and Vice President of Controllers and Tax
|
Subsidiaries of The Dow Chemical Company
1
|
EXHIBIT 21
|
At December 31, 2018
|
|
|
Location
2
|
This list includes companies for which the effective ownership by The Dow Chemical Company is 50 percent or more.
|
|
3229809 Nova Scotia Company
|
Canada
|
3294027 Nova Scotia Company
|
Canada
|
3308597 Nova Scotia Company
|
Canada
|
AM Robin LLC
|
Delaware
|
Amerchol Corporation
|
Delaware
|
American Mortell Corporation
|
Texas
|
Arabian Chemical Company (Latex) Ltd.
3
|
Saudi Arabia
|
Arabian Chemical Company (Polystyrene) Limited
3
|
Saudi Arabia
|
BASF DOW HPPO B.V.
3
|
Netherlands
|
BASF DOW HPPO Technology B.V.
3
|
Netherlands
|
Battleground Water Company
|
Texas
|
Beijing Eastern Rohm and Haas Company Limited
|
China
|
Blue Creek Coal Company, Inc.
|
Delaware
|
Calidria Corporation
|
Delaware
|
Carbide Chemical (Thailand) Limited
|
Thailand
|
Cayuse Pipeline, Inc.
|
Texas
|
Charles Lennig & Company LLC
|
Delaware
|
Chemars III LLC
|
Delaware
|
Chemtech II L.P.
|
Delaware
|
Chemtech Portfolio II Inc.
|
Michigan
|
Chemtech Portfolio Inc.
|
Texas
|
CHPM Company Limited
|
United Kingdom
|
Cisvaal (Proprietary) Limited
|
South Africa
|
DC Alabama, Inc.
|
Delaware
|
DCC Litigation Facility, Inc.
|
Delaware
|
DCOMCO, Inc.
|
Delaware
|
Denmerco Inc.
|
Delaware
|
Devonshire Underwriters Ltd.
|
District of Columbia
|
DoNedPa B.V.
|
Netherlands
|
Dorinco Reinsurance Company
|
Michigan
|
Dorintal Reinsurance Limited
|
Vermont
|
Dow (Shanghai) Holding Co., Ltd.
|
China
|
Dow (Shanghai) Management Co., Ltd.
|
China
|
Dow (Zhangjiagang) Holding Co., Ltd.
|
China
|
Dow Austria Gesellschaft m.b.H.
|
Austria
|
Dow Belgium B.V.B.A.
|
Belgium
|
Dow Benelux B.V.
|
Netherlands
|
Dow Benelux Integrated Center B.V.
|
Netherlands
|
Dow Beteiligungsgesellschaft mbH & Co. KG
|
Germany
|
Dow Brasil Industria e Comercio de Produtos Quimicos Ltda.
|
Brazil
|
Dow Brasil Sudeste Industrial Ltda.
|
Brazil
|
Dow Capital Public Limited Company
|
Ireland
|
Dow Chemical (Australia) Pty Ltd
|
Australia
|
Dow Chemical (China) Investment Company Limited
|
China
|
Dow Chemical (Guangzhou) Company Limited
|
China
|
Dow Chemical (Malaysia) Sdn. Bhd.
|
Malaysia
|
Dow Chemical (Myanmar) Ltd.
|
Myanmar
|
Dow Chemical (NZ) Limited
|
New Zealand
|
Dow Chemical (Shanghai) Company Limited
|
China
|
Subsidiaries of The Dow Chemical Company
1
|
EXHIBIT 21
|
At December 31, 2018
|
|
|
Location
2
|
This list includes companies for which the effective ownership by The Dow Chemical Company is 50 percent or more.
|
|
Dow Chemical (Sichuan) Co., Ltd.
|
China
|
Dow Chemical (Singapore) Private Limited
|
Singapore
|
Dow Chemical (Zhangjiagang) Company Limited
|
China
|
Dow Chemical Bangladesh Private Limited
|
Bangladesh
|
Dow Chemical Canada ULC
|
Canada
|
Dow Chemical China Holdings Pte. Ltd.
|
Singapore
|
Dow Chemical Company Limited
|
United Kingdom
|
Dow Chemical Costa Rica S.A.
|
Costa Rica
|
Dow Chemical Delaware Corp.
|
Delaware
|
Dow Chemical East Africa Limited
|
Kenya
|
Dow Chemical Iberica S.L.
|
Spain
|
Dow Chemical IMEA GmbH
|
Switzerland
|
Dow Chemical Inter-American Limited
|
Delaware
|
Dow Chemical International Ltd.
|
Delaware
|
Dow Chemical International Private Limited
|
India
|
Dow Chemical Japan Limited
|
Japan
|
Dow Chemical Korea Limited
|
Korea
|
Dow Chemical Kuwait B.V.
|
Netherlands
|
Dow Chemical OOO
|
Russia
|
Dow Chemical Pacific (Singapore) Private Limited
|
Singapore
|
Dow Chemical Pacific Limited
|
Hong Kong
|
Dow Chemical Philippines, Inc.
|
Philippines
|
Dow Chemical Romania S.R.L.
|
Romania
|
Dow Chemical Services UK Limited
|
United Kingdom
|
Dow Chemical Silicones Korea, Ltd.
|
Korea
|
Dow Chemical Singapore Holdings Pte. Ltd.
|
Singapore
|
Dow Chemical Taiwan Limited
|
Taiwan
|
Dow Chemical Telecommunications Corp.
|
Delaware
|
Dow Chemical Thailand Ltd.
|
Thailand
|
Dow Chemical Tianjin Holdings Pte. Ltd.
|
Singapore
|
Dow Chemical Vietnam Limited Liability Company
|
Vietnam
|
Dow Chemical West Africa Limited
|
Ghana
|
Dow Corning (Thailand) Limited
|
Thailand
|
Dow Corning Australia Pty. Ltd.
|
Australia
|
Dow Corning China Limited
|
Hong Kong
|
Dow Corning de Argentina S.R.L.
|
Argentina
|
Dow Corning France S.A.S.
|
France
|
Dow Corning Silicones Malaysia SDN. BHD.
|
Malaysia
|
Dow Corning Singapore Pte. Ltd.
|
Singapore
|
Dow Danmark A/S
|
Denmark
|
Dow Deutschland Anlagengesellschaft mbH
|
Germany
|
Dow Deutschland Inc.
|
Delaware
|
Dow Deutschland Verwaltungs Vertriebs GmbH
|
Germany
|
Dow Egypt Services Limited
|
Egypt
|
Dow Engineering Company
|
Delaware
|
Dow Engineering, Inc.
|
Michigan
|
Dow Especialidades Quimicas Ltda.
|
Brazil
|
Dow Europe GmbH
|
Switzerland
|
Dow Europe Holding B.V.
|
Netherlands
|
Subsidiaries of The Dow Chemical Company
1
|
EXHIBIT 21
|
At December 31, 2018
|
|
|
Location
2
|
This list includes companies for which the effective ownership by The Dow Chemical Company is 50 percent or more.
|
|
Dow Financial Services Inc.
|
Delaware
|
Dow France S.A.S.
|
France
|
Dow Global Financial Management, Inc.
|
Delaware
|
Dow Global Technologies LLC
|
Delaware
|
Dow Hellas A.E.
|
Greece
|
Dow Hungary Kft.
|
Hungary
|
Dow Hydrocarbons and Resources LLC
|
Delaware
|
Dow Industrial Chemical Products Nigeria Limited
|
Nigeria
|
Dow InterBranch B.V.
|
Netherlands
|
Dow Internacional Mexicana S.A. de C.V.
|
Mexico
|
Dow International Finance S.a.r.l.
|
Luxembourg
|
Dow International Financial Services
|
Ireland
|
Dow International Holdings Company
|
Delaware
|
Dow International Holdings S.A.
|
Switzerland
|
Dow International Technology Corporation
|
Delaware
|
Dow Intrastate Gas Company
|
Louisiana
|
Dow Investment Argentina S.R.L.
|
Argentina
|
Dow Italia Divisione Commerciale s.r.l.
|
Italy
|
Dow Italia s.r.l.
|
Italy
|
Dow Izolan OOO
|
Russia
|
Dow Izolan Ukraine LLC
|
Ukraine
|
Dow Japan Holdings K.K.
|
Japan
|
Dow Limited
|
United Kingdom
|
Dow Luxembourg Galaxy Holding S.a.r.l.
|
Luxembourg
|
Dow Luxembourg Spectrum Holding S.a.r.l.
|
Luxembourg
|
Dow Material Sciences Ltd.
|
Israel
|
Dow Materials Science Saudi Arabia Limited
|
Saudi Arabia
|
Dow MF Verwaltungs GmbH
|
Germany
|
Dow Mideast Systems S.A.E. (JSC)
|
Egypt
|
Dow-Mitsui Polychemicals Company, Ltd
3
|
Japan
|
Dow Morocco SARL
|
Morocco
|
Dow Netherlands Holding 1 B.V.
|
Netherlands
|
Dow Netherlands Nordic Holding B.V.
|
Netherlands
|
Dow Netherlands Orange Holding B.V.
|
Netherlands
|
Dow Netherlands Pacific Holding B.V.
|
Netherlands
|
Dow Netherlands Tulip Holding B.V.
|
Netherlands
|
Dow Norge A/S
|
Norway
|
Dow Olefinverbund GmbH
|
Germany
|
Dow Performance Materials (Australia) Pty Ltd
|
Australia
|
Dow Peru S.A.
|
Peru
|
Dow Pipeline Company
|
Texas
|
Dow Pipeline Gesellschaft mbH & Co. KG
|
Germany
|
Dow Pipeline Verwaltungsgesellschaft mbH
|
Germany
|
Dow Polska Sp.z.o.o.
|
Poland
|
Dow Portugal Produtos Quimicos, Unipessoal, Lda.
|
Portugal
|
Dow Produktions und Vertriebs GmbH & Co. OHG
|
Germany
|
Dow Quimica Argentina S.R.L.
|
Argentina
|
Dow Quimica Chilena S.A.
|
Chile
|
Dow Quimica de Colombia S.A.
|
Colombia
|
Subsidiaries of The Dow Chemical Company
1
|
EXHIBIT 21
|
At December 31, 2018
|
|
|
Location
2
|
This list includes companies for which the effective ownership by The Dow Chemical Company is 50 percent or more.
|
|
Dow Quimica Mexicana S.A. de C.V.
|
Mexico
|
Dow Roofing Systems LLC
|
Delaware
|
Dow Saudi Arabia Holding B.V.
|
Netherlands
|
Dow Saudi Arabia Investment B.V.
|
Netherlands
|
Dow Saudi Arabia Product Marketing B.V.
|
Netherlands
|
Dow Services Trustees UK Limited
|
United Kingdom
|
Dow Silicones (Shanghai) Co., Ltd.
|
China
|
Dow Silicones (Zhangjiagang) Co., Ltd.
|
China
|
Dow Silicones Belgium SPRL
|
Belgium
|
Dow Silicones Corporation
|
Michigan
|
Dow Silicones Deutschland GmbH
|
Germany
|
Dow Silicones Holding Japan G.K.
|
Japan
|
Dow Silicones Netherlands Holding B.V.
|
Netherlands
|
Dow Silicones UK Limited
|
United Kingdom
|
Dow Siloxane (Zhangjiagang) Holding Co. Private Ltd.
|
Singapore
|
Dow Siloxanes (Zhangjiagang) Co., Ltd.
|
China
|
Dow South Africa Holdings (Pty) Ltd.
|
South Africa
|
Dow Southern Africa (Pty) Ltd
|
South Africa
|
Dow Stade Produktions GmbH & Co. OHG
|
Germany
|
Dow Suomi OY
|
Finland
|
Dow Sverige AB
|
Sweden
|
Dow Switzerland Holding GmbH
|
Switzerland
|
Dow Technology Investments LLC
|
Delaware
|
Dow Thames Limited
|
United Kingdom
|
Dow Toray Co., Ltd.
|
Japan
|
Dow Trent Limited
|
United Kingdom
|
Dow Turkiye Kimya Sanayi ve Ticaret Limited Sirketi
|
Turkey
|
Dow UK Limited
|
United Kingdom
|
Dow Verwaltungsgesellschaft mbH
|
Germany
|
DowAksa Advanced Composites Holdings B.V.
3
|
Netherlands
|
DowBrands Inc.
|
Delaware
|
DuPont (Taiwan) Electronic Materials Ltd.
|
Taiwan
|
DuPont Asia Pacific Limited
|
Delaware
|
DuPont Performance Materials (Shanghai) Co., Ltd.
|
China
|
DuPont Performance Materials Deutschland GmbH
|
Germany
|
DuPont Performance Materials International Sàrl
|
Switzerland
|
DuPont Performance Materials Proprietary Limited
|
South Africa
|
DuPont Performance Materials UK Ltd
|
United Kingdom
|
E&C EMEA Holding 1 B.V.
|
Netherlands
|
EQUATE Marketing Company E.C.
3
|
Bahrain
|
Essex Chemical Corporation
|
New Jersey
|
Finndisp Ltd.
|
Russia
|
Flexible Products Company
|
Georgia
|
Forbanco Inc.
|
Delaware
|
Fort Saskatchewan Ethylene Storage Corporation
3
|
Canada
|
Fort Saskatchewan Ethylene Storage Limited Partnership
|
Canada
|
General Latex and Chemical Corporation
|
Massachusetts
|
Global Industrial Corporation
|
New York
|
GNS Enterprises, LLC
|
Georgia
|
Subsidiaries of The Dow Chemical Company
1
|
EXHIBIT 21
|
At December 31, 2018
|
|
|
Location
2
|
This list includes companies for which the effective ownership by The Dow Chemical Company is 50 percent or more.
|
|
GNS Technologies, LLC
|
Georgia
|
Great Western Pipeline Company, Inc.
|
California
|
Guangdong Zhongshan Amerchol Specialty Chemicals Co., Ltd.
|
China
|
GWN Holding, LLC
|
Delaware
|
H Hotel Holding LLC
|
Delaware
|
Hampshire Chemical Corp.
|
Delaware
|
Hampshire Holdings, Inc.
|
Delaware
|
HPPO Holding & Finance C.V.
3
|
Netherlands
|
Hyperlast Limited
|
United Kingdom
|
Ifco Inc.
|
Delaware
|
Japan Acrylic Chemical Co., Ltd.
|
Japan
|
K/D/S Promix, LLC
3
|
Texas
|
Liana Limited
|
Delaware
|
Material Science de Mexico DDM, S. de R.L. de C.V.
|
Mexico
|
Material Science Servicios de Mexico DDM, S. de R.L. de C.V.
|
Mexico
|
Materials Science Holding, LLC
|
Delaware
|
Materials Science (India) Private Limited
|
India
|
Midland Pipeline Corp.
|
Delaware
|
Mortell Company
|
Delaware
|
Morton International Productos Quimicos Ltda.
|
Brazil
|
Morton International, LLC
|
Indiana
|
MSTG Company Limited
|
United Kingdom
|
MTP HPJV C.V.
|
Netherlands
|
MTP HPJV Management B.V.
|
Netherlands
|
MVCC Limited Partnership
|
Delaware
|
NuvoSun (Shanghai) Co. Ltd.
|
China
|
NuvoSun, Inc.
|
California
|
NZ Tulip Limited
|
New Zealand
|
Palmyra do Brasil Indústria e Comércio de Silício Metálico e Recursos Naturais Ltda.
|
Brazil
|
PBBPolisur S.R.L.
|
Argentina
|
Penuelas Technology Park LLC
|
Delaware
|
Performance Material Products (Singapore) Pte. Ltd.
|
Singapore
|
Performance Material Products Korea Ltd.
|
Korea
|
Performance Materials (Australia) Pty Ltd
|
Australia
|
Performance Materials (Thailand) Limited
|
Thailand
|
Performance Materials Argentina S.A.U.
|
Argentina
|
Performance Materials Belgium BVBA
|
Belgium
|
Performance Materials Bulgaria EOOD
|
Bulgaria
|
Performance Materials Colombia S.A.S.
|
Colombia
|
Performance Materials Czech Republic s.r.o.
|
Czech Republic
|
Performance Materials do Brasil Comercio de Plasticos e Polimeros Ltda.
|
Brazil
|
Performance Materials Finland OY
|
Finland
|
Performance Materials France SAS
|
France
|
Performance Materials Iberica, S.L.
|
Spain
|
Performance Materials Italy S.R.L.
|
Italy
|
Performance Materials Japan Kabushiki Kaisha
|
Japan
|
Performance Materials NA, Inc.
|
Delaware
|
Performance Materials Netherlands, B.V.
|
Netherlands
|
Performance Materials Poland Sp. z o.o.
|
Poland
|
Subsidiaries of The Dow Chemical Company
1
|
EXHIBIT 21
|
At December 31, 2018
|
|
|
Location
2
|
This list includes companies for which the effective ownership by The Dow Chemical Company is 50 percent or more.
|
|
Performance Materials Rus LLC
|
Russia
|
Performance Materials Turkey Endustri Urunleri Limited Sirketi
|
Turkey
|
Performance Materials Ukraine LLC
|
Ukraine
|
Performance Science Materials Company
|
Canada
|
Performance Specialty Products (Hong Kong) Limited
|
Hong Kong
|
Performance Specialty Products Pakistan (Pvt.) Limited
|
Pakistan
|
Petromont and Company, Limited Partnership
3
|
Canada
|
Petromont Inc.
3
|
Canada
|
Petroquimica-Dow S.A. (Petrodow)
|
Chile
|
Photon Systems LLC
|
Delaware
|
PM EMEA Cooperatief U.A.
|
Netherlands
|
PM EMEA Holding 1 B.V.
|
Netherlands
|
PM EMEA Holding 2 B.V.
|
Netherlands
|
PM EMEA Holding 3 B.V.
|
Netherlands
|
PM EMEA Holding 4 B.V.
|
Netherlands
|
PM International Holding 1 B.V.
|
Netherlands
|
PM International Holding 3 B.V.
|
Netherlands
|
PM Japan, Inc.
|
Delaware
|
PM LATAM, Inc.
|
Delaware
|
PM Mexico, LLC
|
Delaware
|
POLY-CARB, Inc.
|
Ohio
|
Polyol Belgium B.V.B.A.
|
Belgium
|
Predate Properties (Pty) Ltd.
|
South Africa
|
PT Dow Indonesia
|
Indonesia
|
PT Rohm and Haas Indonesia
|
Indonesia
|
RH DK Mexico Holding ApS
|
Denmark
|
RH DK Vietnam Holdings ApS
|
Denmark
|
Rofan Services LLC
|
Delaware
|
ROH Delaware, LLC
|
Delaware
|
ROH Delaware, LP
|
Delaware
|
ROH Holdings 1, LLC
|
Delaware
|
ROH Holdings 2, LLC
|
Delaware
|
ROH Monomer Holding Company
|
Delaware
|
ROH Venture GmbH
|
Germany
|
Rohm and Haas (China) Holding Co., Ltd.
|
China
|
Rohm and Haas (Far East) Limited
|
Hong Kong
|
Rohm and Haas (Foshan) Specialty Materials Co., Ltd.
|
China
|
Rohm and Haas (UK) Limited
|
United Kingdom
|
Rohm and Haas Argentina S.R.L.
|
Argentina
|
Rohm and Haas Canada Investments Limited
|
Canada
|
Rohm and Haas Canada LP
|
Canada
|
Rohm and Haas Capital Corporation
|
Delaware
|
Rohm and Haas Chemical (Thailand) Limited
|
Thailand
|
Rohm and Haas Chemicals LLC
|
Delaware
|
Rohm and Haas Chemicals Singapore Pte. Ltd.
|
Singapore
|
Rohm and Haas Chile Limitada
|
Chile
|
Rohm and Haas China, Inc.
|
Delaware
|
Rohm and Haas Colombia Ltda
|
Colombia
|
Rohm and Haas Company
|
Delaware
|
Subsidiaries of The Dow Chemical Company
1
|
EXHIBIT 21
|
At December 31, 2018
|
|
|
Location
2
|
This list includes companies for which the effective ownership by The Dow Chemical Company is 50 percent or more.
|
|
Rohm and Haas Denmark Bermuda GP ApS
|
Denmark
|
Rohm and Haas Denmark China Investment ApS
|
Denmark
|
Rohm and Haas Denmark Finance A/S
|
Denmark
|
Rohm and Haas Denmark Holding Company ApS
|
Denmark
|
Rohm and Haas Electronic Materials Europe Ltd.
|
United Kingdom
|
Rohm and Haas Equity Corporation
|
Delaware
|
Rohm and Haas Espana Production Holding, S.L.
|
Spain
|
Rohm and Haas Espana, S.L.
|
Spain
|
Rohm and Haas Europe Services ApS
|
Denmark
|
Rohm and Haas Europe Trading ApS
|
Denmark
|
Rohm and Haas International Holdings Inc.
|
Delaware
|
Rohm and Haas International SNC
|
France
|
Rohm and Haas International Trading (Shanghai) Co. Ltd.
|
China
|
Rohm and Haas Investment Holdings Inc.
|
Delaware
|
Rohm and Haas Italia S.r.l.
|
Italy
|
Rohm and Haas Kimya Sanayi Limited Sirketi
|
Turkey
|
Rohm and Haas Kimyasal Urunler Uretim Dagitim ve Ticaret A.S.
|
Turkey
|
Rohm and Haas Korea Co., Ltd.
|
Korea
|
Rohm and Haas Latinoamerica, S. de R.L. de C.V.
|
Mexico
|
Rohm and Haas Malaysia Sdn Bhd
|
Malaysia
|
Rohm and Haas Mexico, S. de R.L. de C.V.
|
Mexico
|
Rohm and Haas Nederland B.V.
|
Netherlands
|
Rohm and Haas New Zealand Limited
|
New Zealand
|
Rohm and Haas Quimica Ltda.
|
Brazil
|
Rohm and Haas Singapore (Pte.) Ltd.
|
Singapore
|
Rohm and Haas South Africa (PTY) Limited
|
South Africa
|
Rohm and Haas Taiwan, Inc.
|
Taiwan
|
Rohm and Haas Texas Incorporated
|
Texas
|
Rohm and Haas Vietnam Co., Ltd.
|
Vietnam
|
RUS Polyurethanes Holding B.V.
|
Netherlands
|
Santa Vitoria Acucar e Alcool Ltda.
|
Brazil
|
SD Group Service Company Limited
3
|
Thailand
|
Seadrift Pipeline Corporation
|
Delaware
|
Sentrachem Limited
|
South Africa
|
Sentrachem US, Inc.
|
Delaware
|
Shanghai Eastern Rohm and Haas Co., Ltd.
|
China
|
Siam Polyethylene Company Limited
3
|
Thailand
|
Siam Polystyrene Company Limited
3
|
Thailand
|
Siam Styrene Monomer Company Limited
3
|
Thailand
|
Siam Synthetic Latex Company Limited
3
|
Thailand
|
Site Services Japan, Co., Ltd.
|
Japan
|
South Charleston Sewage Treatment Company
|
West Virginia
|
SP International Holding 5 B.V.
|
Netherlands
|
TDCC Subsidiary C, Inc.
|
Delaware
|
Terminal de Atraque de Productos Petroquimicos, A.I.E.
3
|
Spain
|
Terneuzen Investments Holding B.V.
|
Netherlands
|
Terneuzen Partnership Services B.V.
|
Netherlands
|
Tianjin Panda Terminal (Hong Kong) Limited
|
Hong Kong
|
Tianjin Panda Terminal Holdings Pte. Ltd.
|
Singapore
|
Subsidiaries of The Dow Chemical Company
1
|
EXHIBIT 21
|
At December 31, 2018
|
|
|
Location
2
|
This list includes companies for which the effective ownership by The Dow Chemical Company is 50 percent or more.
|
|
Transformadora de Etileno A.I.E.
3
|
Spain
|
UCAR Emulsion Systems FZE
|
Dubai
|
UCAR Louisiana Pipeline Company
|
Delaware
|
UCAR Pipeline Incorporated
|
Delaware
|
Umetco Minerals Corporation
|
Delaware
|
Union Carbide Asia Limited
|
Hong Kong
|
Union Carbide Asia Pacific, Inc.
|
Delaware
|
Union Carbide Chemicals & Plastics Technology LLC
|
Delaware
|
Union Carbide Corporation
|
New York
|
Union Carbide Customer Services Pte. Ltd.
|
Singapore
|
Union Carbide Middle East Limited
|
Delaware
|
Union Carbide Philippines (Far East), Inc.
|
Philippines
|
Union Carbide South Africa (Proprietary) Limited
|
South Africa
|
Union Polymers Sdn. Bhd.
|
Malaysia
|
Univation (Zhangjiagang) Chemical Company Limited
|
China
|
Univation Technologies (Hong Kong) Limited
|
Hong Kong
|
Univation Technologies International, LLC
|
Delaware
|
Univation Technologies, LLC
|
Delaware
|
Valley Asset Leasing, LLC
|
Delaware
|
Valuepark Terneuzen Beheer B.V.
3
|
Netherlands
|
Valuepark Terneuzen C.V.
3
|
Netherlands
|
Voltas Water Solutions Private Limited
3
|
India
|
Warbler I LLC
|
Delaware
|
Westbridge Insurance Ltd.
|
Vermont
|
Zhejiang Pacific Chemical Corporation
|
China
|
1.
|
This Exhibit 21 excludes subsidiaries of The Dow Chemical Company's agricultural sciences and specialty products businesses which are considered discontinued operations and includes subsidiaries related to the receipt of DuPont's ethylene and ethylene copolymers businesses (other than its ethylene acrylic elastomers business). The Dow Chemical Company became a subsidiary of Dow Inc. effective April 1, 2019.
|
2.
|
Location of incorporation or organization. Primary location of organization is reported for partnerships.
|
3.
|
These companies are 50 percent owned, nonconsolidated affiliates of The Dow Chemical Company and are accounted for using the equity method. Separate financial statements of these companies are not included in this Current Report on Form 8-K. These companies are not controlled, directly or indirectly, by The Dow Chemical Company. Subsidiaries of these companies, if any, are not listed in this Exhibit 21.
|
|
Ankura Consulting Group, LLC's Consent
|
EXHIBIT 23.2
|
|
|
|
Form S-3:
|
|
|
|
No.
|
333-230668
|
|
|
Form S-8:
|
|
|
|
Nos.
|
333-220352-01
|
|
333-230680
|
|
333-230681
|
Form S-4:
|
|
|
|
No.
|
333-88443
|
|
|
Form S-8:
|
|
|
|
Nos.
|
33-61795
|
|
333-40271
|
|
333-91027
|
|
333-103519
|
|
333-220352
|
/s/ B. THOMAS FLORENCE
|
B. Thomas Florence
|
Senior Managing Director
|
Ankura Consulting Group, LLC
|
July 25, 2019
|
|
Consent of Independent Registered Public Accounting Firm
|
EXHIBIT 23.1.1
|
|
|
|
Form S-3:
|
|
|
|
No.
|
333-230668
|
|
|
Form S-8:
|
|
|
|
Nos.
|
333-220352-01
|
|
333-230680
|
|
333-230681
|
/s/ DELOITTE & TOUCHE LLP
|
Deloitte & Touche LLP
|
Midland, Michigan
|
July 25, 2019
|
|
Consent of Independent Registered Public Accounting Firm
|
EXHIBIT 23.1.2
|
|
|
|
Form S-4:
|
|
|
|
No.
|
333-88443
|
|
|
Form S-8:
|
|
|
|
Nos.
|
33-61795
|
|
333-40271
|
|
333-91027
|
|
333-103519
|
|
333-220352
|
/s/ DELOITTE & TOUCHE LLP
|
Deloitte & Touche LLP
|
Midland, Michigan
|
July 25, 2019
|
|
Dow Inc. and Subsidiaries
The Dow Chemical Company and Subsidiaries
|
|
|
Dow Inc. and Subsidiaries
The Dow Chemical Company and Subsidiaries
|
|
|
PART I
|
|
Business
|
Applications/Market Segments
|
Major Products
|
Key Raw Materials
|
Key Competitors
|
Coatings & Performance Monomers
|
Acrylic binders for architectural paints and coatings, industrial coatings and paper; adhesives; dispersants; impact modifiers; inks and paints; opacifiers and surfactants for both architectural and industrial applications; plastics additives; processing aids; protective and functional coatings; rheology modifiers
|
ACOUSTICRYL™ Liquid-Applied Sound Damping Technology; acrylates; ACRYSOL™ Rheology Modifiers; AVANSE™ Acrylic Binders; EVOQUE™ Pre-Composite Polymer; foam cell promoters; FORMASHIELD™ Acrylic Binder; high-quality impact modifiers; MAINCOTE™ Acrylic Epoxy Hybrid; methacrylates; processing aids; RHOPLEX™ Acrylic Resin; TAMOL™ Dispersants; vinyl acetate monomers; weatherable acrylic capstock compounds for thermoplastic and thermosetting materials
|
Acetone, butyl acrylate, methyl methacrylate, propylene, styrene
|
Arkema, BASF, Celanese, Evonik, LyondellBasell, Nan Ya, Owens-Corning, Wacker Chemie
|
Consumer Solutions
|
Personal care, color cosmetics, baby care, home care and specialty applications with a key focus on hair care, skin care, sun care, cleansing, as well as fabric, dish, floor, hard surface and air care applications; commercial glazing; electrical and high-voltage insulation; lamp and luminaire modules assembly; oil and gas; paints and inks; release liners, specialty films and tapes; sporting goods; 3D printing
|
Adhesives and sealants; antifoams and surfactants; coatings and controlled release; coupling agents and crosslinkers; EVOLV3D™ Printing Technology; fluids, emulsions and dispersions;formulating and processing aids; granulation and binders; oils; polymers and emollients; opacifiers; reagents; resins, gels and powders; rheology modifiers; rubber; silicone elastomers; solubility enhancers; aerospace composites; surfactants and solvents; SILASTIC™ Silicone Elastomers; DOWSIL™ Silicone Products
|
Hydrochloric acid, methanol, silica, silicon metal
|
Elkem, Momentive, Shin-Etsu, Wacker Chemie
|
Business
|
Applications/Market Segments
|
Major Products
|
Key Raw Materials
|
Key Competitors
|
Industrial Solutions
|
Broad range of products for specialty applications, including agriculture crop protection offerings, aircraft deicing, solvents for coatings, heat transfer fluids for concentrated solar power, construction, solvents for electronics processing, food preservation, fuel markers, home and personal care, infrastructure applications, lubricant additives, paper, transportation and utilities; energy markets including exploration, production, transmission, refining, mining and gas processing to optimize supply, improve efficiencies and manage emissions
|
Acetone derivatives, butyl glycol ethers, VERSENE™ Chelants, UCAR™ Deicing Fluids, ethanolamines, ethylene oxide, ethyleneamines, UCON™ Fluids, glycol ethers, UCARTHERM™ Heat Transfer Fluids, higher glycols, isopropanolamines, low-VOC solvents, methoxypolyethylene glycol, methyl isobutyl, polyalkylene glycol, CARBOWAX™ SENTRY™
Polyethylene Glycol, TERGITOL™ and TRITON™ Surfactants, demulsifiers, drilling and completion fluids, heat transfer fluids, rheology modifiers, scale inhibitors, shale inhibitors, specialty amine solvents, surfactants, water clarifiers, frothing separating agents
|
Ethylene, methanol, propylene
|
BASF, Eastman, Hexion, Huntsman, INEOS, LyondellBasell, SABIC, Sasol, Shell
|
Polyurethanes & Construction Chemicals
|
Aircraft deicing fluids; alumina; pulp and paper; appliances; automotive; bedding; building and construction; flooring; footwear; heat transfer fluids; hydraulic fluids; infrastructure; packaging; textiles and transportation; construction; caulks and sealants; cement-based tile adhesives; concrete solutions; elastomeric roof coatings; industrial non-wovens; plasters and renders; roof tiles and siding; sport grounds and tape joint compounds
|
Aniline, caustic soda, ethylene dichloride, methylene diphenyl diisocyanate (“MDI”), polyether polyols, propylene glycol, propylene oxide, polyurethane systems, toluene diisocyanate (“TDI”), vinyl chloride monomer, AQUASET™ Acrylic Thermosetting Resins, DOW™ Latex Powder, RHOPLEX™ and PRIMAL™ Acrylic Emulsion Polymers, WALOCEL™ Cellulose Ethers
|
Acetone, aniline, aqueous hydrochloric acid, chlorine, electric power, ethylene, hydrogen peroxide, propylene, styrene
|
Arkema, Ashland, BASF, Covestro, Eastman, Huntsman, INEOS, Olin, Owens-Corning, Yantai Wanhua
|
•
|
EQUATE Petrochemical Company K.S.C.C. (“EQUATE”) - a Kuwait-based company that manufactures ethylene, polyethylene and ethylene glycol, and manufactures and markets monoethylene glycol, diethylene glycol and polyethylene terephthalate resins; owned 42.5 percent by the Company.
|
•
|
The Kuwait Olefins Company K.S.C.C. (“TKOC”) - a Kuwait-based company that manufactures ethylene and ethylene glycol; owned 42.5 percent by the Company.
|
•
|
Map Ta Phut Olefins Company Limited (“Map Ta Phut”) - a Thailand-based company that manufactures propylene and ethylene; the Company has an effective ownership of 32.77 percent (of which 20.27 percent is owned directly by the Company and aligned with the Industrial Intermediates & Infrastructure segment and 12.5 percent is owned indirectly through the Company’s equity interest in Siam Polyethylene Company Limited, an entity that is part of The SCG-Dow Group and aligned with the Packaging & Specialty Plastics segment).
|
•
|
Sadara Chemical Company ("Sadara") - a Saudi Arabian company that manufactures chlorine, ethylene, propylene and aromatics for internal consumption and manufactures and sells polyethylene, ethylene oxide and propylene oxide derivative products, and isocyanates; owned 35 percent by the Company.
|
Business
|
Applications/Market Segments
|
Major Products
|
Key Raw Materials
|
Key Competitors
|
Hydrocarbons & Energy
|
Purchaser of feedstocks; production of cost competitive hydrocarbon monomers utilized by Dow's derivative businesses; and energy, principally for use in Dow’s global operations
|
Ethylene, propylene, benzene, butadiene, octene, aromatics co-products, power, steam, other utilities
|
Butane, condensate, ethane, naphtha, natural gas, propane
|
Chevron Phillips Chemical, ExxonMobil, INEOS, LyondellBasell, SABIC, Shell, Sinopec
|
Packaging and Specialty Plastics
|
Adhesives; construction; cosmetics; electrical transmission and distribution; food and supply chain packaging; footwear; housewares; health and hygiene; industrial specialty applications using polyolefin elastomers, ethylene copolymers, and ethylene propylene diene monomer elastomers; irrigation pipe; photovoltaic encapsulants; sporting goods; telecommunications infrastructure; toys and infant products
|
Acrylics, bio-based plasticizers, elastomers, ethylene copolymer resins, EPDM, ethylene vinyl acetate copolymer, methacrylic acid copolymer resins, polyethylene, high-density polyethylene, low-density polyethylene ("LDPE"), linear low-density polyethylene, polyolefin plastomers, resin additives and modifiers, semiconductive and jacketing compound solutions and wire and cable insulation
|
Ethylene, hexene, octene, propylene
|
Borealis, ExxonMobil, Ineos, Lanxess, LyondellBasell, Nova, SABIC
|
•
|
The Kuwait Styrene Company K.S.C.C. (“TKSC”) - a Kuwait-based company that manufactures styrene monomer; owned 42.5 percent by the Company.
|
•
|
The SCG-Dow Group - a group of Thailand-based companies (consisting of Siam Polyethylene Company Limited; Siam Polystyrene Company Limited; Siam Styrene Monomer Co., Ltd.; and Siam Synthetic Latex Company Limited) that manufacture polyethylene, polystyrene, styrene, latex and specialty elastomers; owned 50 percent by the Company.
|
•
|
Expansion of the capacity of the Company’s new ethylene production facility, bringing the facility’s total ethylene capacity to 2,000 kilotonnes per annum ("KTA") and making it the largest ethylene facility in the world.
|
•
|
Incremental debottleneck projects across its global asset network that will deliver approximately 350 KTA of additional polyethylene, the majority of which will be in North America.
|
•
|
Construction of a 600 KTA polyethylene unit on the U.S. Gulf Coast based on the Company’s proprietary Solution Process technology, to meet consumer-driven demand in specialty packaging, health and hygiene, and industrial and consumer packaging applications.
|
•
|
Construction of a 450 KTA polyolefins facility in Europe to maximize the value of the Company’s ethylene integration in the region and serve growing demand for high-performance pressure pipes and fittings, as well as caps and closures applications.
|
•
|
A new catalyst production business for key catalysts licensed by Univation Technologies, LLC, a wholly owned subsidiary of the Company.
|
Remaining Life of Patents Owned at Dec 31, 2018
|
United States
|
Foreign
|
||
Within 5 years
|
800
|
|
3,500
|
|
6 to 10 years
|
900
|
|
5,800
|
|
11 to 15 years
|
1,600
|
|
8,000
|
|
16 to 20 years
|
200
|
|
500
|
|
Total
|
3,500
|
|
17,800
|
|
Principal Nonconsolidated Affiliate
|
Country
|
Ownership Interest
|
Business Description
|
|
EQUATE Petrochemical Company K.S.C.C.
|
Kuwait
|
42.50
|
%
|
Manufactures ethylene, polyethylene and ethylene glycol, and manufactures and markets monoethylene glycol, diethylene glycol and polyethylene terephthalate resins
|
The Kuwait Olefins Company K.S.C.C.
|
Kuwait
|
42.50
|
%
|
Manufactures ethylene and ethylene glycol
|
The Kuwait Styrene Company K.S.C.C.
|
Kuwait
|
42.50
|
%
|
Manufactures styrene monomer
|
Map Ta Phut Olefins Company Limited
1
|
Thailand
|
32.77
|
%
|
Manufactures propylene and ethylene
|
Sadara Chemical Company
2
|
Saudi Arabia
|
35.00
|
%
|
Manufactures chlorine, ethylene, propylene and aromatics for internal consumption and manufactures and sells polyethylene, ethylene oxide and propylene oxide derivative products, and isocyanates
|
The SCG-Dow Group:
|
|
|
|
|
Siam Polyethylene Company Limited
|
Thailand
|
50.00
|
%
|
Manufactures polyethylene
|
Siam Polystyrene Company Limited
|
Thailand
|
50.00
|
%
|
Manufactures polystyrene
|
Siam Styrene Monomer Co., Ltd.
|
Thailand
|
50.00
|
%
|
Manufactures styrene
|
Siam Synthetic Latex Company Limited
|
Thailand
|
50.00
|
%
|
Manufactures latex and specialty elastomers
|
1.
|
The Company's effective ownership of Map Ta Phut Olefins Company Limited is 32.77 percent, of which the Company directly owns 20.27 percent and indirectly owns 12.5 percent through its equity interest in Siam Polyethylene Company Limited.
|
2.
|
The Company is responsible for marketing the majority of Sadara products outside of the Middle East zone through the Company's established sales channels. Under this arrangement, the Company purchases and sells Sadara products for a marketing fee.
|
Name - Age
|
Present Position with Registrant
|
Year Elected to be an Officer
|
Other Business Experience since January 1, 2014
|
Karen S. Carter, 48
|
Chief Human Resources Officer
|
2019
|
Dow Inc.
: Chief Human Resources Officer since April 1, 2019.
TDCC
: Chief Human Resources Officer since October 2018; Chief Inclusion Officer since July 2017; North America Commercial Vice President, Dow Packaging and Specialty Plastics from February 2016 to July 2017; Global Business Director, Low Density & Slurry Polyethylene, Packaging & Specialty Plastics from April 2015 to January 2016; and Global Marketing Director Value Chain, New Business Development & Sustainability, Performance Plastics from September 2011 to April 2015.
|
Ronald C. Edmonds, 61
|
Controller and Vice President of Controllers and Tax
|
2019
|
Dow Inc.
: Controller and Vice President of Controllers and Tax since April 1, 2019.
TDCC
: Vice President and Controller since November 2009; Vice President of Tax since January 2016.
|
James R. Fitterling, 57
|
Chief Executive Officer
|
2018
|
Dow Inc.
: Chief Executive Officer since August 2018.
TDCC
: Chief Executive Officer since July 2018; President and Chief Operating Officer from February 2016 to July 2018; Vice Chairman and Chief Operating Officer from October 2015 to February 2016; Vice Chairman, Business Operations from October 2014 to October 2015; Executive Vice President, Feedstocks, Performance Plastics and Supply Chain from December 2013 to October 2014.
|
Peter Holicki, 59
|
Senior Vice President of Manufacturing & Engineering and Environment, Health & Safety Operations
|
2019
|
Dow Inc.
: Senior Vice President of Manufacturing & Engineering and Environment, Health & Safety Operations since April 1, 2019.
TDCC
: Senior Vice President of Manufacturing & Engineering and Environment, Health & Safety Operations since October 2015; responsible for oversight of the Emergency Services and Security Expertise Center since September 2014; Corporate Vice President of Manufacturing & Engineering and Environment, Health & Safety Operations January 2014 to October 2015.
|
A. N. Sreeram, 51
|
Senior Vice President of Research & Development and Chief Technology Officer
|
2019
|
Dow Inc.
: Senior Vice President of Research & Development and Chief Technology Officer since April 1, 2019.
TDCC
: Chief Technology Officer since October 2015; Senior Vice President of Research & Development since August 2013; Corporate Vice President, Research & Development from August 2013 to October 2015.
|
Howard I. Ungerleider, 50
|
President and Chief Financial Officer
|
2018
|
Dow Inc.
: President and Chief Financial Officer since August 2018.
TDCC
: Chief Financial Officer since October 2014; President since July 2018; Vice Chairman from October 2015 to July 2018; Executive Vice President from October 2014 to October 2015; Executive Vice President, Advanced Materials from September 2012 to October 2014.
|
Amy E. Wilson, 48
|
General Counsel and Corporate Secretary
|
2018
|
Dow Inc.
: General Counsel and Corporate Secretary since April 1, 2019; Secretary from August 2018 to April 1, 2019.
TDCC
: General Counsel since October 2018; Corporate Secretary since February 2015; Associate General Counsel from April 2017 to September 2018; Assistant General Counsel from February 2015 to April 2017; Assistant Corporate Secretary from 2008 to February 2015; Director of the Office of the Corporate Secretary from August 2013 to October 2018.
|
1.
|
Updated as a result of the separation from DowDuPont, effective April 1, 2019.
|
Major Manufacturing Sites by Segment
|
Performance Materials & Coatings
|
Industrial Intermediates & Infrastructure
|
Packaging & Specialty Plastics
|
Location
|
|||
Bahia Blanca, Argentina
|
|
|
X
|
Candeias, Brazil
|
|
X
|
X
|
Canada:
|
|
|
|
Fort Saskatchewan, Alberta
|
|
|
X
|
Prentiss, Alberta
|
|
|
X
|
Zhangjiagang, China
|
X
|
X
|
X
|
Germany:
|
|
|
|
Boehlen
|
X
|
X
|
X
|
Leuna
|
|
|
X
|
Schkopau
|
|
X
|
X
|
Stade
|
|
X
|
|
Terneuzen, The Netherlands
|
|
X
|
X
|
Tarragona, Spain
|
|
X
|
X
|
Map Ta Phut, Thailand
|
X
|
X
|
X
|
Barry, United Kingdom
|
X
|
|
|
United States:
|
|
|
|
Carrollton, Kentucky
|
X
|
|
|
Hahnville, Louisiana
|
X
|
X
|
X
|
Plaquemine, Louisiana
|
|
X
|
X
|
Midland, Michigan
|
X
|
|
|
Deer Park, Texas
|
X
|
X
|
|
Freeport, Texas
|
X
|
X
|
X
|
Orange, Texas
|
|
|
X
|
Seadrift, Texas
|
|
X
|
X
|
Manufacturing Sites by Region
|
|
Asia Pacific
|
21 manufacturing sites in 10 countries
|
EMEAI
1
|
38 manufacturing sites in 15 countries
|
Latin America
|
18 manufacturing sites in 4 countries
|
U.S. & Canada
|
36 manufacturing sites in 2 countries
|
1.
|
Europe, Middle East, Africa and India
|
|
Dow Inc. and Subsidiaries
The Dow Chemical Company and Subsidiaries
|
|
|
PART II
|
|
Selected Financial Data
|
|
|
|
|
|
||||||||||
In millions, except as noted (Unaudited)
|
2018
|
2017
|
2016
|
2015
|
2014
|
||||||||||
Summary of Operations
|
|
|
|
|
|
||||||||||
Net sales
1
|
$
|
49,604
|
|
$
|
43,730
|
|
$
|
36,264
|
|
$
|
37,101
|
|
$
|
45,427
|
|
Income (loss) from continuing operations, net of tax
2
|
$
|
2,940
|
|
$
|
(1,287
|
)
|
$
|
1,478
|
|
$
|
6,462
|
|
$
|
2,675
|
|
Per share of common stock (in dollars):
|
|
|
|
|
|
||||||||||
Earnings (loss) per common share from continuing operations - basic
2, 3
|
$
|
3.80
|
|
$
|
(1.88
|
)
|
$
|
1.57
|
|
$
|
8.64
|
|
$
|
3.13
|
|
Earnings (loss) per common share from continuing operations - diluted
2, 3
|
$
|
3.80
|
|
$
|
(1.88
|
)
|
$
|
1.55
|
|
$
|
8.31
|
|
$
|
3.09
|
|
Cash dividends declared per share of common stock
4
|
$
|
—
|
|
$
|
1.38
|
|
$
|
1.84
|
|
$
|
1.72
|
|
$
|
1.53
|
|
Year-end Financial Position
|
|
|
|
|
|
||||||||||
Total assets
|
$
|
83,699
|
|
$
|
85,852
|
|
$
|
79,511
|
|
$
|
67,938
|
|
$
|
68,639
|
|
Long-term debt
|
$
|
19,253
|
|
$
|
19,757
|
|
$
|
20,444
|
|
$
|
16,202
|
|
$
|
18,716
|
|
|
|
|
|
|
|
||||||||||
Financial Ratios
|
|
|
|
|
|
||||||||||
Research and development expenses as percent of net sales
|
1.6
|
%
|
1.8
|
%
|
2.1
|
%
|
2.0
|
%
|
1.6
|
%
|
|||||
Income from continuing operations before income taxes as percent of net sales
2
|
7.6
|
%
|
0.5
|
%
|
3.5
|
%
|
21.8
|
%
|
8.4
|
%
|
|||||
Return on stockholders' equity
2
|
14.3
|
%
|
1.5
|
%
|
15.3
|
%
|
28.2
|
%
|
12.3
|
%
|
|||||
Debt as a percent of total capitalization
|
37.2
|
%
|
39.1
|
%
|
43.9
|
%
|
39.5
|
%
|
45.6
|
%
|
1.
|
The Company has certain product and service agreements with DuPont and Corteva that were considered intercompany transactions prior to the separation, but are trade transactions subsequent to the separation. Treatment of these transactions as trade transactions have been reflected in the table above for 2018, 2017 and 2016. The amounts for 2015 and 2014 were not updated as the impact to "Net sales" for these periods was not significant.
|
2.
|
See Notes
1
,
7
,
8
,
10
,
15
,
17
,
18
and
21
to the Consolidated Financial Statements for information on items materially impacting the results for the years ended December 31, 2018, 2017 and 2016, including the effects of the U.S. Tax Cuts and Jobs Act, enacted on December 22, 2017; loss on early redemption of debt; gains on divestitures; integration and separation costs; charges related to restructuring programs; goodwill impairment and other asset related charges; a charge related to payment of plan obligations to certain participants of a U.S. non-qualified pension plan; and the impact of a change in accounting policy for asbestos-related defense and processing costs.
|
3.
|
Earnings (loss) per common share amounts pertain to Dow Inc. only, as TDCC common shares are not publicly traded and are owned solely by Dow Inc.
|
4.
|
Represents cash dividends declared by TDCC prior to the Merger. Subsequent to the Merger, TDCC has no common shares outstanding.
|
Table of Contents
|
Page
|
Summary of Sales Results
|
|
|
|
||||||
In millions
|
2018
|
2017
|
2016
|
||||||
Net sales
|
$
|
49,604
|
|
$
|
43,730
|
|
$
|
36,264
|
|
Pro forma net sales
|
$
|
49,852
|
|
$
|
44,772
|
|
|
1.
|
Portfolio & Other primarily reflects sales related to the receipt of ECP as a common control transaction from the closing of the Merger on August 31, 2017, and the divestiture of the global Ethylene Acrylic Acid copolymers and ionomers business ("EAA Business"), divested on September 1, 2017 (both impacting Packaging & Specialty Plastics). In addition, Portfolio & Other in 2017 includes the ownership restructure of Dow Silicones announced on June 1, 2016 (impacting Performance Materials & Coatings).
|
Sales Variances by Segment and Geographic Region - As Reported
Percentage change from prior year
|
2016
|
|||||||||
Local Price & Product Mix
|
Currency
|
Volume
|
Portfolio & Other
1
|
Total
|
||||||
Performance Materials & Coatings
|
(8
|
)%
|
(1
|
)%
|
(2
|
)%
|
53
|
%
|
42
|
%
|
Industrial Intermediates & Infrastructure
|
(9
|
)
|
(1
|
)
|
2
|
|
(3
|
)
|
(11
|
)
|
Packaging & Specialty Plastics
|
(8
|
)
|
—
|
|
9
|
|
(1
|
)
|
—
|
|
Total
|
(8
|
)%
|
—
|
%
|
5
|
%
|
1
|
%
|
(2
|
)%
|
U.S. & Canada
|
(8
|
)%
|
—
|
%
|
5
|
%
|
1
|
%
|
(2
|
)%
|
EMEAI
|
(7
|
)
|
(1
|
)
|
5
|
|
(2
|
)
|
(5
|
)
|
Asia Pacific
|
(8
|
)
|
—
|
|
8
|
|
13
|
|
13
|
|
Latin America
|
(10
|
)
|
—
|
|
(1
|
)
|
(1
|
)
|
(12
|
)
|
Total
|
(8
|
)%
|
—
|
%
|
5
|
%
|
1
|
%
|
(2
|
)%
|
1.
|
Portfolio & Other reflects sales from June 1, 2016 through December 31, 2016 related to the ownership restructure of Dow Silicones (impacting Performance Materials & Coatings) and sales from January 1, 2016 through April 30, 2016 for the step acquisition of Univation Technologies, LLC, acquired on May 5, 2015 (impacting Packaging & Specialty Plastics). Portfolio & Other also reflects the following divestitures: the chlorine value chain, divested on October 5, 2015 (impacting Industrial Intermediates & Infrastructure and Packaging & Specialty Plastics), ANGUS Chemical Company, divested on February 2, 2015 and the global Sodium Borohydride business, divested on January 30, 2015 (both impacting Industrial Intermediates & Infrastructure).
|
Sales Variances by Segment and Geographic Region - Pro Forma Basis
Percentage change from prior year
|
2018
|
|||||||||
Local Price & Product Mix
|
Currency
|
Volume
|
Portfolio & Other
1
|
Total
|
||||||
Performance Materials & Coatings
|
10
|
%
|
1
|
%
|
(2
|
)%
|
2
|
%
|
11
|
%
|
Industrial Intermediates & Infrastructure
|
5
|
|
1
|
|
13
|
|
—
|
|
19
|
|
Packaging & Specialty Plastics
|
1
|
|
1
|
|
5
|
|
—
|
|
7
|
|
Total
|
4
|
%
|
1
|
%
|
6
|
%
|
—
|
%
|
11
|
%
|
U.S. & Canada
|
3
|
%
|
—
|
%
|
2
|
%
|
1
|
%
|
6
|
%
|
EMEAI
|
5
|
|
3
|
|
4
|
|
—
|
|
12
|
|
Asia Pacific
|
3
|
|
1
|
|
18
|
|
—
|
|
22
|
|
Latin America
|
5
|
|
—
|
|
4
|
|
—
|
|
9
|
|
Total
|
4
|
%
|
1
|
%
|
6
|
%
|
—
|
%
|
11
|
%
|
1.
|
Portfolio & Other primarily reflects sales related to new agreements established with the separation of DowDuPont's materials science business on April 1, 2019.
|
Performance Materials & Coatings
|
|
|
|
|||
Percentage change from prior year
|
2018
|
2017
|
2016
|
|||
Change in Net Sales from Prior Period due to:
|
|
|
|
|||
Local price & product mix
|
10
|
%
|
8
|
%
|
(8
|
)%
|
Currency
|
1
|
|
1
|
|
(1
|
)
|
Volume
|
(2
|
)
|
2
|
|
(2
|
)
|
Portfolio & other
|
—
|
|
26
|
|
53
|
|
Total
|
9
|
%
|
37
|
%
|
42
|
%
|
Change in Pro Forma Net Sales from Prior Period due to:
|
|
|
|
|||
Local price & product mix
|
10
|
%
|
|
|
||
Currency
|
1
|
|
|
|
||
Volume
|
(2
|
)
|
|
|
||
Portfolio & other
|
2
|
|
|
|
||
Total
|
11
|
%
|
|
|
Industrial Intermediates & Infrastructure
|
|
|
|
|||
Percentage change from prior year
|
2018
|
2017
|
2016
|
|||
Change in Net Sales from Prior Period due to:
|
|
|
|
|||
Local price & product mix
|
5
|
%
|
10
|
%
|
(9
|
)%
|
Currency
|
1
|
|
1
|
|
(1
|
)
|
Volume
|
13
|
|
6
|
|
2
|
|
Portfolio & other
|
—
|
|
—
|
|
(3
|
)
|
Total
|
19
|
%
|
17
|
%
|
(11
|
)%
|
Change in Pro Forma Net Sales from Prior Period due to:
|
|
|
|
|||
Local price & product mix
|
5
|
%
|
|
|
||
Currency
|
1
|
|
|
|
||
Volume
|
13
|
|
|
|
||
Portfolio & other
|
—
|
|
|
|
||
Total
|
19
|
%
|
|
|
Packaging & Specialty Plastics
|
|
|
|
|||
Percentage change from prior year
|
2018
|
2017
|
2016
|
|||
Change in Net Sales from Prior Period due to:
|
|
|
|
|||
Local price & product mix
|
1
|
%
|
8
|
%
|
(8
|
)%
|
Currency
|
2
|
|
—
|
|
—
|
|
Volume
|
5
|
|
6
|
|
9
|
|
Portfolio & other
|
5
|
|
3
|
|
(1
|
)
|
Total
|
13
|
%
|
17
|
%
|
—
|
%
|
Change in Pro Forma Net Sales from Prior Period due to:
|
|
|
|
|||
Local price & product mix
|
1
|
%
|
|
|
||
Currency
|
1
|
|
|
|
||
Volume
|
5
|
|
|
|
||
Portfolio & other
|
—
|
|
|
|
||
Total
|
7
|
%
|
|
|
Corporate
|
|
|
|
||||||
In millions
|
2018
|
2017
|
2016
|
||||||
Net sales
|
$
|
285
|
|
$
|
383
|
|
$
|
284
|
|
Pro forma net sales
|
$
|
285
|
|
$
|
383
|
|
|
||
Operating EBIT
|
|
$
|
(421
|
)
|
$
|
(354
|
)
|
||
Pro forma Operating EBIT
|
$
|
(370
|
)
|
$
|
(422
|
)
|
|
||
Equity losses
|
$
|
(20
|
)
|
$
|
(8
|
)
|
$
|
(29
|
)
|
Cash Flow Summary
|
2018
|
2017
1
|
2016
1
|
||||||
In millions
|
|||||||||
Cash provided by (used for):
|
|
|
|
||||||
Operating activities - continuing operations
|
$
|
3,096
|
|
$
|
(6,443
|
)
|
$
|
(3,882
|
)
|
Operating activities - discontinued operations
|
1,158
|
|
1,514
|
|
925
|
|
|||
Operating activities
|
4,254
|
|
(4,929
|
)
|
(2,957
|
)
|
|||
Investing activities - continuing operations
|
(1,826
|
)
|
6,793
|
|
5,371
|
|
|||
Investing activities - discontinued operations
|
(369
|
)
|
725
|
|
(279
|
)
|
|||
Investing activities
|
(2,195
|
)
|
7,518
|
|
5,092
|
|
|||
Financing activities - continuing operations
|
(5,351
|
)
|
(3,275
|
)
|
(3,961
|
)
|
|||
Financing activities - discontinued operations
|
(53
|
)
|
(50
|
)
|
(53
|
)
|
|||
Financing activities
|
(5,404
|
)
|
(3,325
|
)
|
(4,014
|
)
|
|||
Effect of exchange rate changes on cash, cash equivalents and restricted cash
|
(99
|
)
|
320
|
|
(77
|
)
|
|||
Summary
|
|
|
|
||||||
Decrease in cash, cash equivalents and restricted cash
|
(3,444
|
)
|
(416
|
)
|
(1,956
|
)
|
|||
Cash, cash equivalents and restricted cash at beginning of year
|
6,208
|
|
6,624
|
|
8,580
|
|
|||
Cash, cash equivalents and restricted cash at end of year
|
$
|
2,764
|
|
$
|
6,208
|
|
$
|
6,624
|
|
Less: Restricted cash and cash equivalents, included in "Other current assets"
|
40
|
|
19
|
|
17
|
|
|||
Cash and cash equivalents at end of year
|
$
|
2,724
|
|
$
|
6,189
|
|
$
|
6,607
|
|
1.
|
Updated for ASU 2016-15, "Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments" ("ASU 2016-15") (including related SEC interpretive guidance) and ASU 2016-18, "Statement of Cash Flows (Topic 230): Restricted Cash." See Note
2
to the Consolidated Financial Statements for additional information.
|
Net Working Capital at Dec 31
|
2018
|
2017
|
||||
In millions
|
||||||
Current assets
1
|
$
|
19,470
|
|
$
|
22,342
|
|
Current liabilities
1
|
11,059
|
|
11,572
|
|
||
Net working capital
|
$
|
8,411
|
|
$
|
10,770
|
|
Current ratio
|
1.76:1
|
|
1.93:1
|
|
||
Days sales outstanding in receivables
2
|
41
|
|
35
|
|
||
Days sales in inventory
|
58
|
|
54
|
|
||
Days payables outstanding
|
58
|
|
56
|
|
1.
|
Amounts exclude assets and liabilities of discontinued operations.
|
2.
|
Days sales outstanding in receivables (“DSO”) increased by six days in 2018 compared with 2017, primarily due to an increase in accounts receivable as a result of the Company’s accounts receivable securitization facilities moving from off-balance sheet arrangements in 2017 to secured borrowing arrangements in 2018. By including the receivables related to the Company’s off-balance sheet accounts receivable securitization facilities, DSO improved by three days in 2018 compared with 2017.
|
Reconciliation of Non-GAAP Measures
|
2018
|
2017
|
2016
|
||||||
In millions
|
|||||||||
Cash provided by (used for) operating activities - continuing operations (GAAP)
|
$
|
3,096
|
|
$
|
(6,443
|
)
|
$
|
(3,882
|
)
|
Impact of ASU 2016-15 and related interpretive guidance
|
657
|
|
9,462
|
|
8,551
|
|
|||
Cash flows from operating activities - continuing operations - excluding impact of ASU 2016-15 (Non-GAAP)
|
$
|
3,753
|
|
$
|
3,019
|
|
$
|
4,669
|
|
Capital expenditures
|
(2,091
|
)
|
(2,807
|
)
|
(3,489
|
)
|
|||
Free cash flow (Non-GAAP)
|
$
|
1,662
|
|
$
|
212
|
|
$
|
1,180
|
|
Total Debt at Dec 31
|
|
|
||||
In millions
|
2018
|
2017
|
||||
Notes payable
|
$
|
298
|
|
$
|
481
|
|
Long-term debt due within one year
|
338
|
|
748
|
|
||
Long-term debt
|
19,253
|
|
19,757
|
|
||
Gross debt
|
$
|
19,889
|
|
$
|
20,986
|
|
- Cash and cash equivalents
|
$
|
2,724
|
|
$
|
6,189
|
|
- Marketable securities
|
100
|
|
4
|
|
||
Net debt
|
$
|
17,065
|
|
$
|
14,793
|
|
Gross debt as a percent of total capitalization
|
37.2
|
%
|
39.1
|
%
|
||
Net debt as a percent of total capitalization
|
33.7
|
%
|
31.1
|
%
|
Credit Ratings
|
Long-Term Rating
|
Short-Term Rating
|
Outlook
|
Standard & Poor’s
|
BBB
|
A-2
|
Stable
|
Moody’s Investors Service
|
Baa2
|
P-2
|
Stable
|
Fitch Ratings
|
BBB+
|
F2
|
Stable
|
Dividends Paid for the Years Ended Dec 31
|
2017
|
2016
|
||||
In millions, except per share amounts
|
||||||
Dividends paid, per common share
|
$
|
1.84
|
|
$
|
1.84
|
|
Dividends paid to common stockholders
|
$
|
2,179
|
|
$
|
2,037
|
|
Dividends paid to preferred shareholders
1
|
$
|
—
|
|
$
|
425
|
|
1.
|
Dividends paid to preferred shareholders in 2016 includes payment of the fourth quarter 2016 declared dividend.
|
Contractual Obligations at Dec 31, 2018
|
Payments Due In
|
|
|||||||||||||
In millions
|
2019
|
2020-2021
|
2022-2023
|
2024 and beyond
|
Total
|
||||||||||
Long-term debt obligations
1
|
$
|
338
|
|
$
|
8,079
|
|
$
|
1,989
|
|
$
|
9,519
|
|
$
|
19,925
|
|
Expected cash requirements for interest
2
|
948
|
|
1,779
|
|
1,172
|
|
6,915
|
|
10,814
|
|
|||||
Pension and other postretirement benefits
|
388
|
|
804
|
|
2,562
|
|
5,469
|
|
9,223
|
|
|||||
Operating leases
|
366
|
|
625
|
|
496
|
|
855
|
|
2,342
|
|
|||||
Purchase obligations
3
|
3,054
|
|
4,618
|
|
3,764
|
|
6,471
|
|
17,907
|
|
|||||
Other noncurrent obligations
4
|
—
|
|
877
|
|
599
|
|
1,242
|
|
2,718
|
|
|||||
Total
|
$
|
5,094
|
|
$
|
16,782
|
|
$
|
10,582
|
|
$
|
30,471
|
|
$
|
62,929
|
|
1.
|
Excludes unamortized debt discount and issuance costs of
$334 million
. Includes capital lease obligations of
$371 million
. Assumes the option to extend the Dow Silicones Term Loan facility will be exercised.
|
2.
|
Cash requirements for interest on long-term debt was calculated using current interest rates at
December 31, 2018
, and includes $4,913 million of various floating rate notes.
|
3.
|
Includes outstanding purchase orders and other commitments greater than $1 million obtained through a survey conducted within the Company.
|
4.
|
Includes liabilities related to asbestos litigation, environmental remediation, legal settlements and other noncurrent liabilities. The table excludes uncertain tax positions due to uncertainties in the timing of the effective settlement of tax positions with the respective taxing authorities and deferred tax liabilities as it is impractical to determine whether there will be a cash impact related to these liabilities. The table also excludes deferred revenue as it does not represent future cash requirements arising from contractual payment obligations.
|
•
|
Conserve - aggressively pursue energy efficiency and conservation
|
•
|
Optimize - increase and diversify energy resources
|
•
|
Accelerate - develop cost-effective, clean, renewable and alternative energy sources
|
•
|
Transition - to a sustainable energy future
|
Environmental Sites
|
Dow-owned Sites
1
|
Superfund Sites
2
|
||||||
|
2018
|
2017
|
2018
|
2017
|
||||
Number of sites at Jan 1
|
181
|
|
179
|
|
131
|
|
131
|
|
Sites added during year
|
3
|
|
7
|
|
2
|
|
2
|
|
Sites closed during year
|
(6
|
)
|
(5
|
)
|
(2
|
)
|
(2
|
)
|
Number of sites at Dec 31
|
178
|
|
181
|
|
131
|
|
131
|
|
1.
|
Dow-owned sites are sites currently or formerly owned by the Company. In the United States, remediation obligations are imposed by the Resource Conservation and Recovery Act or analogous state law. At
December 31, 2018
,
32
of these sites (
35
sites at
December 31, 2017
) were formerly owned by Dowell Schlumberger, Inc., a group of companies in which the Company previously owned a 50 percent interest. The Company sold its interest in Dowell Schlumberger in 1992.
|
2.
|
Superfund sites are sites, including sites not owned by the Company where remediation obligations are imposed by Superfund Law.
|
Asbestos-Related Claim Activity
|
2018
|
2017
|
2016
|
|||
Claims unresolved at Jan 1
|
15,427
|
|
16,141
|
|
18,778
|
|
Claims filed
|
6,599
|
|
7,010
|
|
7,813
|
|
Claims settled, dismissed or otherwise resolved
|
(9,246
|
)
|
(7,724
|
)
|
(10,450
|
)
|
Claims unresolved at Dec 31
|
12,780
|
|
15,427
|
|
16,141
|
|
Claimants with claims against both Union Carbide and Amchem
|
(4,675
|
)
|
(5,530
|
)
|
(5,741
|
)
|
Individual claimants at Dec 31
|
8,105
|
|
9,897
|
|
10,400
|
|
Total Daily VAR by Exposure Type at Dec 31
|
2018
|
2017
|
||||||||||
In millions
|
Year-end
|
Average
|
Year-end
|
Average
|
||||||||
Commodities
|
$
|
26
|
|
$
|
30
|
|
$
|
32
|
|
$
|
34
|
|
Equity securities
|
12
|
|
7
|
|
4
|
|
9
|
|
||||
Foreign exchange
|
26
|
|
28
|
|
26
|
|
38
|
|
||||
Interest rate
|
81
|
|
80
|
|
69
|
|
76
|
|
||||
Composite
|
$
|
145
|
|
$
|
145
|
|
$
|
131
|
|
$
|
157
|
|
/s/ DELOITTE & TOUCHE LLP
|
/s/ DELOITTE & TOUCHE LLP
|
(In millions, except per share amounts) For the years ended Dec 31,
|
2018
|
2017
|
2016
|
||||||
Net sales
|
$
|
49,604
|
|
$
|
43,730
|
|
$
|
36,264
|
|
Cost of sales
|
41,074
|
|
36,350
|
|
30,053
|
|
|||
Research and development expenses
|
800
|
|
803
|
|
746
|
|
|||
Selling, general and administrative expenses
|
1,782
|
|
1,795
|
|
1,800
|
|
|||
Amortization of intangibles
|
469
|
|
400
|
|
316
|
|
|||
Restructuring, goodwill impairment and asset related charges - net
|
221
|
|
2,739
|
|
579
|
|
|||
Integration and separation costs
|
1,179
|
|
798
|
|
349
|
|
|||
Asbestos-related charge
|
—
|
|
—
|
|
1,113
|
|
|||
Equity in earnings of nonconsolidated affiliates
|
555
|
|
394
|
|
187
|
|
|||
Sundry income (expense) - net
|
96
|
|
(154
|
)
|
517
|
|
|||
Interest income
|
82
|
|
66
|
|
75
|
|
|||
Interest expense and amortization of debt discount
|
1,063
|
|
914
|
|
827
|
|
|||
Income from continuing operations before income taxes
|
3,749
|
|
237
|
|
1,260
|
|
|||
Provision (credit) for income taxes on continuing operations
|
809
|
|
1,524
|
|
(218
|
)
|
|||
Income (loss) from continuing operations, net of tax
|
2,940
|
|
(1,287
|
)
|
1,478
|
|
|||
Income from discontinued operations, net of tax
|
1,835
|
|
1,882
|
|
2,926
|
|
|||
Net income
|
4,775
|
|
595
|
|
4,404
|
|
|||
Net income attributable to noncontrolling interests
|
134
|
|
130
|
|
86
|
|
|||
Net income attributable to Dow Inc.
|
4,641
|
|
465
|
|
4,318
|
|
|||
Preferred stock dividends
|
—
|
|
—
|
|
340
|
|
|||
Net income available for Dow Inc. common stockholders
|
$
|
4,641
|
|
$
|
465
|
|
$
|
3,978
|
|
|
|
|
|
||||||
|
|
|
|
||||||
Per common share data:
|
|
|
|
||||||
Earnings (loss) per common share from continuing operations - basic
|
$
|
3.80
|
|
$
|
(1.88
|
)
|
$
|
1.57
|
|
Earnings per common share from discontinued operations - basic
|
2.41
|
|
2.48
|
|
4.23
|
|
|||
Earnings per common share - basic
|
$
|
6.21
|
|
$
|
0.60
|
|
$
|
5.80
|
|
Earnings (loss) per common share from continuing operations - diluted
|
$
|
3.80
|
|
$
|
(1.88
|
)
|
$
|
1.55
|
|
Earnings per common share from discontinued operations - diluted
|
2.41
|
|
2.48
|
|
4.18
|
|
|||
Earnings per common share - diluted
|
$
|
6.21
|
|
$
|
0.60
|
|
$
|
5.73
|
|
|
|
|
|
||||||
Weighted-average common shares outstanding - basic
|
747.2
|
|
744.8
|
|
681.6
|
|
|||
Weighted-average common shares outstanding - diluted
|
747.2
|
|
744.8
|
|
690.9
|
|
(In millions) For the years ended Dec 31,
|
2018
|
2017
|
2016
|
||||||
Net income
|
$
|
4,775
|
|
$
|
595
|
|
$
|
4,404
|
|
Other comprehensive income (loss), net of tax
|
|
|
|
||||||
Unrealized losses on investments
|
(67
|
)
|
(46
|
)
|
(4
|
)
|
|||
Cumulative translation adjustments
|
(225
|
)
|
900
|
|
(644
|
)
|
|||
Pension and other postretirement benefit plans
|
(40
|
)
|
391
|
|
(620
|
)
|
|||
Derivative instruments
|
75
|
|
(14
|
)
|
113
|
|
|||
Total other comprehensive income (loss)
|
(257
|
)
|
1,231
|
|
(1,155
|
)
|
|||
Comprehensive income
|
4,518
|
|
1,826
|
|
3,249
|
|
|||
Comprehensive income attributable to noncontrolling interests, net of tax
|
97
|
|
172
|
|
83
|
|
|||
Comprehensive income attributable to Dow Inc.
|
$
|
4,421
|
|
$
|
1,654
|
|
$
|
3,166
|
|
(In millions, except share amounts) At Dec 31,
|
2018
|
2017
|
||||
Assets
|
|
|
||||
Current Assets
|
|
|
||||
Cash and cash equivalents (variable interest entities restricted - 2018: $71; 2017: $86)
|
$
|
2,724
|
|
$
|
6,189
|
|
Marketable securities
|
100
|
|
4
|
|
||
Accounts and notes receivable:
|
|
|
||||
Trade (net of allowance for doubtful receivables - 2018: $42; 2017: $59)
|
5,646
|
|
5,386
|
|
||
Other
|
3,389
|
|
4,208
|
|
||
Inventories
|
6,899
|
|
6,045
|
|
||
Other current assets
|
712
|
|
510
|
|
||
Assets of discontinued operations - current
|
19,900
|
|
5,549
|
|
||
Total current assets
|
39,370
|
|
27,891
|
|
||
Investments
|
|
|
||||
Investment in nonconsolidated affiliates
|
3,320
|
|
3,107
|
|
||
Other investments (investments carried at fair value - 2018: $1,699; 2017: $1,512)
|
2,646
|
|
2,507
|
|
||
Noncurrent receivables
|
360
|
|
543
|
|
||
Total investments
|
6,326
|
|
6,157
|
|
||
Property
|
|
|
||||
Property
|
53,984
|
|
52,809
|
|
||
Less accumulated depreciation
|
32,566
|
|
31,225
|
|
||
Net property (variable interest entities restricted - 2018: $683; 2017: $855)
|
21,418
|
|
21,584
|
|
||
Other Assets
|
|
|
||||
Goodwill
|
9,846
|
|
9,833
|
|
||
Other intangible assets (net of accumulated amortization - 2018: $3,379; 2017: $2,842)
|
4,225
|
|
4,729
|
|
||
Deferred income tax assets
|
1,779
|
|
1,114
|
|
||
Deferred charges and other assets
|
735
|
|
814
|
|
||
Assets of discontinued operations - noncurrent
|
—
|
|
13,730
|
|
||
Total other assets
|
16,585
|
|
30,220
|
|
||
Total Assets
|
$
|
83,699
|
|
$
|
85,852
|
|
Liabilities and Equity
|
|
|
||||
Current Liabilities
|
|
|
||||
Notes payable
|
$
|
298
|
|
$
|
481
|
|
Long-term debt due within one year
|
338
|
|
748
|
|
||
Accounts payable:
|
|
|
||||
Trade
|
4,456
|
|
4,004
|
|
||
Other
|
2,479
|
|
2,463
|
|
||
Income taxes payable
|
557
|
|
487
|
|
||
Accrued and other current liabilities
|
2,931
|
|
3,389
|
|
||
Liabilities of discontinued operations - current
|
4,488
|
|
3,008
|
|
||
Total current liabilities
|
15,547
|
|
14,580
|
|
||
Long-Term Debt (variable interest entities nonrecourse - 2018: $75; 2017: $249)
|
19,253
|
|
19,757
|
|
||
Other Noncurrent Liabilities
|
|
|
||||
Deferred income tax liabilities
|
501
|
|
27
|
|
||
Pension and other postretirement benefits - noncurrent
|
8,926
|
|
10,494
|
|
||
Asbestos-related liabilities - noncurrent
|
1,142
|
|
1,237
|
|
||
Other noncurrent obligations
|
4,709
|
|
5,193
|
|
||
Liabilities of discontinued operations - noncurrent
|
—
|
|
1,863
|
|
||
Total other noncurrent liabilities
|
15,278
|
|
18,814
|
|
||
Stockholders’ Equity
|
|
|
||||
Common stock (authorized and issued 100 shares of $0.01 par value each)
|
—
|
|
—
|
|
||
Additional paid-in capital
|
7,042
|
|
6,553
|
|
||
Retained earnings
|
35,460
|
|
33,742
|
|
||
Accumulated other comprehensive loss
|
(9,885
|
)
|
(8,591
|
)
|
||
Unearned ESOP shares
|
(134
|
)
|
(189
|
)
|
||
Dow Inc.’s stockholders’ equity
|
32,483
|
|
31,515
|
|
||
Noncontrolling interests
|
1,138
|
|
1,186
|
|
||
Total equity
|
33,621
|
|
32,701
|
|
||
Total Liabilities and Equity
|
$
|
83,699
|
|
$
|
85,852
|
|
(In millions)
For the years ended Dec 31,
|
2018
|
2017
|
2016
|
||||||
Operating Activities
|
|
|
|
||||||
Net income
|
$
|
4,775
|
|
$
|
595
|
|
$
|
4,404
|
|
Less: Income (loss) from discontinued operations, net of tax
|
1,835
|
|
1,882
|
|
2,926
|
|
|||
Income from continuing operations, net of tax
|
2,940
|
|
(1,287
|
)
|
1,478
|
|
|||
Adjustments to reconcile net income to net cash provided by (used for) operating activities:
|
|
|
|
||||||
Depreciation and amortization
|
2,909
|
|
2,546
|
|
2,225
|
|
|||
Provision (credit) for deferred income tax
|
(429
|
)
|
1,413
|
|
(1,009
|
)
|
|||
Earnings of nonconsolidated affiliates less than dividends received
|
108
|
|
253
|
|
425
|
|
|||
Net periodic pension benefit cost
|
279
|
|
1,032
|
|
292
|
|
|||
Pension contributions
|
(1,651
|
)
|
(1,672
|
)
|
(624
|
)
|
|||
Net gain on sales of assets, businesses and investments
|
(38
|
)
|
(419
|
)
|
(196
|
)
|
|||
Net (gain) loss on step acquisition of nonconsolidated affiliate
|
20
|
|
—
|
|
(1,617
|
)
|
|||
Restructuring, goodwill impairment and asset related charges - net
|
221
|
|
2,739
|
|
579
|
|
|||
Amortization of Merger-related inventory step-up
|
2
|
|
120
|
|
—
|
|
|||
Asbestos-related charge
|
—
|
|
—
|
|
1,113
|
|
|||
Other net loss
|
393
|
|
331
|
|
324
|
|
|||
Changes in assets and liabilities, net of effects of acquired and divested companies:
|
|
|
|
|
|
|
|||
Accounts and notes receivable
|
(855
|
)
|
(11,431
|
)
|
(8,764
|
)
|
|||
Inventories
|
(859
|
)
|
(891
|
)
|
380
|
|
|||
Accounts payable
|
787
|
|
1,081
|
|
547
|
|
|||
Other assets and liabilities, net
|
(731
|
)
|
(258
|
)
|
965
|
|
|||
Cash provided by (used for) operating activities - continuing operations
|
3,096
|
|
(6,443
|
)
|
(3,882
|
)
|
|||
Cash provided by operating activities - discontinued operations
|
1,158
|
|
1,514
|
|
925
|
|
|||
Cash provided by (used for) operating activities
|
4,254
|
|
(4,929
|
)
|
(2,957
|
)
|
|||
Investing Activities
|
|
|
|
||||||
Capital expenditures
|
(2,091
|
)
|
(2,807
|
)
|
(3,489
|
)
|
|||
Investment in gas field developments
|
(114
|
)
|
(121
|
)
|
(113
|
)
|
|||
Purchases of previously leased assets
|
(26
|
)
|
(187
|
)
|
—
|
|
|||
Proceeds from sales of property and businesses, net of cash divested
|
47
|
|
522
|
|
235
|
|
|||
Acquisitions of property and businesses, net of cash acquired
|
(20
|
)
|
47
|
|
(163
|
)
|
|||
Cash acquired in step acquisition of nonconsolidated affiliate
|
—
|
|
—
|
|
1,070
|
|
|||
Investments in and loans to nonconsolidated affiliates
|
(18
|
)
|
(749
|
)
|
(1,020
|
)
|
|||
Distributions and loan repayments from nonconsolidated affiliates
|
55
|
|
69
|
|
98
|
|
|||
Purchases of investments
|
(1,530
|
)
|
(642
|
)
|
(577
|
)
|
|||
Proceeds from sales and maturities of investments
|
1,214
|
|
1,165
|
|
733
|
|
|||
Proceeds from interests in trade accounts receivable conduits
|
657
|
|
9,462
|
|
8,551
|
|
|||
Other investing activities, net
|
—
|
|
34
|
|
46
|
|
|||
Cash provided by (used for) investing activities - continuing operations
|
(1,826
|
)
|
6,793
|
|
5,371
|
|
|||
Cash provided by (used for) investing activities - discontinued operations
|
(369
|
)
|
725
|
|
(279
|
)
|
|||
Cash provided by (used for) investing activities
|
(2,195
|
)
|
7,518
|
|
5,092
|
|
|||
Financing Activities
|
|
|
|
|
|
|
|||
Transfer of business under common control
|
(240
|
)
|
6
|
|
—
|
|
|||
Changes in short-term notes payable
|
(178
|
)
|
268
|
|
(19
|
)
|
|||
Proceeds from issuance of long-term debt
|
1,999
|
|
—
|
|
30
|
|
|||
Payments on long-term debt
|
(3,054
|
)
|
(617
|
)
|
(584
|
)
|
|||
Purchases of treasury stock
|
—
|
|
—
|
|
(916
|
)
|
|||
Proceeds from issuance of parent company stock
|
112
|
|
66
|
|
—
|
|
|||
Proceeds from sales of common stock
|
—
|
|
423
|
|
398
|
|
|||
Employee taxes paid for share-based payment arrangements
|
(77
|
)
|
(81
|
)
|
(58
|
)
|
|||
Distributions to noncontrolling interests
|
(135
|
)
|
(101
|
)
|
(146
|
)
|
|||
Purchases of noncontrolling interests
|
—
|
|
—
|
|
(202
|
)
|
|||
Dividends paid to stockholders
|
—
|
|
(2,179
|
)
|
(2,462
|
)
|
|||
Dividends paid to DowDuPont Inc.
|
(3,711
|
)
|
(1,056
|
)
|
—
|
|
|||
Other financing activities, net
|
(67
|
)
|
(4
|
)
|
(2
|
)
|
|||
Cash used for financing activities - continuing operations
|
(5,351
|
)
|
(3,275
|
)
|
(3,961
|
)
|
|||
Cash used for financing activities - discontinued operations
|
(53
|
)
|
(50
|
)
|
(53
|
)
|
|||
Cash used for financing activities
|
(5,404
|
)
|
(3,325
|
)
|
(4,014
|
)
|
|||
Effect of exchange rate changes on cash, cash equivalents and restricted cash
|
(99
|
)
|
320
|
|
(77
|
)
|
|||
Summary
|
|
|
|
|
|
|
|||
Decrease in cash, cash equivalents and restricted cash
|
(3,444
|
)
|
(416
|
)
|
(1,956
|
)
|
|||
Cash, cash equivalents and restricted cash at beginning of year
|
6,208
|
|
6,624
|
|
8,580
|
|
|||
Cash, cash equivalents and restricted cash at end of year
|
$
|
2,764
|
|
$
|
6,208
|
|
$
|
6,624
|
|
Less: Restricted cash and cash equivalents, included in "Other current assets"
|
40
|
|
19
|
|
17
|
|
|||
Cash and cash equivalents at end of year
|
$
|
2,724
|
|
$
|
6,189
|
|
$
|
6,607
|
|
(In millions, except per share amounts) For the years ended Dec 31,
|
2018
|
2017
|
2016
|
||||||
Preferred Stock
|
|
|
|
||||||
Balance at beginning of year
|
$
|
—
|
|
$
|
—
|
|
$
|
4,000
|
|
Preferred stock converted to common stock
|
—
|
|
—
|
|
(4,000
|
)
|
|||
Balance at end of year
|
—
|
|
—
|
|
—
|
|
|||
Common Stock
|
|
|
|
||||||
Balance at beginning of year
|
—
|
|
3,107
|
|
3,107
|
|
|||
Merger impact
|
—
|
|
(3,107
|
)
|
—
|
|
|||
Balance at end of year
|
—
|
|
—
|
|
3,107
|
|
|||
Additional Paid-in Capital
|
|
|
|
||||||
Balance at beginning of year
|
6,553
|
|
4,262
|
|
4,936
|
|
|||
Common stock issued / sold
|
—
|
|
423
|
|
398
|
|
|||
Issuance of parent company stock - DowDuPont Inc.
|
112
|
|
66
|
|
—
|
|
|||
Stock-based compensation and allocation of ESOP shares
|
377
|
|
(368
|
)
|
(376
|
)
|
|||
Preferred stock converted to common stock
|
—
|
|
—
|
|
(695
|
)
|
|||
Merger impact
|
—
|
|
2,172
|
|
—
|
|
|||
Other
|
—
|
|
(2
|
)
|
(1
|
)
|
|||
Balance at end of year
|
7,042
|
|
6,553
|
|
4,262
|
|
|||
Retained Earnings
|
|
|
|
||||||
Balance at beginning of year
|
33,742
|
|
30,338
|
|
28,425
|
|
|||
Adoption of accounting standards (Note 2)
|
989
|
|
—
|
|
—
|
|
|||
Net income available for Dow Inc. common stockholders
|
4,641
|
|
465
|
|
3,978
|
|
|||
Dividends to stockholders
|
—
|
|
(1,673
|
)
|
(2,037
|
)
|
|||
Dividends to parent - DowDuPont Inc.
|
(3,711
|
)
|
(1,056
|
)
|
—
|
|
|||
Common control transaction
|
(182
|
)
|
5,693
|
|
—
|
|
|||
Other
|
(19
|
)
|
(25
|
)
|
(28
|
)
|
|||
Balance at end of year
|
35,460
|
|
33,742
|
|
30,338
|
|
|||
Accumulated Other Comprehensive Loss
|
|
|
|
||||||
Balance at beginning of year
|
(8,591
|
)
|
(9,822
|
)
|
(8,667
|
)
|
|||
Adoption of accounting standards (Note 2)
|
(1,037
|
)
|
—
|
|
—
|
|
|||
Other comprehensive income (loss)
|
(257
|
)
|
1,231
|
|
(1,155
|
)
|
|||
Balance at end of year
|
(9,885
|
)
|
(8,591
|
)
|
(9,822
|
)
|
|||
Unearned ESOP Shares
|
|
|
|
||||||
Balance at beginning of year
|
(189
|
)
|
(239
|
)
|
(272
|
)
|
|||
Stock-based compensation and allocation of ESOP shares
|
55
|
|
50
|
|
51
|
|
|||
ESOP shares acquired
|
—
|
|
—
|
|
(18
|
)
|
|||
Balance at end of year
|
(134
|
)
|
(189
|
)
|
(239
|
)
|
|||
Treasury Stock
|
|
|
|
||||||
Balance at beginning of year
|
—
|
|
(1,659
|
)
|
(6,155
|
)
|
|||
Common stock issued/sold
|
—
|
|
724
|
|
717
|
|
|||
Treasury stock purchases
|
—
|
|
—
|
|
(916
|
)
|
|||
Preferred stock converted to common stock
|
—
|
|
—
|
|
4,695
|
|
|||
Merger impact
|
—
|
|
935
|
|
—
|
|
|||
Balance at end of year
|
—
|
|
—
|
|
(1,659
|
)
|
|||
Dow Inc.'s Equity
|
32,483
|
|
31,515
|
|
25,987
|
|
|||
Noncontrolling Interests
|
1,138
|
|
1,186
|
|
1,242
|
|
|||
Total Equity
|
$
|
33,621
|
|
$
|
32,701
|
|
$
|
27,229
|
|
(In millions) For the years ended Dec 31,
|
2018
|
2017
|
2016
|
||||||
Net sales
|
$
|
49,604
|
|
$
|
43,730
|
|
$
|
36,264
|
|
Cost of sales
|
41,074
|
|
36,350
|
|
30,053
|
|
|||
Research and development expenses
|
800
|
|
803
|
|
746
|
|
|||
Selling, general and administrative expenses
|
1,782
|
|
1,795
|
|
1,800
|
|
|||
Amortization of intangibles
|
469
|
|
400
|
|
316
|
|
|||
Restructuring, goodwill impairment and asset related charges - net
|
221
|
|
2,739
|
|
579
|
|
|||
Integration and separation costs
|
1,179
|
|
798
|
|
349
|
|
|||
Asbestos-related charge
|
—
|
|
—
|
|
1,113
|
|
|||
Equity in earnings of nonconsolidated affiliates
|
555
|
|
394
|
|
187
|
|
|||
Sundry income (expense) - net
|
96
|
|
(154
|
)
|
517
|
|
|||
Interest income
|
82
|
|
66
|
|
75
|
|
|||
Interest expense and amortization of debt discount
|
1,063
|
|
914
|
|
827
|
|
|||
Income from continuing operations before income taxes
|
3,749
|
|
237
|
|
1,260
|
|
|||
Provision (credit) for income taxes on continuing operations
|
809
|
|
1,524
|
|
(218
|
)
|
|||
Income (loss) from continuing operations, net of tax
|
2,940
|
|
(1,287
|
)
|
1,478
|
|
|||
Income from discontinued operations, net of tax
|
1,835
|
|
1,882
|
|
2,926
|
|
|||
Net income
|
4,775
|
|
595
|
|
4,404
|
|
|||
Net income attributable to noncontrolling interests
|
134
|
|
130
|
|
86
|
|
|||
Net income attributable to The Dow Chemical Company
|
4,641
|
|
465
|
|
4,318
|
|
|||
Preferred stock dividends
|
—
|
|
—
|
|
340
|
|
|||
Net income available for The Dow Chemical Company common stockholder
|
$
|
4,641
|
|
$
|
465
|
|
$
|
3,978
|
|
(In millions) For the years ended Dec 31,
|
2018
|
2017
|
2016
|
||||||
Net income
|
$
|
4,775
|
|
$
|
595
|
|
$
|
4,404
|
|
Other comprehensive income (loss), net of tax
|
|
|
|
||||||
Unrealized losses on investments
|
(67
|
)
|
(46
|
)
|
(4
|
)
|
|||
Cumulative translation adjustments
|
(225
|
)
|
900
|
|
(644
|
)
|
|||
Pension and other postretirement benefit plans
|
(40
|
)
|
391
|
|
(620
|
)
|
|||
Derivative instruments
|
75
|
|
(14
|
)
|
113
|
|
|||
Total other comprehensive income (loss)
|
(257
|
)
|
1,231
|
|
(1,155
|
)
|
|||
Comprehensive income
|
4,518
|
|
1,826
|
|
3,249
|
|
|||
Comprehensive income attributable to noncontrolling interests, net of tax
|
97
|
|
172
|
|
83
|
|
|||
Comprehensive income attributable to The Dow Chemical Company
|
$
|
4,421
|
|
$
|
1,654
|
|
$
|
3,166
|
|
(In millions, except share amounts) At Dec 31,
|
2018
|
2017
|
||||
Assets
|
|
|
||||
Current Assets
|
|
|
||||
Cash and cash equivalents (variable interest entities restricted - 2018: $71; 2017: $86)
|
$
|
2,724
|
|
$
|
6,189
|
|
Marketable securities
|
100
|
|
4
|
|
||
Accounts and notes receivable:
|
|
|
||||
Trade (net of allowance for doubtful receivables - 2018: $42; 2017: $59)
|
5,646
|
|
5,386
|
|
||
Other
|
3,389
|
|
4,208
|
|
||
Inventories
|
6,899
|
|
6,045
|
|
||
Other current assets
|
712
|
|
510
|
|
||
Assets of discontinued operations - current
|
19,900
|
|
5,549
|
|
||
Total current assets
|
39,370
|
|
27,891
|
|
||
Investments
|
|
|
||||
Investment in nonconsolidated affiliates
|
3,320
|
|
3,107
|
|
||
Other investments (investments carried at fair value - 2018: $1,699; 2017: $1,512)
|
2,646
|
|
2,507
|
|
||
Noncurrent receivables
|
360
|
|
543
|
|
||
Total investments
|
6,326
|
|
6,157
|
|
||
Property
|
|
|
||||
Property
|
53,984
|
|
52,809
|
|
||
Less accumulated depreciation
|
32,566
|
|
31,225
|
|
||
Net property (variable interest entities restricted - 2018: $683; 2017: $855)
|
21,418
|
|
21,584
|
|
||
Other Assets
|
|
|
||||
Goodwill
|
9,846
|
|
9,833
|
|
||
Other intangible assets (net of accumulated amortization - 2018: $3,379; 2017: $2,842)
|
4,225
|
|
4,729
|
|
||
Deferred income tax assets
|
1,779
|
|
1,114
|
|
||
Deferred charges and other assets
|
735
|
|
814
|
|
||
Assets of discontinued operations - noncurrent
|
—
|
|
13,730
|
|
||
Total other assets
|
16,585
|
|
30,220
|
|
||
Total Assets
|
$
|
83,699
|
|
$
|
85,852
|
|
Liabilities and Equity
|
|
|
||||
Current Liabilities
|
|
|
||||
Notes payable
|
$
|
298
|
|
$
|
481
|
|
Long-term debt due within one year
|
338
|
|
748
|
|
||
Accounts payable:
|
|
|
||||
Trade
|
4,456
|
|
4,004
|
|
||
Other
|
2,479
|
|
2,463
|
|
||
Income taxes payable
|
557
|
|
487
|
|
||
Accrued and other current liabilities
|
2,931
|
|
3,389
|
|
||
Liabilities of discontinued operations - current
|
4,488
|
|
3,008
|
|
||
Total current liabilities
|
15,547
|
|
14,580
|
|
||
Long-Term Debt (variable interest entities nonrecourse - 2018: $75; 2017: $249)
|
19,253
|
|
19,757
|
|
||
Other Noncurrent Liabilities
|
|
|
||||
Deferred income tax liabilities
|
501
|
|
27
|
|
||
Pension and other postretirement benefits - noncurrent
|
8,926
|
|
10,494
|
|
||
Asbestos-related liabilities - noncurrent
|
1,142
|
|
1,237
|
|
||
Other noncurrent obligations
|
4,709
|
|
5,193
|
|
||
Liabilities of discontinued operations - noncurrent
|
—
|
|
1,863
|
|
||
Total other noncurrent liabilities
|
15,278
|
|
18,814
|
|
||
Stockholders’ Equity
|
|
|
||||
Common stock (authorized and issued 100 shares of $0.01 par value each)
|
—
|
|
—
|
|
||
Additional paid-in capital
|
7,042
|
|
6,553
|
|
||
Retained earnings
|
35,460
|
|
33,742
|
|
||
Accumulated other comprehensive loss
|
(9,885
|
)
|
(8,591
|
)
|
||
Unearned ESOP shares
|
(134
|
)
|
(189
|
)
|
||
The Dow Chemical Company’s stockholders’ equity
|
32,483
|
|
31,515
|
|
||
Noncontrolling interests
|
1,138
|
|
1,186
|
|
||
Total equity
|
33,621
|
|
32,701
|
|
||
Total Liabilities and Equity
|
$
|
83,699
|
|
$
|
85,852
|
|
(In millions)
For the years ended Dec 31,
|
2018
|
2017
|
2016
|
||||||
Operating Activities
|
|
|
|
||||||
Net income
|
$
|
4,775
|
|
$
|
595
|
|
$
|
4,404
|
|
Less: Income (loss) from discontinued operations, net of tax
|
1,835
|
|
1,882
|
|
2,926
|
|
|||
Income from continuing operations, net of tax
|
2,940
|
|
(1,287
|
)
|
1,478
|
|
|||
Adjustments to reconcile net income to net cash provided by (used for) operating activities:
|
|
|
|
||||||
Depreciation and amortization
|
2,909
|
|
2,546
|
|
2,225
|
|
|||
Provision (credit) for deferred income tax
|
(429
|
)
|
1,413
|
|
(1,009
|
)
|
|||
Earnings of nonconsolidated affiliates less than dividends received
|
108
|
|
253
|
|
425
|
|
|||
Net periodic pension benefit cost
|
279
|
|
1,032
|
|
292
|
|
|||
Pension contributions
|
(1,651
|
)
|
(1,672
|
)
|
(624
|
)
|
|||
Net gain on sales of assets, businesses and investments
|
(38
|
)
|
(419
|
)
|
(196
|
)
|
|||
Net (gain) loss on step acquisition of nonconsolidated affiliate
|
20
|
|
—
|
|
(1,617
|
)
|
|||
Restructuring, goodwill impairment and asset related charges - net
|
221
|
|
2,739
|
|
579
|
|
|||
Amortization of Merger-related inventory step-up
|
2
|
|
120
|
|
—
|
|
|||
Asbestos-related charge
|
—
|
|
—
|
|
1,113
|
|
|||
Other net loss
|
393
|
|
331
|
|
324
|
|
|||
Changes in assets and liabilities, net of effects of acquired and divested companies:
|
|
|
|
|
|
|
|||
Accounts and notes receivable
|
(855
|
)
|
(11,431
|
)
|
(8,764
|
)
|
|||
Inventories
|
(859
|
)
|
(891
|
)
|
380
|
|
|||
Accounts payable
|
787
|
|
1,081
|
|
547
|
|
|||
Other assets and liabilities, net
|
(731
|
)
|
(258
|
)
|
965
|
|
|||
Cash provided by (used for) operating activities - continuing operations
|
3,096
|
|
(6,443
|
)
|
(3,882
|
)
|
|||
Cash provided by operating activities - discontinued operations
|
1,158
|
|
1,514
|
|
925
|
|
|||
Cash provided by (used for) operating activities
|
4,254
|
|
(4,929
|
)
|
(2,957
|
)
|
|||
Investing Activities
|
|
|
|
|
|
|
|||
Capital expenditures
|
(2,091
|
)
|
(2,807
|
)
|
(3,489
|
)
|
|||
Investment in gas field developments
|
(114
|
)
|
(121
|
)
|
(113
|
)
|
|||
Purchases of previously leased assets
|
(26
|
)
|
(187
|
)
|
—
|
|
|||
Proceeds from sales of property and businesses, net of cash divested
|
47
|
|
522
|
|
235
|
|
|||
Acquisitions of property and businesses, net of cash acquired
|
(20
|
)
|
47
|
|
(163
|
)
|
|||
Cash acquired in step acquisition of nonconsolidated affiliate
|
—
|
|
—
|
|
1,070
|
|
|||
Investments in and loans to nonconsolidated affiliates
|
(18
|
)
|
(749
|
)
|
(1,020
|
)
|
|||
Distributions and loan repayments from nonconsolidated affiliates
|
55
|
|
69
|
|
98
|
|
|||
Purchases of investments
|
(1,530
|
)
|
(642
|
)
|
(577
|
)
|
|||
Proceeds from sales and maturities of investments
|
1,214
|
|
1,165
|
|
733
|
|
|||
Proceeds from interests in trade accounts receivable conduits
|
657
|
|
9,462
|
|
8,551
|
|
|||
Other investing activities, net
|
—
|
|
34
|
|
46
|
|
|||
Cash provided by (used for) investing activities - continuing operations
|
(1,826
|
)
|
6,793
|
|
5,371
|
|
|||
Cash provided by (used for) investing activities - discontinued operations
|
(369
|
)
|
725
|
|
(279
|
)
|
|||
Cash provided by (used for) investing activities
|
(2,195
|
)
|
7,518
|
|
5,092
|
|
|||
Financing Activities
|
|
|
|
|
|
|
|||
Transfer of business under common control
|
(240
|
)
|
6
|
|
—
|
|
|||
Changes in short-term notes payable
|
(178
|
)
|
268
|
|
(19
|
)
|
|||
Proceeds from issuance of long-term debt
|
1,999
|
|
—
|
|
30
|
|
|||
Payments on long-term debt
|
(3,054
|
)
|
(617
|
)
|
(584
|
)
|
|||
Purchases of treasury stock
|
—
|
|
—
|
|
(916
|
)
|
|||
Proceeds from issuance of parent company stock
|
112
|
|
66
|
|
—
|
|
|||
Proceeds from sales of common stock
|
—
|
|
423
|
|
398
|
|
|||
Employee taxes paid for share-based payment arrangements
|
(77
|
)
|
(81
|
)
|
(58
|
)
|
|||
Distributions to noncontrolling interests
|
(135
|
)
|
(101
|
)
|
(146
|
)
|
|||
Purchases of noncontrolling interests
|
—
|
|
—
|
|
(202
|
)
|
|||
Dividends paid to stockholders
|
—
|
|
(2,179
|
)
|
(2,462
|
)
|
|||
Dividends paid to DowDuPont Inc.
|
(3,711
|
)
|
(1,056
|
)
|
—
|
|
|||
Other financing activities, net
|
(67
|
)
|
(4
|
)
|
(2
|
)
|
|||
Cash used for financing activities - continuing operations
|
(5,351
|
)
|
(3,275
|
)
|
(3,961
|
)
|
|||
Cash used for financing activities - discontinued operations
|
(53
|
)
|
(50
|
)
|
(53
|
)
|
|||
Cash used for financing activities
|
(5,404
|
)
|
(3,325
|
)
|
(4,014
|
)
|
|||
Effect of exchange rate changes on cash, cash equivalents and restricted cash
|
(99
|
)
|
320
|
|
(77
|
)
|
|||
Summary
|
|
|
|
|
|
|
|||
Decrease in cash, cash equivalents and restricted cash
|
(3,444
|
)
|
(416
|
)
|
(1,956
|
)
|
|||
Cash, cash equivalents and restricted cash at beginning of year
|
6,208
|
|
6,624
|
|
8,580
|
|
|||
Cash, cash equivalents and restricted cash at end of year
|
$
|
2,764
|
|
$
|
6,208
|
|
$
|
6,624
|
|
Less: Restricted cash and cash equivalents, included in "Other current assets"
|
40
|
|
19
|
|
17
|
|
|||
Cash and cash equivalents at end of year
|
$
|
2,724
|
|
$
|
6,189
|
|
$
|
6,607
|
|
(In millions, except per share amounts) For the years ended Dec 31,
|
2018
|
2017
|
2016
|
||||||
Preferred Stock
|
|
|
|
||||||
Balance at beginning of year
|
$
|
—
|
|
$
|
—
|
|
$
|
4,000
|
|
Preferred stock converted to common stock
|
—
|
|
—
|
|
(4,000
|
)
|
|||
Balance at end of year
|
—
|
|
—
|
|
—
|
|
|||
Common Stock
|
|
|
|
||||||
Balance at beginning of year
|
—
|
|
3,107
|
|
3,107
|
|
|||
Merger impact
|
—
|
|
(3,107
|
)
|
—
|
|
|||
Balance at end of year
|
—
|
|
—
|
|
3,107
|
|
|||
Additional Paid-in Capital
|
|
|
|
||||||
Balance at beginning of year
|
6,553
|
|
4,262
|
|
4,936
|
|
|||
Common stock issued / sold
|
—
|
|
423
|
|
398
|
|
|||
Issuance of parent company stock - DowDuPont Inc.
|
112
|
|
66
|
|
—
|
|
|||
Stock-based compensation and allocation of ESOP shares
|
377
|
|
(368
|
)
|
(376
|
)
|
|||
Preferred stock converted to common stock
|
—
|
|
—
|
|
(695
|
)
|
|||
Merger impact
|
—
|
|
2,172
|
|
—
|
|
|||
Other
|
—
|
|
(2
|
)
|
(1
|
)
|
|||
Balance at end of year
|
7,042
|
|
6,553
|
|
4,262
|
|
|||
Retained Earnings
|
|
|
|
||||||
Balance at beginning of year
|
33,742
|
|
30,338
|
|
28,425
|
|
|||
Adoption of accounting standards (Note 2)
|
989
|
|
—
|
|
—
|
|
|||
Net income available for The Dow Chemical Company's common stockholder
|
4,641
|
|
465
|
|
3,978
|
|
|||
Dividends to stockholders
|
—
|
|
(1,673
|
)
|
(2,037
|
)
|
|||
Dividends to parent - DowDuPont Inc.
|
(3,711
|
)
|
(1,056
|
)
|
—
|
|
|||
Common control transaction
|
(182
|
)
|
5,693
|
|
—
|
|
|||
Other
|
(19
|
)
|
(25
|
)
|
(28
|
)
|
|||
Balance at end of year
|
35,460
|
|
33,742
|
|
30,338
|
|
|||
Accumulated Other Comprehensive Loss
|
|
|
|
||||||
Balance at beginning of year
|
(8,591
|
)
|
(9,822
|
)
|
(8,667
|
)
|
|||
Adoption of accounting standards (Note 2)
|
(1,037
|
)
|
—
|
|
—
|
|
|||
Other comprehensive income (loss)
|
(257
|
)
|
1,231
|
|
(1,155
|
)
|
|||
Balance at end of year
|
(9,885
|
)
|
(8,591
|
)
|
(9,822
|
)
|
|||
Unearned ESOP Shares
|
|
|
|
||||||
Balance at beginning of year
|
(189
|
)
|
(239
|
)
|
(272
|
)
|
|||
Stock-based compensation and allocation of ESOP shares
|
55
|
|
50
|
|
51
|
|
|||
ESOP shares acquired
|
—
|
|
—
|
|
(18
|
)
|
|||
Balance at end of year
|
(134
|
)
|
(189
|
)
|
(239
|
)
|
|||
Treasury Stock
|
|
|
|
||||||
Balance at beginning of year
|
—
|
|
(1,659
|
)
|
(6,155
|
)
|
|||
Common stock issued/sold
|
—
|
|
724
|
|
717
|
|
|||
Treasury stock purchases
|
—
|
|
—
|
|
(916
|
)
|
|||
Preferred stock converted to common stock
|
—
|
|
—
|
|
4,695
|
|
|||
Merger impact
|
—
|
|
935
|
|
—
|
|
|||
Balance at end of year
|
—
|
|
—
|
|
(1,659
|
)
|
|||
The Dow Chemical Company's Equity
|
32,483
|
|
31,515
|
|
25,987
|
|
|||
Noncontrolling Interests
|
1,138
|
|
1,186
|
|
1,242
|
|
|||
Total Equity
|
$
|
33,621
|
|
$
|
32,701
|
|
$
|
27,229
|
|
Note
|
|
Page
|
1
|
||
2
|
||
3
|
||
4
|
||
5
|
||
6
|
||
7
|
||
8
|
||
9
|
||
10
|
||
11
|
||
12
|
||
13
|
||
14
|
||
15
|
||
16
|
||
17
|
||
18
|
||
19
|
||
20
|
||
21
|
||
22
|
||
23
|
||
24
|
||
25
|
||
26
|
||
27
|
||
28
|
•
|
TDCC divested its global Ethylene Acrylic Acid copolymers and ionomers business ("EAA Business") to SK Global Chemical Co., Ltd., on September 1, 2017, as part of a divestiture commitment given to the European Commission ("EC") in connection with the EC's conditional approval of the Merger granted on March 27, 2017. See Note
7
for additional information on this transaction.
|
•
|
DuPont divested its Cereal Broadleaf Herbicides and Chewing Insecticides portfolios as well as its Crop Protection research and development ("R&D") pipeline and organization (excluding seed treatment, nematicides, late-stage R&D programs and certain personnel needed to support marketed products and R&D programs that will remain with DuPont) (collectively, the "DuPont Divested Assets") to FMC Corporation ("FMC") on November 1, 2017, as part of the EC's conditional approval granted on March 27, 2017. Also on November 1, 2017, DuPont completed its acquisition of FMC's Health and Nutrition business, excluding its Omega-3 products.
|
•
|
On May 2, 2017, TDCC and DuPont announced that China's Ministry of Commerce ("MOFCOM") granted conditional regulatory approval for the companies' proposed merger of equals which included commitments already made to the EC including DuPont's divestiture of the DuPont Divested Assets and TDCC's divestiture of the EAA Business. In addition, TDCC and DuPont made commitments related to the supply and distribution in China of certain herbicide and insecticide ingredients and formulations for rice crops for five years after the closing of the Merger.
|
•
|
TDCC divested a select portion of Dow AgroSciences' corn seed business in Brazil to CITIC Agri Fund on November 30, 2017. The divestiture was part of the commitment given to Brazil's Administrative Council for Economic Defense ("CADE") in connection with the CADE's conditional approval of the Merger granted on May 17, 2017, which was incremental to commitments already made to the EC, China and regulatory agencies in other jurisdictions. This divestiture was included in discontinued operations of the Company.
|
•
|
On June 15, 2017, TDCC and DuPont announced that a proposed agreement had been reached with the Antitrust Division of the United States Department of Justice that permitted the companies to proceed with the proposed merger of equals transaction. The proposed agreement was consistent with commitments already made to the EC.
|
ECP Assets Received and Liabilities Assumed on Aug 31, 2017
|
Carrying value
|
||
In millions
|
|||
Cash and cash equivalents
|
$
|
1
|
|
Accounts and notes receivable - Trade
|
169
|
|
|
Accounts and notes receivable - Other
|
32
|
|
|
Inventories
|
529
|
|
|
Other current assets
|
6
|
|
|
Investment in nonconsolidated affiliates
|
116
|
|
|
Net property
|
817
|
|
|
Goodwill
|
3,617
|
|
|
Other intangible assets
|
1,484
|
|
|
Deferred income tax assets
|
9
|
|
|
Total Assets
|
$
|
6,780
|
|
Accounts payable - Trade
|
102
|
|
|
Accounts payable - Other
|
29
|
|
|
Accrued and other current liabilities
|
31
|
|
|
Deferred income tax liabilities
|
683
|
|
|
Pension and other postretirement benefits - noncurrent
|
6
|
|
|
Other noncurrent obligations
|
3
|
|
|
Total Liabilities
|
$
|
854
|
|
Net Assets (impact to "Retained earnings")
|
$
|
5,926
|
|
ECP Results of Operations
|
2018
|
Sep 1 -
Dec 31, 2017
|
||||
In millions
|
||||||
Net sales
|
$
|
1,512
|
|
$
|
558
|
|
Income (loss) from continuing operations before income taxes
1
|
$
|
178
|
|
$
|
(46
|
)
|
1.
|
Includes the amortization of the fair value step-up of inventory recognized in "Cost of Sales" of
$2 million
in 2018 and
$120 million
for the period of September 1, 2017 through December 31, 2017.
|
Results of Operations of AgCo and SpecCo
|
2018
|
2017
|
2016
|
||||||
In millions
|
|||||||||
Net sales
|
$
|
12,187
|
|
$
|
12,337
|
|
$
|
11,894
|
|
Cost of sales
|
7,668
|
|
7,769
|
|
7,615
|
|
|||
Research and development expenses
|
761
|
|
854
|
|
848
|
|
|||
Selling, general and administrative expenses
|
1,108
|
|
1,143
|
|
1,152
|
|
|||
Amortization of intangibles
|
249
|
|
255
|
|
228
|
|
|||
Restructuring and asset related charges - net
|
411
|
|
376
|
|
16
|
|
|||
Integration and separation costs
|
—
|
|
18
|
|
—
|
|
|||
Equity in earnings of nonconsolidated affiliates
|
400
|
|
372
|
|
254
|
|
|||
Sundry income (expense) - net
|
(13
|
)
|
245
|
|
862
|
|
|||
Interest income
|
26
|
|
40
|
|
33
|
|
|||
Interest expense and amortization of debt discount
|
56
|
|
61
|
|
31
|
|
|||
Income from discontinued operations before income taxes
|
$
|
2,347
|
|
$
|
2,518
|
|
$
|
3,153
|
|
Provision for income taxes
|
512
|
|
636
|
|
227
|
|
|||
Income from discontinued operations, net of tax
|
$
|
1,835
|
|
$
|
1,882
|
|
$
|
2,926
|
|
Carrying Values of AgCo and SpecCo
1
|
Dec 31, 2018
|
Dec 31, 2017
|
||||
In millions
|
||||||
Accounts and notes receivable - Trade
|
$
|
2,768
|
|
$
|
2,124
|
|
Accounts and notes receivable - Other
|
773
|
|
545
|
|
||
Inventories
|
2,826
|
|
2,763
|
|
||
Other current assets
|
151
|
|
117
|
|
||
Investment in nonconsolidated affiliates
|
612
|
|
749
|
|
||
Other investments
|
2
|
|
2
|
|
||
Noncurrent receivables
|
35
|
|
54
|
|
||
Net property
|
3,014
|
|
3,043
|
|
||
Goodwill
|
7,590
|
|
7,622
|
|
||
Other intangible assets
|
1,830
|
|
2,075
|
|
||
Deferred income tax assets
|
239
|
|
169
|
|
||
Deferred charges and other assets
|
60
|
|
16
|
|
||
Total assets of discontinued operations
|
$
|
19,900
|
|
$
|
19,279
|
|
Notes payable
|
7
|
|
2
|
|
||
Long-term debt due within one year
|
4
|
|
4
|
|
||
Accounts payable - Trade
|
1,118
|
|
1,477
|
|
||
Accounts payable - Other
|
868
|
|
631
|
|
||
Income taxes payable
|
234
|
|
207
|
|
||
Accrued and other current liabilities
|
716
|
|
687
|
|
||
Long-Term Debt
|
5
|
|
8
|
|
||
Deferred income tax liabilities
|
568
|
|
741
|
|
||
Pension and other postretirement benefits - noncurrent
|
306
|
|
307
|
|
||
Other noncurrent obligations
|
662
|
|
807
|
|
||
Total liabilities of discontinued operations
|
$
|
4,488
|
|
$
|
4,871
|
|
1.
|
Includes assets and liabilities of consolidated variable interest entities related to discontinued operations.
|
Net Trade Sales by Segment and Business
|
2018
|
||
In millions
|
|||
Coatings & Performance Monomers
|
$
|
3,979
|
|
Consumer Solutions
|
5,698
|
|
|
Performance Materials & Coatings
|
$
|
9,677
|
|
Industrial Solutions
|
$
|
4,812
|
|
Polyurethanes & Construction Chemicals
|
10,615
|
|
|
Others
|
20
|
|
|
Industrial Intermediates & Infrastructure
|
$
|
15,447
|
|
Hydrocarbons & Energy
|
$
|
7,587
|
|
Packaging and Specialty Plastics
|
16,608
|
|
|
Packaging & Specialty Plastics
|
$
|
24,195
|
|
Corporate
|
$
|
285
|
|
Total
|
$
|
49,604
|
|
Contract Balances
|
Dec 31, 2018
|
Topic 606 Adjustments Jan 1, 2018
|
Dec 31, 2017
|
||||||
In millions
|
|||||||||
Accounts and notes receivable - Trade
|
$
|
5,646
|
|
$
|
—
|
|
$
|
5,386
|
|
Contract assets - current
1
|
$
|
19
|
|
$
|
1
|
|
$
|
—
|
|
Contract assets - noncurrent
2
|
$
|
1
|
|
$
|
—
|
|
$
|
—
|
|
Contract liabilities - current
3
|
$
|
134
|
|
$
|
21
|
|
$
|
116
|
|
Contract liabilities - noncurrent
4
|
$
|
1,318
|
|
$
|
47
|
|
$
|
1,365
|
|
DowDuPont Synergy Program
|
Severance and Related Benefit Costs
|
Asset Write-downs and Write-offs
|
Costs Associated with Exit and Disposal Activities
|
Total
|
||||||||
In millions
|
||||||||||||
2017 restructuring charges
|
|
|
|
|
||||||||
Performance Materials & Coatings
|
$
|
—
|
|
$
|
9
|
|
$
|
2
|
|
$
|
11
|
|
Industrial Intermediates & Infrastructure
|
—
|
|
12
|
|
—
|
|
12
|
|
||||
Packaging & Specialty Plastics
|
—
|
|
33
|
|
3
|
|
36
|
|
||||
Corporate
|
307
|
|
33
|
|
—
|
|
340
|
|
||||
Total 2017 restructuring charges
|
$
|
307
|
|
$
|
87
|
|
$
|
5
|
|
$
|
399
|
|
Charges against the reserve
|
—
|
|
(87
|
)
|
—
|
|
(87
|
)
|
||||
Cash payments
|
(37
|
)
|
—
|
|
—
|
|
(37
|
)
|
||||
Reserve balance at Dec 31, 2017
|
$
|
270
|
|
$
|
—
|
|
$
|
5
|
|
$
|
275
|
|
2018 restructuring charges
|
|
|
|
|
||||||||
Performance Materials & Coatings
|
$
|
—
|
|
$
|
7
|
|
$
|
—
|
|
$
|
7
|
|
Industrial Intermediates & Infrastructure
|
—
|
|
—
|
|
11
|
|
11
|
|
||||
Packaging & Specialty Plastics
|
—
|
|
10
|
|
3
|
|
13
|
|
||||
Corporate
|
137
|
|
16
|
|
—
|
|
153
|
|
||||
Total 2018 restructuring charges
|
$
|
137
|
|
$
|
33
|
|
$
|
14
|
|
$
|
184
|
|
Charges against the reserve
|
—
|
|
(33
|
)
|
—
|
|
(33
|
)
|
||||
Cash payments
|
(197
|
)
|
—
|
|
(12
|
)
|
(209
|
)
|
||||
Reserve balance at Dec 31, 2018
|
$
|
210
|
|
$
|
—
|
|
$
|
7
|
|
$
|
217
|
|
•
|
The Company recorded a charge of
$22 million
for asset write-downs and write-offs aligned with an energy project, including the write-off of capital projects and other non-manufacturing assets in Packaging & Specialty Plastics.
|
•
|
The Company recorded a charge of
$65 million
for other miscellaneous asset write-downs and write-offs, including the shutdown of several small manufacturing facilities and the write-off of non-manufacturing assets, certain corporate facilities and data centers. The charge related to Performance Materials & Coatings (
$9 million
), Industrial Intermediates & Infrastructure (
$12 million
), Packaging & Specialty Plastics (
$11 million
) and Corporate (
$33 million
). These manufacturing facilities will be shut down primarily by the end of 2019.
|
•
|
The Company recorded a charge of
$33 million
for other miscellaneous asset write-downs and write-offs, including the shutdown of several small manufacturing facilities and the write-off of non-manufacturing assets and certain corporate facilities. The charge related to Performance Materials & Coatings (
$7 million
), Packaging & Specialty Plastics ($
10 million
) and Corporate (
$16 million
). These manufacturing facilities will be shut down by the end of the third quarter of 2019.
|
2016 Restructuring Charges
|
Severance and Related Benefit Costs
|
Asset Write-downs and Write-offs
|
Costs Associated with Exit and Disposal Activities
|
Total
|
||||||||
In millions
|
||||||||||||
Performance Materials & Coatings
|
$
|
—
|
|
$
|
27
|
|
$
|
15
|
|
$
|
42
|
|
Industrial Intermediates & Infrastructure
|
—
|
|
70
|
|
13
|
|
83
|
|
||||
Packaging & Specialty Plastics
|
—
|
|
10
|
|
—
|
|
10
|
|
||||
Corporate
|
255
|
|
46
|
|
—
|
|
301
|
|
||||
2016 restructuring charges
|
$
|
255
|
|
$
|
153
|
|
$
|
28
|
|
$
|
436
|
|
Charges against the reserve
|
—
|
|
(153
|
)
|
—
|
|
(153
|
)
|
||||
Cash payments
|
(66
|
)
|
—
|
|
(1
|
)
|
(67
|
)
|
||||
Reserve balance at Dec 31, 2016
|
$
|
189
|
|
$
|
—
|
|
$
|
27
|
|
$
|
216
|
|
Adjustments to the reserve
1
|
—
|
|
—
|
|
(7
|
)
|
(7
|
)
|
||||
Cash payments
|
(137
|
)
|
—
|
|
(3
|
)
|
(140
|
)
|
||||
Reserve balance at Dec 31, 2017
|
$
|
52
|
|
$
|
—
|
|
$
|
17
|
|
$
|
69
|
|
Adjustments to the reserve
1
|
(8
|
)
|
—
|
|
14
|
|
6
|
|
||||
Cash payments
|
(38
|
)
|
—
|
|
(4
|
)
|
(42
|
)
|
||||
Reserve balance at Jun 30, 2018
|
$
|
6
|
|
$
|
—
|
|
$
|
27
|
|
$
|
33
|
|
1.
|
Included in "Restructuring, goodwill impairment and asset related charges - net" in the consolidated statements of income. Charges for severance and related benefit costs related to Corporate and costs associated with exit and disposal activities related to Performance Materials & Coatings.
|
•
|
The Company recorded a charge of
$70 million
for asset write-downs and write-offs including the shutdown of a solar manufacturing facility in Midland, Michigan; the write-down of a solar facility in Milpitas, California; and, the write-off of capital projects and in-process research and development. The charge was related to Industrial Intermediates & Infrastructure. The Midland facility was shut down in the third quarter of 2016.
|
•
|
To enhance competitiveness and streamline costs associated with the ownership restructure of Dow Silicones, a silicones manufacturing facility in Yamakita, Japan, was shut down in the fourth quarter of 2018. In addition, an idled facility was shut down in the second quarter of 2016. As a result, the Company recorded a charge of
$25 million
related to Performance Materials & Coatings.
|
•
|
The Company recorded a charge of
$25 million
related to Corporate to close and/or consolidate certain corporate facilities and data centers.
|
•
|
A decision was made to shut down a small manufacturing facility and to write-down other non-manufacturing assets, including a cost method investment and certain aircraft. As a result, the Company recorded a charge of
$33 million
related to Performance Materials & Coatings (
$2 million
), Packaging & Specialty Plastics (
$10 million
) and Corporate (
$21 million
). The manufacturing facility was shut down in the second quarter of 2016.
|
Sundry Income (Expense) – Net
|
|
|
|
||||||
In millions
|
2018
|
2017
|
2016
|
||||||
Non-operating pension and other postretirement benefit plan net credits (costs)
1
|
$
|
123
|
|
$
|
(676
|
)
|
$
|
35
|
|
Gain on sales of other assets and investments
|
18
|
|
117
|
|
157
|
|
|||
Foreign exchange losses
|
(119
|
)
|
(72
|
)
|
(126
|
)
|
|||
Post-closing adjustments on divestiture of MEGlobal
|
20
|
|
—
|
|
(1
|
)
|
|||
Gain and post-closing adjustments related to Dow Silicones ownership restructure
2
|
(20
|
)
|
—
|
|
1,617
|
|
|||
Loss on early extinguishment of debt
3
|
(54
|
)
|
—
|
|
—
|
|
|||
Gain on divestiture of the EAA Business
4
|
—
|
|
227
|
|
—
|
|
|||
Gain related to Nova patent infringement award
5
|
—
|
|
137
|
|
—
|
|
|||
Impact of split-off of chlorine value chain
|
—
|
|
7
|
|
6
|
|
|||
Settlement of the urethane matters class action lawsuit and opt-out cases
5
|
—
|
|
—
|
|
(1,235
|
)
|
|||
Costs associated with transactions and productivity actions
|
—
|
|
—
|
|
(41
|
)
|
|||
Loss on divestitures
|
—
|
|
—
|
|
(25
|
)
|
|||
Implant liability adjustment
5
|
—
|
|
—
|
|
16
|
|
|||
Reclassification of cumulative translation adjustments
|
4
|
|
8
|
|
—
|
|
|||
Other - net
|
124
|
|
98
|
|
114
|
|
|||
Total sundry income (expense) – net
|
$
|
96
|
|
$
|
(154
|
)
|
$
|
517
|
|
1.
|
Presented in accordance with ASU 2017-07. See Notes
2
and
21
for additional information.
|
2.
|
See Note
6
for additional information.
|
3.
|
See Note
17
for additional information.
|
4.
|
See Note
7
for additional information.
|
5.
|
See Note
18
for additional information.
|
Supplemental Cash Flow Information
|
2018
|
2017
|
2016
|
||||||
In millions
|
|||||||||
Cash paid during year for:
|
|
|
|
||||||
Interest, net of amounts capitalized
|
$
|
1,143
|
|
$
|
1,115
|
|
$
|
1,162
|
|
Income taxes
|
$
|
1,193
|
|
$
|
1,259
|
|
$
|
1,306
|
|
•
|
As a result of The Act, the Company remeasured its U.S. federal deferred tax assets and liabilities based on the rates at which they are expected to reverse in the future, which is generally 21 percent. The Company recorded a cumulative benefit of
$81 million
(
$79 million
benefit in 2018 and
$2 million
benefit in 2017) to “Provision (credit) for income taxes on continuing operations” in the consolidated statements of income with respect to the remeasurement of the Company's deferred tax balances.
|
•
|
The Act required a mandatory deemed repatriation of post-1986 undistributed foreign earnings and profits, which results in a one-time transition tax. The Company recorded a cumulative charge of
$789 million
(
$85 million
benefit in 2018 and
$874 million
charge in 2017) to "Provision (credit) for income taxes on continuing operations" in the consolidated statements of income with respect to the one-time transition tax.
|
•
|
In 2018, the Company recorded an indirect impact of The Act related to prepaid tax on the intercompany sale of inventory. The amount recorded related to inventory was a charge of
$38 million
to "Provision (credit) for income taxes on continuing operations" in the consolidated statements of income.
|
•
|
For tax years beginning after December 31, 2017, The Act introduced new provisions for U.S. taxation of certain global intangible low-taxed income (“GILTI”). The Company has made the policy election to record any liability associated with GILTI in the period in which it is incurred.
|
Geographic Allocation of Income and Provision (Credit) for Income Taxes on Continuing Operations
|
|
|
|
||||||
In millions
|
2018
|
2017
|
2016
|
||||||
Income (loss) from continuing operations before income taxes
|
|
|
|
||||||
Domestic
1, 2
|
$
|
745
|
|
$
|
(2,226
|
)
|
$
|
(991
|
)
|
Foreign
1
|
3,004
|
|
2,463
|
|
2,251
|
|
|||
Income from continuing operations before income taxes
|
$
|
3,749
|
|
$
|
237
|
|
$
|
1,260
|
|
Current tax expense (benefit)
|
|
|
|
||||||
Federal
|
$
|
324
|
|
$
|
(864
|
)
|
$
|
164
|
|
State and local
|
13
|
|
4
|
|
21
|
|
|||
Foreign
|
901
|
|
971
|
|
606
|
|
|||
Total current tax expense
|
$
|
1,238
|
|
$
|
111
|
|
$
|
791
|
|
Deferred tax expense (benefit)
|
|
|
|
||||||
Federal
3
|
$
|
(318
|
)
|
$
|
1,499
|
|
$
|
(1,029
|
)
|
State and local
|
(32
|
)
|
85
|
|
(59
|
)
|
|||
Foreign
|
(79
|
)
|
(171
|
)
|
79
|
|
|||
Total deferred tax expense (benefit)
|
$
|
(429
|
)
|
$
|
1,413
|
|
$
|
(1,009
|
)
|
Provision (credit) for income taxes on continuing operations
|
$
|
809
|
|
$
|
1,524
|
|
$
|
(218
|
)
|
Income (loss) from continuing operations, net of tax
|
$
|
2,940
|
|
$
|
(1,287
|
)
|
$
|
1,478
|
|
1.
|
In 2016, the domestic component of "Income from continuing operations before income taxes" included approximately
$1.4 billion
of income from portfolio actions. See Notes
6
and
7
for additional information.
|
2.
|
In 2017, the domestic component of "Income from continuing operations before income taxes" included approximately
$1.4 billion
of expense related to goodwill impairment and litigation settlements. In 2016, the domestic component of "Income from continuing operations before income taxes" included approximately
$2.6 billion
of expenses related to the urethane matters class action lawsuit and opt-out cases settlements, asbestos-related charge and charges for environmental matters. See Notes
15
and
18
for additional information.
|
3.
|
The 2018 and 2017 amounts reflect the tax impact of The Act which accelerated the utilization of tax credits and required remeasurement of all U.S. deferred tax assets and liabilities. The 2016 amount reflects the tax impact of accrued one-time items and reduced domestic income which limited the utilization of tax credits.
|
1.
|
Includes the impact of valuation allowances in foreign jurisdictions.
|
2.
|
See Notes
6
and
7
for additional information.
|
3.
|
Reflects the impact of the adoption of ASU 2016-09, "Compensation - Stock Compensation (Topic 718), Improvements to Employee Share-Based Payment Accounting," which was adopted January 1, 2017, and resulted in the recognition of excess tax benefits related to stock-based compensation in "Provision (credit) for income taxes on continuing operations."
|
Deferred Tax Balances at Dec 31
|
2018
|
2017
|
||||||||||
In millions
|
Assets
|
Liabilities
|
Assets
|
Liabilities
|
||||||||
Property
|
$
|
406
|
|
$
|
2,519
|
|
$
|
488
|
|
$
|
2,467
|
|
Tax loss and credit carryforwards
|
2,079
|
|
—
|
|
1,687
|
|
—
|
|
||||
Postretirement benefit obligations
|
2,115
|
|
143
|
|
2,411
|
|
149
|
|
||||
Other accruals and reserves
|
1,220
|
|
151
|
|
1,409
|
|
174
|
|
||||
Intangibles
|
157
|
|
954
|
|
126
|
|
1,019
|
|
||||
Inventory
|
53
|
|
239
|
|
52
|
|
232
|
|
||||
Investments
|
190
|
|
84
|
|
275
|
|
87
|
|
||||
Other – net
|
620
|
|
247
|
|
427
|
|
405
|
|
||||
Subtotal
|
$
|
6,840
|
|
$
|
4,337
|
|
$
|
6,875
|
|
$
|
4,533
|
|
Valuation allowances
|
(1,225
|
)
|
—
|
|
(1,255
|
)
|
—
|
|
||||
Total
|
$
|
5,615
|
|
$
|
4,337
|
|
$
|
5,620
|
|
$
|
4,533
|
|
Operating Loss and Tax Credit Carryforwards at Dec 31
|
2018
|
2017
|
||||
In millions
|
Assets
|
Assets
|
||||
Operating loss carryforwards
|
|
|
||||
Expire within 5 years
|
$
|
245
|
|
$
|
222
|
|
Expire after 5 years or indefinite expiration
|
1,196
|
|
1,255
|
|
||
Total operating loss carryforwards
|
$
|
1,441
|
|
$
|
1,477
|
|
Tax credit carryforwards
|
|
|
||||
Expire within 5 years
|
$
|
32
|
|
$
|
39
|
|
Expire after 5 years or indefinite expiration
|
606
|
|
171
|
|
||
Total tax credit carryforwards
|
$
|
638
|
|
$
|
210
|
|
Total operating loss and tax credit carryforwards
|
$
|
2,079
|
|
$
|
1,687
|
|
Total Gross Unrecognized Tax Benefits
|
|
|
|
||||||
In millions
|
2018
|
2017
|
2016
|
||||||
Total unrecognized tax benefits at Jan 1
|
$
|
255
|
|
$
|
231
|
|
$
|
280
|
|
Decreases related to positions taken on items from prior years
|
(8
|
)
|
(4
|
)
|
(12
|
)
|
|||
Increases related to positions taken on items from prior years
1
|
68
|
|
37
|
|
153
|
|
|||
Increases related to positions taken in the current year
2
|
2
|
|
12
|
|
135
|
|
|||
Settlement of uncertain tax positions with tax authorities
1
|
—
|
|
(12
|
)
|
(325
|
)
|
|||
Decreases due to expiration of statutes of limitations
|
(1
|
)
|
(9
|
)
|
—
|
|
|||
Foreign exchange gain
|
(2
|
)
|
—
|
|
—
|
|
|||
Total unrecognized tax benefits at Dec 31
|
$
|
314
|
|
$
|
255
|
|
$
|
231
|
|
Total unrecognized tax benefits that, if recognized, would impact the effective tax rate
|
$
|
235
|
|
$
|
245
|
|
$
|
225
|
|
Total amount of interest and penalties (benefit) recognized in "Provision (credit) for income taxes on continuing operations"
|
$
|
(12
|
)
|
$
|
2
|
|
$
|
(55
|
)
|
Total accrual for interest and penalties recognized in the consolidated balance sheets
|
$
|
109
|
|
$
|
110
|
|
$
|
89
|
|
1.
|
The 2016 balance includes the impact of a settlement agreement related to a historical change in the legal ownership structure of a nonconsolidated affiliate discussed below.
|
2.
|
The 2016 balance includes
$126 million
assumed in the Dow Silicones ownership restructure.
|
Tax Years Subject to Examination by Major Tax Jurisdiction at Dec 31, 2018
|
Earliest Open Year
|
Jurisdiction
|
|
Argentina
|
2011
|
Brazil
|
2006
|
Canada
|
2012
|
China
|
2008
|
Germany
|
2009
|
Italy
|
2013
|
The Netherlands
|
2016
|
Switzerland
|
2012
|
United States:
|
|
Federal income tax
|
2004
|
State and local income tax
|
2004
|
Net Income (Loss) for Earnings Per Share Calculations
|
2018
|
2017
|
2016
|
||||||
In millions
|
|||||||||
Income (loss) from continuing operations, net of tax
|
$
|
2,940
|
|
$
|
(1,287
|
)
|
$
|
1,478
|
|
Net income attributable to noncontrolling interests - continuing operations
|
(102
|
)
|
(102
|
)
|
(53
|
)
|
|||
Preferred stock dividends
1, 2
|
—
|
|
—
|
|
(340
|
)
|
|||
Net income attributable to participating securities - continuing operations
3
|
—
|
|
(8
|
)
|
(14
|
)
|
|||
Income (loss) from continuing operations attributable to common stockholders
|
$
|
2,838
|
|
$
|
(1,397
|
)
|
$
|
1,071
|
|
Income from discontinued operations, net of tax
|
$
|
1,835
|
|
$
|
1,882
|
|
$
|
2,926
|
|
Net income attributable to noncontrolling interests - discontinued operations
|
(32
|
)
|
(28
|
)
|
(33
|
)
|
|||
Net income attributable to participating securities - discontinued operations
3
|
—
|
|
(6
|
)
|
(8
|
)
|
|||
Income from discontinued operations attributable to common stockholders
|
$
|
1,803
|
|
$
|
1,848
|
|
$
|
2,885
|
|
Net income attributable to common stockholders
|
$
|
4,641
|
|
$
|
451
|
|
$
|
3,956
|
|
Earnings Per Share Calculations - Basic
|
2018
|
2017
|
2016
|
||||||
Dollars per share
|
|||||||||
Income (loss) from continuing operations attributable to common stockholders
|
$
|
3.80
|
|
$
|
(1.88
|
)
|
$
|
1.57
|
|
Income from discontinued operations, net of tax
|
2.41
|
|
2.48
|
|
4.23
|
|
|||
Net income attributable to common stockholders
|
$
|
6.21
|
|
$
|
0.60
|
|
$
|
5.80
|
|
Earnings Per Share Calculations - Diluted
|
2018
|
2017
|
2016
|
||||||
Dollars per share
|
|||||||||
Income (loss) from continuing operations attributable to common stockholders
|
$
|
3.80
|
|
$
|
(1.88
|
)
|
$
|
1.55
|
|
Income from discontinued operations, net of tax
|
2.41
|
|
2.48
|
|
4.18
|
|
|||
Net income attributable to common stockholders
|
$
|
6.21
|
|
$
|
0.60
|
|
$
|
5.73
|
|
Share Count Information
|
2018
|
2017
|
2016
|
|||
Shares in millions
|
||||||
Weighted-average common shares - basic
4, 5, 6
|
747.2
|
|
744.8
|
|
681.6
|
|
Plus dilutive effect of equity compensation plans
|
—
|
|
—
|
|
9.3
|
|
Weighted-average common shares - diluted
4, 5, 6
|
747.2
|
|
744.8
|
|
690.9
|
|
Stock options and restricted stock units excluded from EPS calculations
7
|
—
|
|
1.1
|
|
1.1
|
|
1.
|
On December 30, 2016, TDCC converted all shares of its Cumulative Convertible Perpetual Preferred Stock, Series A ("Preferred Stock") into shares of TDCC's common stock. As a result of this conversion, no shares of TDCC Preferred Stock are issued or outstanding. See Note
19
for additional information.
|
2.
|
Preferred Stock dividends were not added back in the calculation of diluted earnings per share for the period ended December 31, 2016, because the effect of an assumed conversion of TDCC's Preferred Stock would have been antidilutive.
|
3.
|
Restricted stock units (formerly termed deferred stock) are considered participating securities due to the Company's practice of paying dividend equivalents on unvested shares.
|
4.
|
Share amounts for the year ended December 31, 2018 were based on
2,246.3 million
DowDuPont common shares outstanding as of the Record Date for the April 1, 2019 distribution, less
4.6 million
Employee Stock Ownership Plan ("ESOP") shares that had not been released and were not considered outstanding, adjusted for the Distribution Ratio. There was no dilutive effect for the year ended December 31, 2018 as the Company did not engage in activities giving rise to dilution.
|
5.
|
Share amounts for the year ended December 31, 2017 were based on
2,246.3 million
DowDuPont common shares outstanding as of the Record Date for the April 1, 2019 distribution, less
4.6 million
ESOP shares that had not been released and were not considered outstanding, adjusted for the Distribution Ratio and further adjusted by
2.4 million
shares for the effect of TDCC basic common shares outstanding during the pre-Merger period. The year ended December 31, 2017 reflected a loss from continuing operations, and as such, the basic share count was used for purposes of calculating earnings per share on a diluted basis.
|
6.
|
Share amounts for the year ended December 31, 2016 were based on TDCC weighted average common shares outstanding of
1,108.1 million
(basic) and
1,123.2 million
(diluted), adjusted by a conversion factor of
0.6151
used to present TDCC shares of
1,214.8 million
at the time of Merger on a basis that is equivalent to the Dow Inc. common shares at distribution of
747.2 million
.
|
7.
|
These outstanding options to purchase shares of common stock and restricted stock units were excluded from the calculation of diluted earnings per share because the effect of including them would have been antidilutive. For the year ended December 31, 2018, the Company did not engage in activities giving rise to dilution.
|
Inventories at Dec 31
|
|
|
||||
In millions
|
2018
|
2017
|
||||
Finished goods
|
$
|
4,313
|
|
$
|
3,888
|
|
Work in process
|
1,335
|
|
906
|
|
||
Raw materials
|
674
|
|
631
|
|
||
Supplies
|
826
|
|
790
|
|
||
Total
|
$
|
7,148
|
|
$
|
6,215
|
|
Adjustment of inventories to a LIFO basis
|
(249
|
)
|
(170
|
)
|
||
Total inventories
|
$
|
6,899
|
|
$
|
6,045
|
|
Property at Dec 31
|
Estimated Useful
Lives (Years)
|
2018
|
2017
|
|||||
In millions
|
||||||||
Land and land improvements
|
0-25
|
|
$
|
2,059
|
|
$
|
1,868
|
|
Buildings
|
5-50
|
|
4,745
|
|
4,600
|
|
||
Machinery and equipment
|
3-25
|
|
40,250
|
|
38,131
|
|
||
Other property
|
3-50
|
|
5,084
|
|
4,969
|
|
||
Construction in progress
|
—
|
|
1,846
|
|
3,241
|
|
||
Total property
|
|
$
|
53,984
|
|
$
|
52,809
|
|
In millions
|
2018
|
2017
|
2016
|
||||||
Depreciation expense
|
$
|
2,174
|
|
$
|
1,955
|
|
$
|
1,729
|
|
Capitalized interest
|
$
|
88
|
|
$
|
240
|
|
$
|
243
|
|
Investments in Nonconsolidated Affiliates at Dec 31
|
2018
1
|
2017
1
|
||||
In millions
|
||||||
Investment in nonconsolidated affiliates
|
$
|
3,320
|
|
$
|
3,107
|
|
1.
|
The carrying amount of the Company’s investments in nonconsolidated affiliates at
December 31, 2018
, was
$39 million
less than its share of the investees’ net assets, (
$63 million
less at
December 31, 2017
), exclusive of additional differences relating to EQUATE Petrochemical Company K.S.C.C. ("EQUATE") and AFSI, which are discussed separately in the disclosures that follow.
|
Dividends Received from Nonconsolidated Affiliates
|
2018
|
2017
1
|
2016
|
||||||
In millions
|
|||||||||
Dividends from nonconsolidated affiliates
|
$
|
663
|
|
$
|
654
|
|
$
|
612
|
|
1.
|
Includes a non-cash dividend of
$7 million
.
|
Principal Nonconsolidated Affiliates at Dec 31
|
Country
|
Ownership Interest
|
|||||
|
2018
|
2017
|
2016
|
||||
EQUATE Petrochemical Company K.S.C.C.
|
Kuwait
|
42.5
|
%
|
42.5
|
%
|
42.5
|
%
|
The Kuwait Olefins Company K.S.C.C.
|
Kuwait
|
42.5
|
%
|
42.5
|
%
|
42.5
|
%
|
The Kuwait Styrene Company K.S.C.C.
|
Kuwait
|
42.5
|
%
|
42.5
|
%
|
42.5
|
%
|
Map Ta Phut Olefins Company Limited
1
|
Thailand
|
32.77
|
%
|
32.77
|
%
|
32.77
|
%
|
Sadara Chemical Company
|
Saudi Arabia
|
35
|
%
|
35
|
%
|
35
|
%
|
The SCG-Dow Group:
|
|
|
|
|
|||
Siam Polyethylene Company Limited
|
Thailand
|
50
|
%
|
50
|
%
|
50
|
%
|
Siam Polystyrene Company Limited
|
Thailand
|
50
|
%
|
50
|
%
|
50
|
%
|
Siam Styrene Monomer Co., Ltd.
|
Thailand
|
50
|
%
|
50
|
%
|
50
|
%
|
Siam Synthetic Latex Company Limited
|
Thailand
|
50
|
%
|
50
|
%
|
50
|
%
|
1.
|
The Company's effective ownership of Map Ta Phut Olefins Company Limited ("Map Ta Phut") is
32.77 percent
, of which the Company directly owns
20.27
percent and indirectly owns
12.5 percent
through its equity interest in Siam Polyethylene Company Limited.
|
Investment in Principal Nonconsolidated Affiliates at Dec 31
|
2018
|
2017
|
||||
In millions
|
||||||
Investment in nonconsolidated affiliates
|
$
|
2,876
|
|
$
|
2,657
|
|
Equity Earnings from Principal Nonconsolidated Affiliates
|
2018
|
2017
|
2016
1
|
||||||
In millions
|
|||||||||
Equity in earnings of principal nonconsolidated affiliates
|
$
|
561
|
|
$
|
347
|
|
$
|
241
|
|
1.
|
Equity in earnings of principal nonconsolidated affiliates for 2016 includes the results of Dow Silicones through May 31, 2016.
|
Summarized Income Statement Information
1
|
2018
|
2017
|
2016
2
|
||||||
In millions
|
|||||||||
Sales
|
$
|
14,461
|
|
$
|
11,629
|
|
$
|
10,825
|
|
Gross profit
|
$
|
2,320
|
|
$
|
1,992
|
|
$
|
1,975
|
|
Income from continuing operations, net of tax
|
$
|
1,173
|
|
$
|
689
|
|
$
|
410
|
|
1.
|
The results in this table reflect purchase and sale activity between certain principal nonconsolidated affiliates and the Company, as previously discussed in the "Transactions with Nonconsolidated Affiliates" section.
|
2.
|
The summarized income statement information for 2016 includes the results of Dow Silicones through May 31, 2016.
|
Goodwill
|
Performance Materials & Coatings
|
Industrial Intermediates & Infrastructure
|
Packaging & Specialty Plastics
|
Total
|
||||||||
In millions
|
||||||||||||
Balance at Jan 1, 2017
|
$
|
4,938
|
|
$
|
1,085
|
|
$
|
1,518
|
|
$
|
7,541
|
|
Divestiture of the EAA Business
1
|
—
|
|
—
|
|
(23
|
)
|
(23
|
)
|
||||
Dissolution of joint venture
2
|
48
|
|
—
|
|
—
|
|
48
|
|
||||
Goodwill impairment
|
(1,491
|
)
|
—
|
|
—
|
|
(1,491
|
)
|
||||
Receipt of the ECP businesses
3
|
—
|
|
—
|
|
3,617
|
|
3,617
|
|
||||
Measurement period adjustment - ECP
3
|
—
|
|
—
|
|
(96
|
)
|
(96
|
)
|
||||
Foreign currency impact
|
194
|
|
16
|
|
32
|
|
242
|
|
||||
Other
|
—
|
|
—
|
|
(5
|
)
|
(5
|
)
|
||||
Balance at Dec 31, 2017
|
$
|
3,689
|
|
$
|
1,101
|
|
$
|
5,043
|
|
$
|
9,833
|
|
Foreign currency impact
|
(39
|
)
|
(6
|
)
|
(24
|
)
|
(69
|
)
|
||||
Measurement period adjustment - ECP
3
|
—
|
|
—
|
|
82
|
|
82
|
|
||||
Balance at Dec 31, 2018
|
$
|
3,650
|
|
$
|
1,095
|
|
$
|
5,101
|
|
$
|
9,846
|
|
1.
|
On September 1, 2017, the Company divested its EAA Business to SK Global Chemical Co., Ltd. See Note
7
for additional information.
|
2.
|
On December 31, 2017, the Company dissolved a crude acrylic acid joint venture. See Note
25
for additional information.
|
Other Intangible Assets at Dec 31
|
2018
|
2017
|
||||||||||||||||
In millions
|
Gross
Carrying
Amount
|
Accum
Amort
|
Net
|
Gross
Carrying
Amount
|
Accum
Amort
|
Net
|
||||||||||||
Intangible assets with finite lives:
|
|
|
|
|
|
|
||||||||||||
Developed technology
|
$
|
2,634
|
|
$
|
(1,252
|
)
|
$
|
1,382
|
|
$
|
2,630
|
|
$
|
(1,021
|
)
|
$
|
1,609
|
|
Software
|
1,404
|
|
(805
|
)
|
599
|
|
1,323
|
|
(727
|
)
|
596
|
|
||||||
Trademarks/tradenames
|
352
|
|
(329
|
)
|
23
|
|
366
|
|
(284
|
)
|
82
|
|
||||||
Customer-related
|
3,211
|
|
(993
|
)
|
2,218
|
|
3,247
|
|
(810
|
)
|
2,437
|
|
||||||
Other
|
—
|
|
—
|
|
—
|
|
2
|
|
—
|
|
2
|
|
||||||
Total other intangible assets, finite lives
|
$
|
7,601
|
|
$
|
(3,379
|
)
|
$
|
4,222
|
|
$
|
7,568
|
|
$
|
(2,842
|
)
|
$
|
4,726
|
|
In-process research and development ("IPR&D")
|
3
|
|
—
|
|
3
|
|
3
|
|
—
|
|
3
|
|
||||||
Total other intangible assets
|
$
|
7,604
|
|
$
|
(3,379
|
)
|
$
|
4,225
|
|
$
|
7,571
|
|
$
|
(2,842
|
)
|
$
|
4,729
|
|
ECP Intangible Assets at Aug 31, 2017
|
Gross Carrying Amount
|
Weighted-average Amort. Period
(in years)
|
||
In millions
|
||||
Intangible assets with finite lives:
|
|
|
||
Developed technology
|
$
|
366
|
|
14
|
Trademarks/tradenames
|
20
|
|
7
|
|
Customer-related
|
1,098
|
|
15
|
|
Total
|
$
|
1,484
|
|
15
|
Amortization Expense from Continuing Operations
|
2018
|
2017
|
2016
|
||||||
In millions
|
|||||||||
Other intangible assets, excluding software
|
$
|
469
|
|
$
|
400
|
|
$
|
316
|
|
Software, included in “Cost of sales” from continuing operations
|
$
|
93
|
|
$
|
82
|
|
$
|
69
|
|
Interests Held at Dec 31
|
|
|
||||
In millions
|
2018
|
2017
|
||||
Carrying value of interests held
1
|
$
|
—
|
|
$
|
677
|
|
Percentage of anticipated credit losses
|
—
|
%
|
2.64
|
%
|
||
Impact to carrying value - 10% adverse change
|
$
|
—
|
|
$
|
—
|
|
Impact to carrying value - 20% adverse change
|
$
|
—
|
|
$
|
1
|
|
1.
|
Included in "Accounts and notes receivable - other" in the consolidated balance sheets.
|
Cash Proceeds
|
|
|
|
||||||
In millions
|
2018
|
2017
|
2016
|
||||||
Sale of receivables
|
$
|
—
|
|
$
|
1
|
|
$
|
1
|
|
Collections reinvested in revolving receivables
|
$
|
—
|
|
$
|
21,293
|
|
$
|
21,652
|
|
Interests in conduits
1
|
$
|
657
|
|
$
|
9,462
|
|
$
|
8,551
|
|
1.
|
Presented in "Investing Activities" in the consolidated statements of cash flows in accordance with ASU 2016-15. See Note
2
for additional information. In connection with the review and implementation of ASU 2016-15, the Company also changed the prior year value of “Interests in conduits” due to additional interpretive guidance of the required method for calculating the cash received from beneficial interests in the conduits, including additional guidance from the SEC's Office of the Chief Accountant issued in the third quarter of 2018 that indicated an entity must evaluate daily transaction activity to calculate the value of cash received from beneficial interests in conduits.
|
Trade Accounts Receivable Sold at Dec 31
|
|
|
||||
In millions
|
2018
|
2017
|
||||
Delinquencies on sold receivables still outstanding
|
$
|
—
|
|
$
|
82
|
|
Trade accounts receivable outstanding and derecognized
|
$
|
—
|
|
$
|
612
|
|
Notes Payable at Dec 31
|
|
|
||||
In millions
|
2018
|
2017
|
||||
Commercial paper
|
$
|
10
|
|
$
|
231
|
|
Notes payable to banks and other lenders
|
288
|
|
250
|
|
||
Total notes payable
|
$
|
298
|
|
$
|
481
|
|
Year-end average interest rates
|
8.28
|
%
|
4.37
|
%
|
Long-Term Debt at Dec 31
|
2018 Average Rate
|
2018
|
2017
Average
Rate
|
2017
|
||||||
In millions
|
||||||||||
Promissory notes and debentures:
|
|
|
|
|
||||||
Final maturity 2018
|
—
|
%
|
$
|
—
|
|
5.78
|
%
|
$
|
339
|
|
Final maturity 2019
|
9.80
|
%
|
7
|
|
8.55
|
%
|
2,122
|
|
||
Final maturity 2020
|
4.46
|
%
|
1,547
|
|
4.46
|
%
|
1,547
|
|
||
Final maturity 2021
|
4.71
|
%
|
1,424
|
|
4.71
|
%
|
1,424
|
|
||
Final maturity 2022
|
3.50
|
%
|
1,373
|
|
3.50
|
%
|
1,373
|
|
||
Final maturity 2023
|
7.64
|
%
|
325
|
|
7.64
|
%
|
325
|
|
||
Final maturity 2024 and thereafter
|
5.73
|
%
|
8,859
|
|
5.92
|
%
|
6,857
|
|
||
Other facilities:
|
|
|
|
|
||||||
U.S. dollar loans, various rates and maturities
|
3.59
|
%
|
4,533
|
|
2.44
|
%
|
4,564
|
|
||
Foreign currency loans, various rates and maturities
|
3.20
|
%
|
708
|
|
2.98
|
%
|
806
|
|
||
Medium-term notes, varying maturities through 2025
|
3.26
|
%
|
778
|
|
3.20
|
%
|
873
|
|
||
Tax-exempt bonds
|
—
|
%
|
—
|
|
5.66
|
%
|
343
|
|
||
Capital lease obligations
|
|
371
|
|
|
277
|
|
||||
Unamortized debt discount and issuance costs
|
|
(334
|
)
|
|
(345
|
)
|
||||
Long-term debt due within one year
1
|
|
(338
|
)
|
|
(748
|
)
|
||||
Long-term debt
|
|
|
$
|
19,253
|
|
|
|
$
|
19,757
|
|
1.
|
Presented net of current portion of unamortized debt issuance costs.
|
1.
|
Assumes the option to extend a term loan facility related to the Dow Silicones ownership restructure will be exercised.
|
Committed and Available Credit Facilities at Dec 31, 2018
|
|||||||||
In millions
|
Effective Date
|
Committed Credit
|
Credit Available
|
Maturity Date
|
Interest
|
||||
Five Year Competitive Advance and Revolving Credit Facility
|
October 2018
|
$
|
5,000
|
|
$
|
5,000
|
|
October 2023
|
Floating rate
|
Bilateral Revolving Credit Facility
|
August 2015
|
100
|
|
100
|
|
March 2019
|
Floating rate
|
||
Bilateral Revolving Credit Facility
|
August 2015
|
100
|
|
100
|
|
October 2019
|
Floating rate
|
||
Bilateral Revolving Credit Facility
|
August 2015
|
100
|
|
100
|
|
March 2020
|
Floating rate
|
||
Bilateral Revolving Credit Facility
|
August 2015
|
280
|
|
280
|
|
March 2020
|
Floating rate
|
||
Bilateral Revolving Credit Facility
|
August 2015
|
100
|
|
100
|
|
March 2020
|
Floating rate
|
||
Bilateral Revolving Credit Facility
|
August 2015
|
200
|
|
200
|
|
March 2020
|
Floating rate
|
||
Term Loan Facility
1
|
February 2016
|
4,500
|
|
—
|
|
December 2021
|
Floating rate
|
||
Bilateral Revolving Credit Facility
|
May 2016
|
200
|
|
200
|
|
May 2020
|
Floating rate
|
||
Bilateral Revolving Credit Facility
|
July 2016
|
200
|
|
200
|
|
July 2020
|
Floating rate
|
||
Bilateral Revolving Credit Facility
|
August 2016
|
100
|
|
100
|
|
August 2020
|
Floating rate
|
||
North American Securitization Facility
|
September 2018
|
800
|
|
800
|
|
September 2019
|
Floating rate
|
||
European Securitization Facility
2
|
October 2018
|
457
|
|
457
|
|
October 2020
|
Floating rate
|
||
Total Committed and Available Credit Facilities
|
|
$
|
12,137
|
|
$
|
7,637
|
|
|
|
1.
|
Assumes the option to extend the Dow Silicones term loan facility will be exercised.
|
2.
|
Equivalent to
Euro 400 million
.
|
(a)
|
the obligation to maintain the ratio of the Company’s consolidated indebtedness to consolidated capitalization at no greater than
0.65
to
1.00
at any time the aggregate outstanding amount of loans under the Five Year Competitive Advance and Revolving Credit Facility Agreement dated October 30, 2018, equals or exceeds
$500 million
,
|
(b)
|
a default if the Company or an applicable subsidiary fails to make any payment, including principal, premium or interest, under the applicable agreement on other indebtedness of, or guaranteed by, the Company or such applicable subsidiary in an aggregate amount of
$100 million
or more when due, or any other default or other event under the applicable agreement with respect to such indebtedness occurs which permits or results in the acceleration of
$400 million
or more in the aggregate of principal, and
|
(c)
|
a default if the Company or any applicable subsidiary fails to discharge or stay within 60 days after the entry of a final judgment against the Company or such applicable subsidiary of more than
$400 million
.
|
Guarantees
|
Dec 31, 2018
|
Dec 31, 2017
|
||||||||||||
In millions
|
Final
Expiration
|
Maximum
Future Payments
|
Recorded
Liability
|
Final
Expiration
|
Maximum
Future Payments
|
Recorded
Liability
|
||||||||
Guarantees
|
2023
|
$
|
4,273
|
|
$
|
22
|
|
2023
|
$
|
4,434
|
|
$
|
44
|
|
Residual value guarantees
|
2028
|
885
|
|
130
|
|
2027
|
889
|
|
135
|
|
||||
Total guarantees
|
|
$
|
5,158
|
|
$
|
152
|
|
|
$
|
5,323
|
|
$
|
179
|
|
Asset Retirement Obligations
|
2018
|
2017
|
||||
In millions
|
||||||
Balance at Jan 1
|
$
|
100
|
|
$
|
104
|
|
Additional accruals
|
9
|
|
2
|
|
||
Liabilities settled
|
(3
|
)
|
(6
|
)
|
||
Accretion expense
|
3
|
|
5
|
|
||
Revisions in estimated cash flows
|
—
|
|
(9
|
)
|
||
Other
|
—
|
|
4
|
|
||
Balance at Dec 31
|
$
|
109
|
|
$
|
100
|
|
Treasury Shares Issued Under Stock-Based Compensation Programs
|
|
|
|
||
In thousands
|
2018
|
2017
1
|
2016
|
||
To employees and non-employee directors
|
N/A
|
14,195
|
|
14,494
|
|
1.
|
Reflects activity prior to the Merger.
|
Shares of TDCC Common Stock
|
Issued
|
Held in Treasury
|
||
In thousands
|
||||
Balance at Jan 1, 2016
|
1,242,795
|
|
125,853
|
|
Issued
1
|
—
|
|
(14,494
|
)
|
Repurchased
|
—
|
|
17,107
|
|
Preferred stock converted to common stock
|
—
|
|
(96,804
|
)
|
Balance at Dec 31, 2016
|
1,242,795
|
|
31,662
|
|
Issued
1
|
—
|
|
(14,195
|
)
|
Converted to DowDuPont shares or canceled on Aug 31, 2017
2
|
(1,242,795
|
)
|
(17,467
|
)
|
Balance at Aug 31, 2017
|
—
|
|
—
|
|
1.
|
Shares issued to employees and non-employee directors under the Company's equity compensation plans.
|
2.
|
Each share of TDCC Common Stock issued and outstanding immediately prior to the Merger was converted into one share of DowDuPont Common Stock; treasury shares were canceled as a result of the Merger.
|
Accumulated Other Comprehensive Loss
|
Unrealized Gains (Losses) on Investments
|
Cumulative Translation Adj
|
Pension and Other Postretire Benefits
|
Derivative Instruments
|
Total Accum Other Comp Loss
|
||||||||||
In millions
|
|||||||||||||||
2016
|
|
|
|
|
|
||||||||||
Balance at Jan 1, 2016
|
$
|
47
|
|
$
|
(1,737
|
)
|
$
|
(6,769
|
)
|
$
|
(208
|
)
|
$
|
(8,667
|
)
|
Other comprehensive income (loss) before reclassifications
|
32
|
|
(644
|
)
|
(1,354
|
)
|
84
|
|
(1,882
|
)
|
|||||
Amounts reclassified from accumulated other comprehensive income (loss)
|
(36
|
)
|
—
|
|
734
|
|
29
|
|
727
|
|
|||||
Net other comprehensive income (loss)
|
$
|
(4
|
)
|
$
|
(644
|
)
|
$
|
(620
|
)
|
$
|
113
|
|
$
|
(1,155
|
)
|
Balance at Dec 31, 2016
|
$
|
43
|
|
$
|
(2,381
|
)
|
$
|
(7,389
|
)
|
$
|
(95
|
)
|
$
|
(9,822
|
)
|
2017
|
|
|
|
|
|
||||||||||
Other comprehensive income (loss) before reclassifications
|
25
|
|
908
|
|
(23
|
)
|
1
|
|
911
|
|
|||||
Amounts reclassified from accumulated other comprehensive income (loss)
|
(71
|
)
|
(8
|
)
|
414
|
|
(15
|
)
|
320
|
|
|||||
Net other comprehensive income (loss)
|
$
|
(46
|
)
|
$
|
900
|
|
$
|
391
|
|
$
|
(14
|
)
|
$
|
1,231
|
|
Balance at Dec 31, 2017
|
$
|
(3
|
)
|
$
|
(1,481
|
)
|
$
|
(6,998
|
)
|
$
|
(109
|
)
|
$
|
(8,591
|
)
|
2018
|
|
|
|
|
|
||||||||||
Balance at Jan 1, 2018
1
|
$
|
17
|
|
$
|
(1,481
|
)
|
$
|
(6,998
|
)
|
$
|
(109
|
)
|
$
|
(8,571
|
)
|
Other comprehensive income (loss) before reclassifications
|
(74
|
)
|
(221
|
)
|
(495
|
)
|
4
|
|
(786
|
)
|
|||||
Amounts reclassified from accumulated other comprehensive income (loss)
|
7
|
|
(4
|
)
|
455
|
|
71
|
|
529
|
|
|||||
Net other comprehensive income (loss)
|
$
|
(67
|
)
|
$
|
(225
|
)
|
$
|
(40
|
)
|
$
|
75
|
|
$
|
(257
|
)
|
Reclassification of stranded tax effects
2
|
$
|
(1
|
)
|
$
|
(107
|
)
|
$
|
(927
|
)
|
$
|
(22
|
)
|
$
|
(1,057
|
)
|
Balance at Dec 31, 2018
|
$
|
(51
|
)
|
$
|
(1,813
|
)
|
$
|
(7,965
|
)
|
$
|
(56
|
)
|
$
|
(9,885
|
)
|
1.
|
The beginning balance of "Unrealized gains (losses) on investments" was increased by
$20 million
to reflect the impact of adoption of ASU 2016-01. See Note 2 for additional information.
|
2.
|
Amounts reclassified to retained earnings as a result of the adoption of ASU 2018-02. See Note 2 for additional information.
|
Tax Benefit (Expense)
1
|
2018
|
2017
|
2016
|
||||||
In millions
|
|||||||||
Unrealized gains (losses) on investments
|
$
|
17
|
|
$
|
26
|
|
$
|
(2
|
)
|
Cumulative translation adjustments
|
(6
|
)
|
(98
|
)
|
(171
|
)
|
|||
Pension and other postretirement benefit plans
|
(9
|
)
|
(213
|
)
|
438
|
|
|||
Derivative instruments
|
(20
|
)
|
(3
|
)
|
(32
|
)
|
|||
Tax benefit (expense) from income taxes related to other comprehensive income
(loss) items
|
$
|
(18
|
)
|
$
|
(288
|
)
|
$
|
233
|
|
1.
|
Prior year amounts have been updated to conform with the current year presentation.
|
Reclassifications Out of Accumulated Other Comprehensive Loss
In millions
|
2018
|
2017
|
2016
|
Consolidated Statements of Income Classification
|
|||||||
Unrealized (gains) losses on investments
|
$
|
9
|
|
$
|
(110
|
)
|
$
|
(56
|
)
|
See (1) below
|
|
Tax (benefit) expense
|
(2
|
)
|
39
|
|
20
|
|
See (2) below
|
||||
After tax
|
$
|
7
|
|
$
|
(71
|
)
|
$
|
(36
|
)
|
|
|
Cumulative translation adjustments
|
$
|
(4
|
)
|
$
|
(8
|
)
|
$
|
—
|
|
See (3) below
|
|
Pension and other postretirement benefit plans
|
$
|
594
|
|
$
|
607
|
|
$
|
913
|
|
See (4) below
|
|
Tax benefit
|
(139
|
)
|
(193
|
)
|
(179
|
)
|
See (2) below
|
||||
After tax
|
$
|
455
|
|
$
|
414
|
|
$
|
734
|
|
|
|
Derivative instruments
|
$
|
89
|
|
$
|
(13
|
)
|
$
|
34
|
|
See (5) below
|
|
Tax benefit
|
(18
|
)
|
(2
|
)
|
(5
|
)
|
See (2) below
|
||||
After tax
|
$
|
71
|
|
$
|
(15
|
)
|
$
|
29
|
|
|
|
Total reclassifications for the period, after tax
|
$
|
529
|
|
$
|
320
|
|
$
|
727
|
|
|
1.
|
"Net sales" and "Sundry income (expense) - net."
|
2.
|
"Provision (credit) for income taxes on continuing operations."
|
3.
|
"Sundry income (expense) - net."
|
4.
|
These AOCL components are included in the computation of net periodic benefit cost of the Company's defined benefit pension and other postretirement benefit plans. See Note
21
for additional information. In the year ended December 31, 2016,
$360 million
was included in “Sundry income (expense) - net” (
zero
impact to "Provision (credit) for income taxes on continuing operations") related to the Dow Silicones ownership restructure. See Note
6
for additional information.
|
5.
|
"Cost of sales," "Sundry income (expense) - net" and "Interest expense and amortization of debt discount."
|
Noncontrolling Interests
|
|
|
|
||||||
In millions
|
2018
|
2017
|
2016
1
|
||||||
Balance at Jan 1
|
$
|
1,186
|
|
$
|
1,242
|
|
$
|
809
|
|
Net income attributable to noncontrolling interests - continuing operations
|
102
|
|
102
|
|
53
|
|
|||
Net income attributable to noncontrolling interests - discontinued operations
|
32
|
|
28
|
|
33
|
|
|||
Distributions to noncontrolling interests
2
|
(145
|
)
|
(109
|
)
|
(123
|
)
|
|||
Acquisition of noncontrolling interests
3
|
—
|
|
—
|
|
473
|
|
|||
Deconsolidation of noncontrolling interests
4
|
—
|
|
(119
|
)
|
—
|
|
|||
Cumulative translation adjustments
|
(39
|
)
|
41
|
|
(4
|
)
|
|||
Other
|
2
|
|
1
|
|
1
|
|
|||
Balance at Dec 31
|
$
|
1,138
|
|
$
|
1,186
|
|
$
|
1,242
|
|
1.
|
The 2016 activity presented in the table excludes a
$202 million
cash payment for the purchase of a noncontrolling interest, as the noncontrolling interest was classified as "Accrued and other current liabilities" in the consolidated balance sheets.
|
2.
|
Distributions to noncontrolling interests is net of
$27 million
in
2018
(
$20 million
in
2017
and
$53 million
in
2016
) in dividends paid to a joint venture, which were reclassified to "Equity in earnings of nonconsolidated affiliates" in the consolidated statements of income, and include amounts attributable to discontinued operations.
|
3.
|
Assumed in the ownership restructure of Dow Silicones. See Note
6
for additional information.
|
4.
|
On June 30, 2017, the Company sold its ownership interest in the SKC Haas Display Films group of companies.
|
Weighted-Average Assumptions for All Pension Plans
|
Benefit Obligations
at Dec 31
|
Net Periodic Costs
for the Year Ended
|
||||||||
|
2018
|
2017
|
2018
|
2017
|
2016
|
|||||
Discount rate
|
3.69
|
%
|
3.17
|
%
|
3.17
|
%
|
3.52
|
%
|
3.85
|
%
|
Interest crediting rate for applicable benefits
|
3.72
|
%
|
3.61
|
%
|
3.61
|
%
|
3.45
|
%
|
4.81
|
%
|
Rate of compensation increase
|
3.84
|
%
|
3.88
|
%
|
3.88
|
%
|
3.90
|
%
|
4.04
|
%
|
Expected return on plan assets
|
—
|
|
—
|
|
7.11
|
%
|
7.16
|
%
|
7.22
|
%
|
Weighted-Average Assumptions for U.S. Pension Plans
|
Benefit Obligations
at Dec 31
|
Net Periodic Costs
for the Year Ended
|
||||||||
|
2018
|
2017
|
2018
|
2017
|
2016
|
|||||
Discount rate
|
4.39
|
%
|
3.66
|
%
|
3.66
|
%
|
4.11
|
%
|
4.40
|
%
|
Interest crediting rate for applicable benefits
|
4.50
|
%
|
4.50
|
%
|
4.50
|
%
|
4.50
|
%
|
4.50
|
%
|
Rate of compensation increase
|
4.25
|
%
|
4.25
|
%
|
4.25
|
%
|
4.25
|
%
|
4.50
|
%
|
Expected return on plan assets
|
—
|
|
—
|
|
7.92
|
%
|
7.91
|
%
|
7.77
|
%
|
Weighted-Average Assumptions for U.S. Other Postretirement Benefits Plans
|
Benefit Obligations
at Dec 31
|
Net Periodic Costs
for the Year Ended
|
||||||||
|
2018
|
2017
|
2018
|
2017
|
2016
|
|||||
Discount rate
|
4.24
|
%
|
3.51
|
%
|
3.51
|
%
|
3.83
|
%
|
3.96
|
%
|
Health care cost trend rate assumed for next year
|
6.50
|
%
|
6.75
|
%
|
6.75
|
%
|
7.00
|
%
|
7.25
|
%
|
Rate to which the cost trend rate is assumed to decline (the ultimate health care cost trend rate)
|
5.00
|
%
|
5.00
|
%
|
5.00
|
%
|
5.00
|
%
|
5.00
|
%
|
Year that the rate reaches the ultimate health care cost trend rate
|
2025
|
|
2025
|
|
2025
|
|
2025
|
|
2025
|
|
Change in Projected Benefit Obligations, Plan Assets and Funded Status of All Significant Plans
|
Defined Benefit Pension Plans
|
Other Postretirement Benefits
|
||||||||||
In millions
|
2018
|
2017
|
2018
|
2017
|
||||||||
Change in projected benefit obligations:
|
|
|
|
|
||||||||
Benefit obligations at beginning of year
|
$
|
31,851
|
|
$
|
30,280
|
|
$
|
1,567
|
|
$
|
1,835
|
|
Service cost
|
520
|
|
506
|
|
12
|
|
14
|
|
||||
Interest cost
|
886
|
|
883
|
|
45
|
|
54
|
|
||||
Plan participants' contributions
|
19
|
|
14
|
|
—
|
|
—
|
|
||||
Actuarial changes in assumptions and experience
|
(1,754
|
)
|
1,804
|
|
(13
|
)
|
(198
|
)
|
||||
Benefits paid
|
(1,476
|
)
|
(1,440
|
)
|
(123
|
)
|
(151
|
)
|
||||
Plan amendments
|
17
|
|
14
|
|
—
|
|
—
|
|
||||
Acquisitions/divestitures/other
1
|
(45
|
)
|
50
|
|
—
|
|
—
|
|
||||
Effect of foreign exchange rates
|
(418
|
)
|
932
|
|
(10
|
)
|
13
|
|
||||
Termination benefits/curtailment cost/settlements
2
|
—
|
|
(1,192
|
)
|
—
|
|
—
|
|
||||
Benefit obligations at end of year
|
$
|
29,600
|
|
$
|
31,851
|
|
$
|
1,478
|
|
$
|
1,567
|
|
|
|
|
|
|
||||||||
Change in plan assets:
|
|
|
|
|
||||||||
Fair value of plan assets at beginning of year
|
$
|
23,401
|
|
$
|
21,208
|
|
$
|
—
|
|
$
|
—
|
|
Actual return on plan assets
|
(742
|
)
|
2,500
|
|
—
|
|
—
|
|
||||
Employer contributions
|
1,656
|
|
1,676
|
|
—
|
|
—
|
|
||||
Plan participants' contributions
|
19
|
|
14
|
|
—
|
|
—
|
|
||||
Benefits paid
|
(1,476
|
)
|
(1,440
|
)
|
—
|
|
—
|
|
||||
Acquisitions/divestitures/other
3
|
—
|
|
(15
|
)
|
—
|
|
—
|
|
||||
Effect of foreign exchange rates
|
(314
|
)
|
646
|
|
—
|
|
—
|
|
||||
Settlements
4
|
—
|
|
(1,188
|
)
|
—
|
|
—
|
|
||||
Fair value of plan assets at end of year
|
$
|
22,544
|
|
$
|
23,401
|
|
$
|
—
|
|
$
|
—
|
|
|
|
|
|
|
||||||||
Funded status:
|
|
|
|
|
||||||||
U.S. plans with plan assets
|
$
|
(4,066
|
)
|
$
|
(5,363
|
)
|
$
|
—
|
|
$
|
—
|
|
Non-U.S. plans with plan assets
|
(2,041
|
)
|
(2,257
|
)
|
—
|
|
—
|
|
||||
All other plans
|
(695
|
)
|
(720
|
)
|
(1,478
|
)
|
(1,567
|
)
|
||||
Plans of discontinued operations
|
(254
|
)
|
(110
|
)
|
—
|
|
—
|
|
||||
Funded status at end of year
|
$
|
(7,056
|
)
|
$
|
(8,450
|
)
|
$
|
(1,478
|
)
|
$
|
(1,567
|
)
|
|
|
|
|
|
||||||||
Amounts recognized in the consolidated balance sheets at Dec 31:
|
|
|
|
|
||||||||
Deferred charges and other assets
|
$
|
491
|
|
$
|
548
|
|
$
|
—
|
|
$
|
—
|
|
Accrued and other current liabilities
|
(50
|
)
|
(47
|
)
|
(131
|
)
|
(125
|
)
|
||||
Pension and other postretirement benefits - noncurrent
|
(7,227
|
)
|
(8,679
|
)
|
(1,347
|
)
|
(1,442
|
)
|
||||
Liabilities of discontinued operations - current
|
(270
|
)
|
(1
|
)
|
—
|
|
—
|
|
||||
Liabilities of discontinued operations - noncurrent
|
—
|
|
(271
|
)
|
—
|
|
—
|
|
||||
Net amount recognized
|
$
|
(7,056
|
)
|
$
|
(8,450
|
)
|
$
|
(1,478
|
)
|
$
|
(1,567
|
)
|
|
|
|
|
|
||||||||
Pretax amounts recognized in accumulated other comprehensive loss at Dec 31:
|
|
|
|
|
||||||||
Net loss (gain)
|
$
|
10,841
|
|
$
|
10,899
|
|
$
|
(315
|
)
|
$
|
(326
|
)
|
Prior service credit
|
(224
|
)
|
(265
|
)
|
—
|
|
—
|
|
||||
Pretax balance in accumulated other comprehensive loss at end of year
|
$
|
10,617
|
|
$
|
10,634
|
|
$
|
(315
|
)
|
$
|
(326
|
)
|
1.
|
The 2018 impact includes the divestiture of a business with pension benefit obligations of
$37 million
. The 2017 impact includes the reclassification of a China pension liability of
$69 million
from "Other noncurrent obligations" to "Pension and other postretirement benefits - noncurrent" and the divestiture of a South Korean company with pension benefit obligations of
$25 million
.
|
2.
|
The 2017 impact includes the settlement of certain plan obligations for a U.S. non-qualified pension plan of
$1,170 million
required due to a change in control provision. The 2017 impact also includes the conversion of a South Korean pension plan of
$22 million
to a defined contribution plan.
|
3.
|
The 2017 impact relates to the divestiture of a South Korean company.
|
4.
|
The 2017 impact includes payments made of
$1,170 million
to settle certain plan obligations of a U.S. non-qualified pension plan required due to a change in control provision. The 2017 impact also includes payments made of
$18 million
to convert a South Korean pension plan to a defined contribution plan.
|
Net Periodic Benefit Costs for All Significant Plans for the Year Ended Dec 31
|
Defined Benefit Pension Plans
|
Other Postretirement Benefits
|
||||||||||||||||
In millions
|
2018
|
2017
|
2016
|
2018
|
2017
|
2016
|
||||||||||||
Net Periodic Benefit Costs:
|
|
|
|
|
|
|
||||||||||||
Service cost
|
$
|
520
|
|
$
|
506
|
|
$
|
463
|
|
$
|
12
|
|
$
|
14
|
|
$
|
13
|
|
Interest cost
|
886
|
|
883
|
|
846
|
|
45
|
|
54
|
|
52
|
|
||||||
Expected return on plan assets
|
(1,644
|
)
|
(1,548
|
)
|
(1,447
|
)
|
—
|
|
—
|
|
—
|
|
||||||
Amortization of prior service credit
|
(24
|
)
|
(25
|
)
|
(24
|
)
|
—
|
|
—
|
|
(3
|
)
|
||||||
Amortization of unrecognized (gain) loss
|
642
|
|
638
|
|
587
|
|
(24
|
)
|
(6
|
)
|
(7
|
)
|
||||||
Curtailment/settlement/other
1
|
—
|
|
683
|
|
(36
|
)
|
—
|
|
—
|
|
—
|
|
||||||
Net periodic benefit costs
|
$
|
380
|
|
$
|
1,137
|
|
$
|
389
|
|
$
|
33
|
|
$
|
62
|
|
$
|
55
|
|
Less: discontinued operations
|
101
|
|
105
|
|
97
|
|
3
|
|
3
|
|
3
|
|
||||||
Net periodic benefit costs - continuing operations
|
$
|
279
|
|
$
|
1,032
|
|
$
|
292
|
|
$
|
30
|
|
$
|
59
|
|
$
|
52
|
|
Changes in plan assets and benefit obligations recognized in other comprehensive (income) loss:
|
|
|
|
|
|
|
||||||||||||
Net (gain) loss
|
$
|
584
|
|
$
|
845
|
|
$
|
1,954
|
|
$
|
(13
|
)
|
$
|
(199
|
)
|
$
|
14
|
|
Prior service cost
|
17
|
|
14
|
|
—
|
|
—
|
|
—
|
|
—
|
|
||||||
Amortization of prior service credit
|
24
|
|
25
|
|
24
|
|
—
|
|
—
|
|
3
|
|
||||||
Amortization of unrecognized gain (loss)
|
(642
|
)
|
(638
|
)
|
(587
|
)
|
24
|
|
6
|
|
7
|
|
||||||
Settlement loss
2
|
—
|
|
(687
|
)
|
—
|
|
—
|
|
—
|
|
—
|
|
||||||
Total recognized in other comprehensive (income) loss
|
$
|
(17
|
)
|
$
|
(441
|
)
|
$
|
1,391
|
|
$
|
11
|
|
$
|
(193
|
)
|
$
|
24
|
|
Total recognized in net periodic benefit cost and other comprehensive (income) loss
|
$
|
363
|
|
$
|
696
|
|
$
|
1,780
|
|
$
|
44
|
|
$
|
(131
|
)
|
$
|
79
|
|
1.
|
The 2017 impact relates to the settlement of a U.S. non-qualified plan triggered by a change in control provision. The 2016 impact relates to the curtailment of benefits for certain participants of a Dow Silicones plan in the U.S.
|
2.
|
The 2017 impact relates to the settlement of a U.S. non-qualified plan triggered by a change in control provision.
|
Estimated Future Benefit Payments at Dec 31, 2018
|
Defined Benefit Pension Plans
|
Other Postretirement Benefits
|
||||
In millions
|
||||||
2019
|
$
|
1,546
|
|
$
|
133
|
|
2020
|
1,554
|
|
129
|
|
||
2021
|
1,580
|
|
129
|
|
||
2022
|
1,619
|
|
125
|
|
||
2023
|
1,656
|
|
120
|
|
||
2024-2028
|
8,596
|
|
519
|
|
||
Total
|
$
|
16,551
|
|
$
|
1,155
|
|
Basis of Fair Value Measurements
|
Dec 31, 2018
|
Dec 31, 2017
|
||||||||||||||||||||||
In millions
|
Total
|
Level 1
|
Level 2
|
Level 3
|
Total
|
Level 1
|
Level 2
|
Level 3
|
||||||||||||||||
Cash and cash equivalents
|
$
|
877
|
|
$
|
818
|
|
$
|
59
|
|
$
|
—
|
|
$
|
772
|
|
$
|
671
|
|
$
|
101
|
|
$
|
—
|
|
Equity securities:
|
|
|
|
|
|
|
|
|
||||||||||||||||
U.S. equity securities
1
|
$
|
3,493
|
|
$
|
3,251
|
|
$
|
241
|
|
$
|
1
|
|
$
|
3,755
|
|
$
|
3,416
|
|
$
|
339
|
|
$
|
—
|
|
Non - U.S. equity securities
|
4,242
|
|
3,497
|
|
707
|
|
38
|
|
5,551
|
|
4,533
|
|
978
|
|
40
|
|
||||||||
Total equity securities
|
$
|
7,735
|
|
$
|
6,748
|
|
$
|
948
|
|
$
|
39
|
|
$
|
9,306
|
|
$
|
7,949
|
|
$
|
1,317
|
|
$
|
40
|
|
Fixed income securities:
|
|
|
|
|
|
|
|
|
||||||||||||||||
Debt - government-issued
|
$
|
4,751
|
|
$
|
285
|
|
$
|
4,466
|
|
$
|
—
|
|
$
|
4,596
|
|
$
|
158
|
|
$
|
4,437
|
|
$
|
1
|
|
Debt - corporate-issued
|
2,929
|
|
411
|
|
2,518
|
|
—
|
|
3,300
|
|
351
|
|
2,935
|
|
14
|
|
||||||||
Debt - asset-backed
|
90
|
|
—
|
|
89
|
|
1
|
|
101
|
|
—
|
|
100
|
|
1
|
|
||||||||
Total fixed income securities
|
$
|
7,770
|
|
$
|
696
|
|
$
|
7,073
|
|
$
|
1
|
|
$
|
7,997
|
|
$
|
509
|
|
$
|
7,472
|
|
$
|
16
|
|
Alternative investments:
2
|
|
|
|
|
|
|
|
|
||||||||||||||||
Private market securities
|
$
|
1
|
|
$
|
—
|
|
$
|
—
|
|
$
|
1
|
|
$
|
—
|
|
$
|
—
|
|
$
|
—
|
|
$
|
—
|
|
Real estate
|
19
|
|
19
|
|
—
|
|
—
|
|
21
|
|
21
|
|
—
|
|
—
|
|
||||||||
Derivatives - asset position
|
451
|
|
17
|
|
434
|
|
—
|
|
261
|
|
2
|
|
259
|
|
—
|
|
||||||||
Derivatives - liability position
|
(506
|
)
|
(19
|
)
|
(487
|
)
|
—
|
|
(305
|
)
|
(2
|
)
|
(303
|
)
|
—
|
|
||||||||
Total alternative investments
|
$
|
(35
|
)
|
$
|
17
|
|
$
|
(53
|
)
|
$
|
1
|
|
$
|
(23
|
)
|
$
|
21
|
|
$
|
(44
|
)
|
$
|
—
|
|
Other investments
2
|
$
|
380
|
|
$
|
47
|
|
$
|
333
|
|
$
|
—
|
|
$
|
273
|
|
$
|
37
|
|
$
|
236
|
|
$
|
—
|
|
Subtotal
|
$
|
16,727
|
|
$
|
8,326
|
|
$
|
8,360
|
|
$
|
41
|
|
$
|
18,325
|
|
$
|
9,187
|
|
$
|
9,082
|
|
$
|
56
|
|
Investments measured at net asset value:
2
|
|
|
|
|
|
|
|
|
||||||||||||||||
Hedge funds
|
$
|
1,637
|
|
|
|
|
$
|
1,595
|
|
|
|
|
||||||||||||
Private market securities
|
2,196
|
|
|
|
|
1,390
|
|
|
|
|
||||||||||||||
Real estate
|
2,080
|
|
|
|
|
2,200
|
|
|
|
|
||||||||||||||
Total investments measured at net asset value
|
$
|
5,913
|
|
|
|
|
$
|
5,185
|
|
|
|
|
||||||||||||
Items to reconcile to fair value of plan assets:
|
|
|
|
|
|
|
|
|
||||||||||||||||
Pension trust receivables
3
|
$
|
29
|
|
|
|
|
|
|
|
$
|
27
|
|
|
|
|
|
|
|
||||||
Pension trust payables
4
|
(125
|
)
|
|
|
|
|
|
|
(136
|
)
|
|
|
|
|
|
|
||||||||
Total
|
$
|
22,544
|
|
|
|
|
|
|
|
$
|
23,401
|
|
|
|
|
|
|
|
1.
|
No DowDuPont common stock was directly held at
December 31, 2018
or
December 31, 2017
.
|
2.
|
The Company reviewed its fair value technique and elected to present assets valued at net asset value per share as a practical expedient outside of the fair value hierarchy. The assets are presented as "Investments measured at net asset value."
|
3.
|
Primarily receivables for investment securities sold.
|
4.
|
Primarily payables for investment securities purchased.
|
Fair Value Measurement of Level 3 Pension Plan Assets
|
Equity Securities
|
Fixed Income Securities
|
Alternative Investments
|
Other Investments
|
Total
|
||||||||||
In millions
|
|||||||||||||||
Balance at Jan 1, 2017, as previously reported
|
$
|
33
|
|
$
|
17
|
|
$
|
4,117
|
|
$
|
95
|
|
$
|
4,262
|
|
Reclassification of investments measured at net asset value
1
|
—
|
|
—
|
|
(4,061
|
)
|
(95
|
)
|
(4,156
|
)
|
|||||
Balance at Jan 1, 2017, as restated
|
$
|
33
|
|
$
|
17
|
|
$
|
56
|
|
$
|
—
|
|
$
|
106
|
|
Actual return on assets:
|
|
|
|
|
|
||||||||||
Relating to assets sold during 2017
|
(1
|
)
|
—
|
|
5
|
|
—
|
|
4
|
|
|||||
Relating to assets held at Dec 31, 2017
|
5
|
|
1
|
|
(1
|
)
|
—
|
|
5
|
|
|||||
Purchases, sales and settlements, net
|
3
|
|
(2
|
)
|
(60
|
)
|
—
|
|
(59
|
)
|
|||||
Balance at Dec 31, 2017
|
$
|
40
|
|
$
|
16
|
|
$
|
—
|
|
$
|
—
|
|
$
|
56
|
|
Actual return on assets:
|
|
|
|
|
|
||||||||||
Relating to assets sold during 2018
|
—
|
|
4
|
|
(1
|
)
|
1
|
|
4
|
|
|||||
Relating to assets held at Dec 31, 2018
|
(3
|
)
|
(4
|
)
|
—
|
|
—
|
|
(7
|
)
|
|||||
Purchases, sales and settlements, net
|
2
|
|
(15
|
)
|
2
|
|
(1
|
)
|
(12
|
)
|
|||||
Balance at Dec 31, 2018
|
$
|
39
|
|
$
|
1
|
|
$
|
1
|
|
$
|
—
|
|
$
|
41
|
|
1.
|
The Company reviewed its fair value technique and elected to present assets valued at net asset value per share as a practical expedient outside of the fair value hierarchy, including those classified as Level 3 pension plan assets. The assets are presented as "Investments measured at net asset value."
|
Weighted-Average Assumptions
|
2018
|
2017
|
2016
|
|||
Dividend yield
|
2.13
|
%
|
3.01
|
%
|
4.13
|
%
|
Expected volatility
|
23.34
|
%
|
23.71
|
%
|
31.60
|
%
|
Risk-free interest rate
|
2.83
|
%
|
1.28
|
%
|
1.12
|
%
|
Expected life of stock options granted during period (years)
|
6.2
|
|
7.5
|
|
7.8
|
|
Life of Employee Stock Purchase Plan (months)
|
—
|
|
3
|
|
4
|
|
Stock Options
|
2018
|
|||||
Shares in thousands
|
Shares
|
Exercise
Price
1
|
||||
Outstanding at Jan 1, 2018
|
26,628
|
|
$
|
38.30
|
|
|
Granted
|
6,571
|
|
$
|
71.43
|
|
|
Exercised
|
(4,074
|
)
|
$
|
30.65
|
|
|
Forfeited/Expired
|
(279
|
)
|
$
|
61.47
|
|
|
Outstanding at Dec 31, 2018
|
28,846
|
|
$
|
46.70
|
|
|
Remaining contractual life in years
|
|
|
5.46
|
|
||
Aggregate intrinsic value in millions
|
$
|
327
|
|
|
|
|
Exercisable at Dec 31, 2018
|
21,813
|
|
$
|
39.99
|
|
|
Remaining contractual life in years
|
|
|
4.40
|
|
||
Aggregate intrinsic value in millions
|
$
|
322
|
|
|
|
Additional Information about Stock Options
|
|
|
|
||||||
In millions, except per share amounts
|
2018
|
2017
|
2016
|
||||||
Weighted-average fair value per share of options granted
|
$
|
15.38
|
|
$
|
14.44
|
|
$
|
10.95
|
|
Total compensation expense for stock option plans
|
$
|
68
|
|
$
|
37
|
|
$
|
32
|
|
Related tax benefit
|
$
|
15
|
|
$
|
14
|
|
$
|
12
|
|
Total amount of cash received from the exercise of options
|
$
|
112
|
|
$
|
310
|
|
$
|
312
|
|
Total intrinsic value of options exercised
1
|
$
|
160
|
|
$
|
286
|
|
$
|
153
|
|
Related tax benefit
|
$
|
36
|
|
$
|
106
|
|
$
|
57
|
|
RSU Awards
|
2018
|
||||
Shares in thousands
|
Shares
|
Grant Date
Fair Value
1
|
|||
Nonvested at Jan 1, 2018
|
13,346
|
|
$
|
50.71
|
|
Granted
|
2,022
|
|
$
|
71.46
|
|
Vested
|
(5,409
|
)
|
$
|
46.04
|
|
Canceled
|
(224
|
)
|
$
|
59.40
|
|
Nonvested at Dec 31, 2018
|
9,735
|
|
$
|
57.41
|
|
Additional Information about RSUs
|
|
|
|
||||||
In millions, except per share amounts
|
2018
|
2017
|
2016
|
||||||
Weighted-average fair value per share of RSUs granted
|
$
|
71.46
|
|
$
|
61.29
|
|
$
|
46.25
|
|
Total fair value of RSUs vested
1
|
$
|
382
|
|
$
|
179
|
|
$
|
166
|
|
Related tax benefit
|
$
|
86
|
|
$
|
66
|
|
$
|
61
|
|
Total compensation expense for RSU awards
|
$
|
144
|
|
$
|
178
|
|
$
|
97
|
|
Related tax benefit
|
$
|
32
|
|
$
|
66
|
|
$
|
36
|
|
1.
|
Includes the fair value of shares vested in prior years and delivered in the reporting year.
|
PSU Awards
|
Target
Shares
Granted
1
|
Grant Date
Fair Value
2
|
||||
Shares in thousands
|
||||||
Year
|
Performance Period
|
|||||
2017
|
Sep 1, 2017 – Aug 31, 2019
|
232
|
|
$
|
71.16
|
|
2017
3
|
Jan 1, 2017 – Dec 31, 2019
|
1,728
|
|
$
|
81.99
|
|
2016
3
|
Jan 1, 2016 – Dec 31, 2018
|
2,283
|
|
$
|
52.68
|
|
1.
|
At the end of the performance period, the actual number of shares issued can range from
zero
to
200%
of target shares granted.
|
2.
|
Weighted-average per share.
|
3.
|
Converted to RSUs as a result of the Merger.
|
Additional Information about PSUs
|
|
|
|
||||||
In millions, except share amounts
|
2018
|
2017
|
2016
|
||||||
Total fair value of PSUs vested and delivered
1
|
$
|
—
|
|
$
|
202
|
|
$
|
103
|
|
Related tax benefit
|
$
|
—
|
|
$
|
75
|
|
$
|
38
|
|
Total compensation expense for PSU awards
|
$
|
12
|
|
$
|
106
|
|
$
|
125
|
|
Related tax benefit
|
$
|
3
|
|
$
|
39
|
|
$
|
46
|
|
Shares of PSUs settled in cash (in thousands)
2
|
—
|
|
616
|
|
861
|
|
|||
Total cash paid to settle PSUs
3
|
$
|
—
|
|
$
|
38
|
|
$
|
40
|
|
1.
|
Includes the fair value of shares vested in prior years and delivered in the reporting year.
|
2.
|
PSU awards vested in prior years and delivered in the reporting year.
|
3.
|
Cash paid to certain executive employees for PSU awards vested in prior periods and delivered in the reporting year, equal to the value of the stock award on the date of delivery.
|
Restricted Stock
|
Shares Issued
(in thousands)
|
Weighted-Average Fair Value
|
|||
Year
|
|||||
2018
|
36
|
|
$
|
62.82
|
|
2017
|
33
|
|
$
|
62.04
|
|
2016
|
32
|
|
$
|
50.55
|
|
Additional Information about Employee Stock Purchase Plan
|
|
|
|
||||||
In millions, except per share amounts
|
2018
|
2017
|
2016
|
||||||
Weighted-average fair value per share of purchase rights granted
|
$
|
—
|
|
$
|
10.70
|
|
$
|
3.40
|
|
Total compensation expense for ESPP
|
$
|
—
|
|
$
|
38
|
|
$
|
7
|
|
Related tax benefit
|
$
|
—
|
|
$
|
14
|
|
$
|
3
|
|
Total amount of cash received from the exercise of purchase rights
|
$
|
—
|
|
$
|
179
|
|
$
|
86
|
|
Total intrinsic value of purchase rights exercised
1
|
$
|
—
|
|
$
|
48
|
|
$
|
23
|
|
Related tax benefit
|
$
|
—
|
|
$
|
18
|
|
$
|
9
|
|
1.
|
Difference between the market price at exercise and the price paid by the employee to exercise the purchase rights.
|
Fair Value of Financial Instruments at Dec 31
|
2018
|
2017
|
||||||||||||||||||||||
In millions
|
Cost
|
Gain
|
Loss
|
Fair Value
|
Cost
|
Gain
|
Loss
|
Fair Value
|
||||||||||||||||
Cash equivalents
|
$
|
566
|
|
$
|
—
|
|
$
|
—
|
|
$
|
566
|
|
$
|
2,280
|
|
$
|
—
|
|
$
|
—
|
|
$
|
2,280
|
|
Marketable securities
|
$
|
100
|
|
$
|
—
|
|
$
|
—
|
|
$
|
100
|
|
$
|
4
|
|
$
|
—
|
|
$
|
—
|
|
$
|
4
|
|
Other investments:
|
|
|
|
|
|
|
|
|
||||||||||||||||
Debt securities:
|
|
|
|
|
|
|
|
|
||||||||||||||||
Government debt
1
|
$
|
714
|
|
$
|
9
|
|
$
|
(23
|
)
|
$
|
700
|
|
$
|
637
|
|
$
|
13
|
|
$
|
(11
|
)
|
$
|
639
|
|
Corporate bonds
|
1,026
|
|
20
|
|
(63
|
)
|
983
|
|
704
|
|
32
|
|
(3
|
)
|
733
|
|
||||||||
Total debt securities
|
$
|
1,740
|
|
$
|
29
|
|
$
|
(86
|
)
|
$
|
1,683
|
|
$
|
1,341
|
|
$
|
45
|
|
$
|
(14
|
)
|
$
|
1,372
|
|
Equity securities
2
|
16
|
|
1
|
|
(1
|
)
|
16
|
|
164
|
|
2
|
|
(26
|
)
|
140
|
|
||||||||
Total other investments
|
$
|
1,756
|
|
$
|
30
|
|
$
|
(87
|
)
|
$
|
1,699
|
|
$
|
1,505
|
|
$
|
47
|
|
$
|
(40
|
)
|
$
|
1,512
|
|
Total cash equivalents, marketable securities and other investments
|
$
|
2,422
|
|
$
|
30
|
|
$
|
(87
|
)
|
$
|
2,365
|
|
$
|
3,789
|
|
$
|
47
|
|
$
|
(40
|
)
|
$
|
3,796
|
|
Long-term debt including debt due within one year
3
|
$
|
(19,591
|
)
|
$
|
351
|
|
$
|
(972
|
)
|
$
|
(20,212
|
)
|
$
|
(20,505
|
)
|
$
|
6
|
|
$
|
(2,104
|
)
|
$
|
(22,603
|
)
|
Derivatives relating to:
|
|
|
|
|
|
|
|
|
||||||||||||||||
Interest rates
|
$
|
—
|
|
$
|
—
|
|
$
|
(64
|
)
|
$
|
(64
|
)
|
$
|
—
|
|
$
|
—
|
|
$
|
(4
|
)
|
$
|
(4
|
)
|
Foreign currency
|
—
|
|
120
|
|
(43
|
)
|
77
|
|
—
|
|
22
|
|
(112
|
)
|
(90
|
)
|
||||||||
Commodities
4
|
—
|
|
91
|
|
(178
|
)
|
(87
|
)
|
—
|
|
130
|
|
(256
|
)
|
(126
|
)
|
||||||||
Total derivatives
|
$
|
—
|
|
$
|
211
|
|
$
|
(285
|
)
|
$
|
(74
|
)
|
$
|
—
|
|
$
|
152
|
|
$
|
(372
|
)
|
$
|
(220
|
)
|
1.
|
U.S. Treasury obligations, U.S. agency obligations, agency mortgage-backed securities and other municipalities’ obligations.
|
2.
|
Equity securities with a readily determinable fair value. Presented in accordance with ASU 2016-01. See Note
2
for additional information.
|
3.
|
Cost includes fair value hedge adjustments of
$18 million
at
December 31, 2018
and
$19 million
at
December 31, 2017
on
$2,290 million
of debt at
December 31, 2018
and
$2,390 million
of debt at
December 31, 2017
.
|
4.
|
Presented net of cash collateral where master netting arrangements allow.
|
Investing Results
1
|
|
|
|
||||||
In millions
|
2018
|
2017
|
2016
|
||||||
Proceeds from sales of available-for-sale securities
|
$
|
1,053
|
|
$
|
245
|
|
$
|
396
|
|
Gross realized gains
|
$
|
21
|
|
$
|
5
|
|
$
|
15
|
|
Gross realized losses
|
$
|
30
|
|
$
|
—
|
|
$
|
1
|
|
1.
|
Prior period amounts were updated to conform with the current year presentation as a result of the adoption of ASU 2016-01. See Note
2
for additional information.
|
Temporarily Impaired Debt Securities at
Dec 31, 2018
|
Less than 12 months
|
12 months or more
|
Total
|
|||||||||||||||
Fair
Value
|
Unrealized
Losses
|
Fair
Value |
Unrealized
Losses |
Fair Value
|
Unrealized Losses
|
|||||||||||||
In millions
|
||||||||||||||||||
Government debt
1
|
$
|
287
|
|
$
|
(17
|
)
|
$
|
187
|
|
$
|
(6
|
)
|
$
|
474
|
|
$
|
(23
|
)
|
Corporate bonds
|
724
|
|
(58
|
)
|
64
|
|
(5
|
)
|
788
|
|
(63
|
)
|
||||||
Total temporarily impaired debt securities
|
$
|
1,011
|
|
$
|
(75
|
)
|
$
|
251
|
|
$
|
(11
|
)
|
$
|
1,262
|
|
$
|
(86
|
)
|
1.
|
U.S. Treasury obligations, U.S. agency obligations, agency mortgage-backed securities and other municipalities' obligations.
|
Temporarily Impaired Debt Securities at
Dec 31, 2017
|
Less than 12 months
|
12 months or more
|
Total
|
|||||||||||||||
Fair
Value
|
Unrealized
Losses
|
Fair
Value |
Unrealized
Losses |
Fair Value
|
Unrealized Losses
|
|||||||||||||
In millions
|
||||||||||||||||||
Government debt
1
|
$
|
295
|
|
$
|
(4
|
)
|
$
|
151
|
|
$
|
(7
|
)
|
$
|
446
|
|
$
|
(11
|
)
|
Corporate bonds
|
163
|
|
(2
|
)
|
19
|
|
(1
|
)
|
182
|
|
(3
|
)
|
||||||
Total temporarily impaired debt securities
|
$
|
458
|
|
$
|
(6
|
)
|
$
|
170
|
|
$
|
(8
|
)
|
$
|
628
|
|
$
|
(14
|
)
|
1.
|
U.S. Treasury obligations, U.S. agency obligations, agency mortgage-backed securities and other municipalities' obligations.
|
Notional Amounts - Net
|
Dec 31, 2018
|
Dec 31, 2017
|
||||
In millions
|
||||||
Derivatives designated as hedging instruments:
|
|
|
||||
Interest rate swaps
|
$
|
2,049
|
|
$
|
185
|
|
Foreign currency contracts
|
$
|
4,457
|
|
$
|
4,343
|
|
Derivatives not designated as hedging instruments:
|
|
|
||||
Interest rate swaps
|
$
|
5
|
|
$
|
—
|
|
Foreign currency contracts
|
$
|
19,285
|
|
$
|
12,041
|
|
Commodity Notionals - Net
|
Dec 31, 2018
|
Dec 31, 2017
|
Notional Volume Unit
|
||
|
|||||
Derivatives designated as hedging instruments:
|
|
|
|
||
Hydrocarbon derivatives
|
39.9
|
|
71.3
|
|
million barrels of oil equivalent
|
Derivatives not designated as hedging instruments:
|
|
|
|
||
Hydrocarbon derivatives
|
1.2
|
|
4.1
|
|
million barrels of oil equivalent
|
Power derivatives
|
73.9
|
|
—
|
|
thousands of megawatt hours
|
Fair Value of Derivative Instruments
|
Dec 31, 2018
|
|||||||||
In millions
|
Balance Sheet Classification
|
Gross
|
Counterparty and Cash Collateral Netting
1
|
Net Amounts Included in the Consolidated Balance Sheets
|
||||||
Asset derivatives:
|
|
|
|
|
||||||
Derivatives designated as hedging instruments:
|
|
|
|
|
||||||
Foreign currency contracts
|
Other current assets
|
$
|
98
|
|
$
|
(42
|
)
|
$
|
56
|
|
Commodity contracts
|
Other current assets
|
47
|
|
(13
|
)
|
34
|
|
|||
Commodity contracts
|
Deferred charges and other assets
|
18
|
|
(3
|
)
|
15
|
|
|||
Total
|
|
$
|
163
|
|
$
|
(58
|
)
|
$
|
105
|
|
Derivatives not designated as hedging instruments:
|
|
|
|
|
||||||
Foreign currency contracts
|
Other current assets
|
$
|
128
|
|
$
|
(64
|
)
|
$
|
64
|
|
Commodity contracts
|
Other current assets
|
41
|
|
(1
|
)
|
40
|
|
|||
Commodity contracts
|
Deferred charges and other assets
|
4
|
|
(2
|
)
|
2
|
|
|||
Total
|
|
$
|
173
|
|
$
|
(67
|
)
|
$
|
106
|
|
Total asset derivatives
|
|
$
|
336
|
|
$
|
(125
|
)
|
$
|
211
|
|
|
|
|
|
|
||||||
Liability derivatives:
|
|
|
|
|
||||||
Derivatives designated as hedging instruments:
|
|
|
|
|
||||||
Interest rate swaps
|
Other noncurrent obligations
|
$
|
64
|
|
$
|
—
|
|
$
|
64
|
|
Foreign currency contracts
|
Accrued and other current liabilities
|
46
|
|
(42
|
)
|
4
|
|
|||
Commodity contracts
|
Accrued and other current liabilities
|
111
|
|
(18
|
)
|
93
|
|
|||
Commodity contracts
|
Other noncurrent obligations
|
86
|
|
(9
|
)
|
77
|
|
|||
Total
|
|
$
|
307
|
|
$
|
(69
|
)
|
$
|
238
|
|
Derivatives not designated as hedging instruments:
|
|
|
|
|
||||||
Foreign currency contracts
|
Accrued and other current liabilities
|
$
|
103
|
|
$
|
(64
|
)
|
$
|
39
|
|
Commodity contracts
|
Accrued and other current liabilities
|
7
|
|
(4
|
)
|
3
|
|
|||
Commodity contracts
|
Other noncurrent obligations
|
8
|
|
(3
|
)
|
5
|
|
|||
Total
|
|
$
|
118
|
|
$
|
(71
|
)
|
$
|
47
|
|
Total liability derivatives
|
|
$
|
425
|
|
$
|
(140
|
)
|
$
|
285
|
|
1.
|
Counterparty and cash collateral amounts represent the estimated net settlement amount when applying netting and set-off rights included in master netting arrangements between the Company and its counterparties and the payable or receivable for cash collateral held or placed with the same counterparty.
|
Fair Value of Derivative Instruments
|
Dec 31, 2017
|
|||||||||
In millions
|
Balance Sheet Classification
|
Gross
|
Counterparty and Cash Collateral Netting
1
|
Net Amounts Included in the Consolidated Balance Sheets
|
||||||
Asset derivatives:
|
|
|
|
|
||||||
Derivatives designated as hedging instruments:
|
|
|
|
|
||||||
Foreign currency contracts
|
Other current assets
|
$
|
51
|
|
$
|
(46
|
)
|
$
|
5
|
|
Commodity contracts
|
Other current assets
|
20
|
|
(4
|
)
|
16
|
|
|||
Commodity contracts
|
Deferred charges and other assets
|
70
|
|
(5
|
)
|
65
|
|
|||
Total
|
|
$
|
141
|
|
$
|
(55
|
)
|
$
|
86
|
|
Derivatives not designated as hedging instruments:
|
|
|
|
|
||||||
Foreign currency contracts
|
Other current assets
|
$
|
75
|
|
$
|
(58
|
)
|
$
|
17
|
|
Commodity contracts
|
Other current assets
|
50
|
|
(5
|
)
|
45
|
|
|||
Commodity contracts
|
Deferred charges and other assets
|
7
|
|
(3
|
)
|
4
|
|
|||
Total
|
|
$
|
132
|
|
$
|
(66
|
)
|
$
|
66
|
|
Total asset derivatives
|
|
$
|
273
|
|
$
|
(121
|
)
|
$
|
152
|
|
|
|
|
|
|
||||||
Liability derivatives:
|
|
|
|
|
||||||
Derivatives designated as hedging instruments:
|
|
|
|
|
||||||
Interest rate swaps
|
Other noncurrent obligations
|
$
|
4
|
|
$
|
—
|
|
$
|
4
|
|
Foreign currency contracts
|
Accrued and other current liabilities
|
109
|
|
(46
|
)
|
63
|
|
|||
Commodity contracts
|
Accrued and other current liabilities
|
96
|
|
(15
|
)
|
81
|
|
|||
Commodity contracts
|
Other noncurrent obligations
|
143
|
|
(12
|
)
|
131
|
|
|||
Total
|
|
$
|
352
|
|
$
|
(73
|
)
|
$
|
279
|
|
Derivatives not designated as hedging instruments:
|
|
|
|
|
||||||
Foreign currency contracts
|
Accrued and other current liabilities
|
$
|
107
|
|
$
|
(58
|
)
|
$
|
49
|
|
Commodity contracts
|
Accrued and other current liabilities
|
45
|
|
(6
|
)
|
39
|
|
|||
Commodity contracts
|
Other noncurrent obligations
|
8
|
|
(3
|
)
|
5
|
|
|||
Total
|
|
$
|
160
|
|
$
|
(67
|
)
|
$
|
93
|
|
Total liability derivatives
|
|
$
|
512
|
|
$
|
(140
|
)
|
$
|
372
|
|
1.
|
Counterparty and cash collateral amounts represent the estimated net settlement amount when applying netting and set-off rights included in master netting arrangements between the Company and its counterparties and the payable or receivable for cash collateral held or placed with the same counterparty.
|
Effect of Derivative Instruments
|
Amount of gain (loss) recognized in OCI
1
|
Amount of gain (loss) recognized in income
2
|
|
||||||||||||||||
In millions
|
2018
|
2017
|
2016
|
2018
|
2017
|
2016
|
Income Statement Classification
|
||||||||||||
Derivatives designated as hedging instruments:
|
|
|
|
|
|
|
|
||||||||||||
Fair value hedges:
|
|
|
|
|
|
|
|
||||||||||||
Interest rate swaps
|
$
|
—
|
|
$
|
—
|
|
$
|
—
|
|
$
|
—
|
|
$
|
(2
|
)
|
$
|
—
|
|
Interest expense and amortization of debt discount
3
|
Cash flow hedges:
|
|
|
|
|
|
|
|
||||||||||||
Interest rate swaps
|
26
|
|
2
|
|
2
|
|
(3
|
)
|
4
|
|
6
|
|
Interest expense and amortization of debt discount
|
||||||
Foreign currency contracts
|
19
|
|
(30
|
)
|
8
|
|
(18
|
)
|
7
|
|
(5
|
)
|
Cost of sales
|
||||||
Foreign currency contracts
|
(3
|
)
|
(5
|
)
|
25
|
|
—
|
|
(17
|
)
|
(13
|
)
|
Sundry income (expense) - net
|
||||||
Commodity contracts
|
(46
|
)
|
37
|
|
57
|
|
(69
|
)
|
10
|
|
(23
|
)
|
Cost of sales
|
||||||
Net investment hedges:
|
|
|
|
|
|
|
|
||||||||||||
Foreign currency contracts
|
116
|
|
(73
|
)
|
5
|
|
—
|
|
—
|
|
—
|
|
|
||||||
Total derivatives designated as hedging instruments
|
$
|
112
|
|
$
|
(69
|
)
|
$
|
97
|
|
$
|
(90
|
)
|
$
|
2
|
|
$
|
(35
|
)
|
|
Derivatives not designated as hedging instruments:
|
|
|
|
|
|
|
|
||||||||||||
Foreign currency contracts
|
$
|
—
|
|
$
|
—
|
|
$
|
—
|
|
$
|
101
|
|
$
|
(289
|
)
|
$
|
(180
|
)
|
Sundry income (expense) - net
|
Commodity contracts
|
—
|
|
—
|
|
—
|
|
(12
|
)
|
(9
|
)
|
6
|
|
Cost of sales
|
||||||
Total derivatives not designated as hedging instruments
|
$
|
—
|
|
$
|
—
|
|
$
|
—
|
|
$
|
89
|
|
$
|
(298
|
)
|
$
|
(174
|
)
|
|
Total derivatives
|
$
|
112
|
|
$
|
(69
|
)
|
$
|
97
|
|
$
|
(1
|
)
|
$
|
(296
|
)
|
$
|
(209
|
)
|
|
1.
|
OCI is defined as other comprehensive income (loss).
|
2.
|
Pretax amounts.
|
3.
|
Gain (loss) recognized in income of derivatives is offset by gain (loss) recognized in income of the hedged item.
|
Basis of Fair Value Measurements on a Recurring Basis
|
Dec 31, 2018
|
Dec 31, 2017
|
||||||||||||||||||||||
In millions
|
Level 1
|
Level 2
|
Level 3
|
Total
|
Level 1
|
Level 2
|
Level 3
|
Total
|
||||||||||||||||
Assets at fair value:
|
|
|
|
|
|
|
|
|
||||||||||||||||
Cash equivalents
1
|
$
|
—
|
|
$
|
566
|
|
$
|
—
|
|
$
|
566
|
|
$
|
—
|
|
$
|
2,280
|
|
$
|
—
|
|
$
|
2,280
|
|
Marketable securities
|
—
|
|
100
|
|
—
|
|
100
|
|
—
|
|
4
|
|
—
|
|
4
|
|
||||||||
Interests in trade accounts receivable conduits
2
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
677
|
|
677
|
|
||||||||
Equity securities
3
|
16
|
|
—
|
|
—
|
|
16
|
|
88
|
|
52
|
|
—
|
|
140
|
|
||||||||
Debt securities:
3
|
|
|
|
|
|
|
|
|
||||||||||||||||
Government debt
4
|
—
|
|
700
|
|
—
|
|
700
|
|
—
|
|
639
|
|
—
|
|
639
|
|
||||||||
Corporate bonds
|
—
|
|
983
|
|
—
|
|
983
|
|
—
|
|
733
|
|
—
|
|
733
|
|
||||||||
Derivatives relating to:
5
|
|
|
|
|
|
|
|
|
||||||||||||||||
Foreign currency
|
—
|
|
226
|
|
—
|
|
226
|
|
—
|
|
126
|
|
—
|
|
126
|
|
||||||||
Commodities
|
17
|
|
93
|
|
—
|
|
110
|
|
47
|
|
100
|
|
—
|
|
147
|
|
||||||||
Total assets at fair value
|
$
|
33
|
|
$
|
2,668
|
|
$
|
—
|
|
$
|
2,701
|
|
$
|
135
|
|
$
|
3,934
|
|
$
|
677
|
|
$
|
4,746
|
|
Liabilities at fair value:
|
|
|
|
|
|
|
|
|
||||||||||||||||
Long-term debt including debt due within one year
6
|
$
|
—
|
|
$
|
20,212
|
|
$
|
—
|
|
$
|
20,212
|
|
$
|
—
|
|
$
|
22,603
|
|
$
|
—
|
|
$
|
22,603
|
|
Derivatives relating to:
5
|
|
|
|
|
|
|
|
|
||||||||||||||||
Interest rates
|
—
|
|
64
|
|
—
|
|
64
|
|
—
|
|
4
|
|
—
|
|
4
|
|
||||||||
Foreign currency
|
—
|
|
149
|
|
—
|
|
149
|
|
—
|
|
216
|
|
—
|
|
216
|
|
||||||||
Commodities
|
23
|
|
189
|
|
—
|
|
212
|
|
31
|
|
261
|
|
—
|
|
292
|
|
||||||||
Total liabilities at fair value
|
$
|
23
|
|
$
|
20,614
|
|
$
|
—
|
|
$
|
20,637
|
|
$
|
31
|
|
$
|
23,084
|
|
$
|
—
|
|
$
|
23,115
|
|
1.
|
Treasury bills, time deposits, and money market funds included in "Cash and cash equivalents" in the consolidated balance sheets and held at amortized cost, which approximates fair value.
|
1.
|
Included in "Accounts and notes receivable – Other" in the consolidated balance sheets.
|
2.
|
Included in "Selling, general and administrative expenses" in the consolidated statements of income.
|
3.
|
Presented in accordance with ASU 2016-15. See Note
2
for additional information. In connection with the review and implementation of ASU 2016-15, the Company also changed the prior year value of “Purchases” and "Settlements" due to additional interpretive guidance of the required method for calculating the cash received from beneficial interests in the conduits, including additional guidance from the SEC's Office of the Chief Accountant issued in the third quarter of 2018 that indicated an entity must evaluate daily transaction activity to calculate the value of cash received from beneficial interests in conduits.
|
4.
|
Includes noncash transactions of
$23 million
for the year ended
December 31, 2018
.
|
Basis of Fair Value Measurements on a Nonrecurring Basis at Dec 31
|
(Level 1)
|
(Level 3)
|
Total Losses
|
||||||
In millions
|
|||||||||
2018
|
|
|
|
||||||
Assets at fair value:
|
|
|
|
||||||
Long-lived assets and other assets
|
$
|
—
|
|
$
|
—
|
|
$
|
(67
|
)
|
2017
|
|
|
|
||||||
Assets at fair value:
|
|
|
|
||||||
Long-lived assets, intangible assets, other assets and equity method investments
|
$
|
—
|
|
$
|
61
|
|
$
|
(955
|
)
|
Goodwill
|
$
|
—
|
|
$
|
—
|
|
$
|
(1,491
|
)
|
2016
|
|
|
|
||||||
Assets at fair value:
|
|
|
|
||||||
Long-lived assets, other assets and equity method investments
|
$
|
46
|
|
$
|
—
|
|
$
|
(296
|
)
|
1.
|
All assets were restricted at
December 31, 2018
and
2017
.
|
2.
|
All liabilities were nonrecourse at
December 31, 2018
and
2017
.
|
Balances Due To or Due From DuPont and its Affiliates
|
Dec 31, 2018
|
Dec 31, 2017
|
||||
In millions
|
||||||
Accounts and notes receivable - Other
|
$
|
89
|
|
$
|
12
|
|
Accounts payable - Other
|
$
|
19
|
|
$
|
11
|
|
•
|
EQUATE - a Kuwait-based company that manufactures ethylene, polyethylene and ethylene glycol, and manufactures and markets monoethylene glycol, diethylene glycol and polyethylene terephthalate resins; owned
42.5 percent
by the Company.
|
•
|
The Kuwait Olefins Company K.S.C.C. (“TKOC”) - a Kuwait-based company that manufactures ethylene and ethylene glycol; owned
42.5 percent
by the Company.
|
•
|
Map Ta Phut - a Thailand-based company that manufactures propylene and ethylene; the Company has an effective ownership of
32.77 percent
(of which
20.27 percent
is owned directly by the Company and aligned with the Industrial Intermediates & Infrastructure segment and
12.5 percent
is owned indirectly through the Company’s equity interest in Siam Polyethylene Company Limited, an entity that is part of The SCG-Dow Group and aligned with the Packaging & Specialty Plastics segment).
|
•
|
Sadara - a Saudi Arabian company that manufactures chlorine, ethylene, propylene and aromatics for internal consumption and manufactures and sells polyethylene, ethylene oxide and propylene oxide derivative products, and isocyanates; owned
35 percent
by the Company.
|
•
|
The Kuwait Styrene Company K.S.C.C. - a Kuwait-based company that manufactures styrene monomer; owned
42.5 percent
by the Company.
|
•
|
The SCG-Dow Group - a group of Thailand-based companies (consisting of Siam Polyethylene Company Limited; Siam Polystyrene Company Limited; Siam Styrene Monomer Co., Ltd.; and Siam Synthetic Latex Company Limited) that manufacture polyethylene, polystyrene, styrene, latex and specialty elastomers; owned
50 percent
by the Company.
|
Geographic Region Information
|
United
States
|
EMEAI
|
Rest of
World
|
Total
|
||||||||
In millions
|
||||||||||||
2018
|
|
|
|
|
||||||||
Sales to external customers
|
$
|
16,613
|
|
$
|
17,406
|
|
$
|
15,585
|
|
$
|
49,604
|
|
Long-lived assets
|
$
|
14,750
|
|
$
|
2,657
|
|
$
|
4,011
|
|
$
|
21,418
|
|
2017
|
|
|
|
|
||||||||
Sales to external customers
|
$
|
15,316
|
|
$
|
15,226
|
|
$
|
13,188
|
|
$
|
43,730
|
|
Long-lived assets
|
$
|
14,771
|
|
$
|
2,547
|
|
$
|
4,266
|
|
$
|
21,584
|
|
2016
|
|
|
|
|
||||||||
Sales to external customers
|
$
|
12,911
|
|
$
|
12,238
|
|
$
|
11,115
|
|
$
|
36,264
|
|
Long-lived assets
|
$
|
12,906
|
|
$
|
2,263
|
|
$
|
4,992
|
|
$
|
20,161
|
|
Segment Information
|
Perf. Materials & Coatings
|
Ind. Interm. & Infrast.
|
Pack. & Spec. Plastics
|
Corp.
|
Total
|
||||||||||
In millions
|
|||||||||||||||
2018
|
|
|
|
|
|
||||||||||
Net sales
|
$
|
9,677
|
|
$
|
15,447
|
|
$
|
24,195
|
|
$
|
285
|
|
$
|
49,604
|
|
Pro forma net sales
|
9,865
|
|
15,465
|
|
24,237
|
|
285
|
|
49,852
|
|
|||||
Restructuring and asset related charges - net
1
|
21
|
|
11
|
|
46
|
|
143
|
|
221
|
|
|||||
Equity in earnings (losses) of nonconsolidated affiliates
|
4
|
|
284
|
|
287
|
|
(20
|
)
|
555
|
|
|||||
Pro forma Operating EBIT
2
|
1,246
|
|
1,767
|
|
3,593
|
|
(370
|
)
|
6,236
|
|
|||||
Depreciation and amortization
|
888
|
|
607
|
|
1,385
|
|
29
|
|
2,909
|
|
|||||
Total assets
3
|
16,050
|
|
14,092
|
|
30,279
|
|
3,378
|
|
63,799
|
|
|||||
Investments in nonconsolidated affiliates
|
99
|
|
1,850
|
|
1,278
|
|
93
|
|
3,320
|
|
|||||
Capital expenditures
|
427
|
|
433
|
|
1,231
|
|
—
|
|
2,091
|
|
|||||
2017
|
|
|
|
|
|
||||||||||
Net sales
|
$
|
8,892
|
|
$
|
12,951
|
|
$
|
21,504
|
|
$
|
383
|
|
$
|
43,730
|
|
Pro forma net sales
|
8,892
|
|
12,951
|
|
22,546
|
|
383
|
|
44,772
|
|
|||||
Restructuring, goodwill impairment and asset related charges - net
1
|
1,578
|
|
17
|
|
716
|
|
428
|
|
2,739
|
|
|||||
Equity in earnings (losses) of nonconsolidated affiliates
|
40
|
|
172
|
|
190
|
|
(8
|
)
|
394
|
|
|||||
Pro forma Operating EBIT
2
|
817
|
|
1,470
|
|
3,712
|
|
(422
|
)
|
5,577
|
|
|||||
Depreciation and amortization
|
885
|
|
572
|
|
1,055
|
|
34
|
|
2,546
|
|
|||||
Total assets
3
|
17,483
|
|
14,115
|
|
30,633
|
|
4,342
|
|
66,573
|
|
|||||
Investments in nonconsolidated affiliates
|
103
|
|
1,700
|
|
1,184
|
|
120
|
|
3,107
|
|
|||||
Capital expenditures
|
463
|
|
310
|
|
2,034
|
|
—
|
|
2,807
|
|
|||||
2016
|
|
|
|
|
|
||||||||||
Net sales
|
$
|
6,476
|
|
$
|
11,100
|
|
$
|
18,404
|
|
$
|
284
|
|
$
|
36,264
|
|
Restructuring and asset related charges - net
1
|
42
|
|
83
|
|
10
|
|
444
|
|
579
|
|
|||||
Asbestos-related charge
4
|
—
|
|
—
|
|
—
|
|
1,113
|
|
1,113
|
|
|||||
Equity in earnings (losses) of nonconsolidated affiliates
|
97
|
|
(18
|
)
|
137
|
|
(29
|
)
|
187
|
|
|||||
Operating EBIT
5
|
260
|
|
743
|
|
3,855
|
|
(354
|
)
|
4,504
|
|
|||||
Depreciation and amortization
|
678
|
|
620
|
|
903
|
|
24
|
|
2,225
|
|
|||||
Total assets
3
|
17,731
|
|
13,739
|
|
23,051
|
|
5,837
|
|
60,358
|
|
|||||
Investments in nonconsolidated affiliates
|
280
|
|
1,632
|
|
853
|
|
209
|
|
2,974
|
|
|||||
Capital expenditures
|
435
|
|
262
|
|
2,792
|
|
—
|
|
3,489
|
|
1.
|
See Note
8
for information regarding the Company's restructuring programs, goodwill impairment and other asset related charges.
|
2.
|
A reconciliation of "Income (loss) from continuing operations, net of tax" to pro forma Operating EBIT is provided below.
|
3.
|
Excludes assets of discontinued operations of
$19,900 million
,
$19,279 million
and
$19,153 million
for 2018, 2017 and 2016, respectively.
|
4.
|
See Note
18
for information regarding the asbestos-related charge.
|
5.
|
A reconciliation of "Income from continuing operations, net of tax" to Operating EBIT is provided on the following page.
|
1.
|
Pro forma adjustments include: (1) the margin impact of various manufacturing, supply and service related agreements entered into with DowDuPont and Corteva in connection with the separation which provide for different pricing than the historical intercompany and intracompany pricing practices of TDCC and DuPont (including for 2018 only), (2) the inclusion of ECP for the period of January 1, 2017 through August 31, 2017, (3) the removal of the amortization of ECP's inventory step-up recognized in connection with the Merger (4) the elimination of the impact of events directly attributable to the Merger, internal reorganization and business realignment, separation, distribution and other related transactions (e.g., one-time transaction costs) and (5) the elimination of the effect of a consummated divestiture agreed to with certain regulatory agencies as a condition of approval for the Merger.
|
Significant Items by Segment for 2018
|
Perf. Materials & Coatings
|
Ind. Interm. & Infrast.
|
Pack. & Spec. Plastics
|
Corp.
|
Total
|
||||||||||
In millions
|
|||||||||||||||
Impact of Dow Silicones ownership restructure
1
|
$
|
(20
|
)
|
$
|
—
|
|
$
|
—
|
|
$
|
—
|
|
$
|
(20
|
)
|
Integration and separation costs
2
|
—
|
|
—
|
|
—
|
|
(1,074
|
)
|
(1,074
|
)
|
|||||
Restructuring and asset related charges - net
3
|
(21
|
)
|
(11
|
)
|
(46
|
)
|
(120
|
)
|
(198
|
)
|
|||||
Gain on divestiture
4
|
—
|
|
20
|
|
—
|
|
—
|
|
20
|
|
|||||
Loss on early extinguishment of debt
5
|
—
|
|
—
|
|
—
|
|
(54
|
)
|
(54
|
)
|
|||||
Total
|
$
|
(41
|
)
|
$
|
9
|
|
$
|
(46
|
)
|
$
|
(1,248
|
)
|
$
|
(1,326
|
)
|
1.
|
Includes a loss related to a post-closing adjustment related to the Dow Silicones ownership restructure.
|
2.
|
Costs related to post-Merger integration and separation and distribution activities, and costs related to the Dow Silicones ownership restructure.
|
3.
|
Includes Board approved restructuring plans and asset-related charges, which include other asset impairments. See Note
8
for additional information.
|
4.
|
Includes a gain related to the Company's sale of its equity interest in MEGlobal.
|
5.
|
The Company retired outstanding notes payable resulting in a loss on early extinguishment. See Note
17
for additional information.
|
Significant Items by Segment for 2017
|
Perf. Materials & Coatings
|
Ind. Interm. & Infrast.
|
Pack. & Spec. Plastics
|
Corp.
|
Total
|
||||||||||
In millions
|
|||||||||||||||
Litigation related charges, awards and adjustments
1
|
$
|
—
|
|
$
|
—
|
|
$
|
137
|
|
$
|
—
|
|
$
|
137
|
|
Integration and separation costs
2
|
—
|
|
—
|
|
—
|
|
(716
|
)
|
(716
|
)
|
|||||
Restructuring, goodwill impairment and asset related charges - net
3
|
(1,578
|
)
|
(17
|
)
|
(716
|
)
|
(431
|
)
|
(2,742
|
)
|
|||||
Gain on divestiture
4
|
—
|
|
—
|
|
—
|
|
7
|
|
7
|
|
|||||
Transaction costs and productivity actions
5
|
—
|
|
—
|
|
—
|
|
(58
|
)
|
(58
|
)
|
|||||
Total
|
$
|
(1,578
|
)
|
$
|
(17
|
)
|
$
|
(579
|
)
|
$
|
(1,198
|
)
|
$
|
(3,372
|
)
|
1.
|
Includes a gain associated with a patent infringement matter with Nova. See Note
18
for additional information.
|
2.
|
Costs related to post-Merger integration, separation and distribution activities, and costs related to the Dow Silicones ownership restructure.
|
3.
|
Includes Board approved restructuring plans, goodwill impairment and asset-related charges, which includes other asset impairments. See Note
8
for additional information.
|
4.
|
Includes post-closing adjustments related to the split-off of the Company's chlorine value chain.
|
5.
|
Includes implementation costs associated with the Company's restructuring programs and other productivity actions.
|
Significant Items by Segment for 2016
|
Perf. Materials & Coatings
|
Ind. Interm. & Infrast.
|
Pack. & Spec. Plastics
|
Corp.
|
Total
|
||||||||||
In millions
|
|||||||||||||||
Impact of Dow Silicones ownership restructure
1
|
$
|
1,389
|
|
$
|
—
|
|
$
|
—
|
|
$
|
—
|
|
$
|
1,389
|
|
Litigation related charges, awards and adjustments
2
|
16
|
|
(1,235
|
)
|
—
|
|
—
|
|
(1,219
|
)
|
|||||
Asbestos-related charge
3
|
—
|
|
—
|
|
—
|
|
(1,113
|
)
|
(1,113
|
)
|
|||||
Integration and separation costs
4
|
—
|
|
—
|
|
—
|
|
(349
|
)
|
(349
|
)
|
|||||
Restructuring and asset related charges - net
5
|
(42
|
)
|
(83
|
)
|
(10
|
)
|
(444
|
)
|
(579
|
)
|
|||||
Loss on divestitures
6
|
—
|
|
—
|
|
—
|
|
(14
|
)
|
(14
|
)
|
|||||
Environmental charges
7
|
—
|
|
(1
|
)
|
(2
|
)
|
(292
|
)
|
(295
|
)
|
|||||
Transaction costs and productivity actions
8
|
—
|
|
—
|
|
—
|
|
(195
|
)
|
(195
|
)
|
|||||
Charge for the termination of a terminal use agreement
9
|
—
|
|
—
|
|
(117
|
)
|
—
|
|
(117
|
)
|
|||||
Total
|
$
|
1,363
|
|
$
|
(1,319
|
)
|
$
|
(129
|
)
|
$
|
(2,407
|
)
|
$
|
(2,492
|
)
|
1.
|
Includes a non-taxable gain of
$1,617 million
related to the Dow Silicones ownership restructure; a
$213 million
charge for the fair value step-up of Dow Silicones' inventories; and, a pretax loss of
$15 million
related to the early redemption of debt incurred by Dow Silicones. See Note
6
for additional information.
|
2.
|
Includes a loss of
$1,235 million
related to the Company's settlement of the urethane matters class action lawsuit and the opt-out cases litigation and a gain of
$16 million
related to a decrease in Dow Silicones' implant liability. See Note
18
for additional information.
|
3.
|
Pretax charge related to the Company's election to change its method of accounting for asbestos-related defense costs from expensing as incurred to estimating and accruing a liability. As a result of this accounting policy change, the Company recorded a pretax charge of
$1,009 million
for asbestos-related defense costs through the terminal date of 2049. The Company also recorded a pretax charge of
$104 million
to increase the asbestos-related liability for pending and future claims through the terminal date of 2049. See Note
18
for additional information.
|
4.
|
Costs related to the Merger and the ownership restructure of Dow Silicones.
|
5.
|
Includes the Company's restructuring activities. Also reflects a pretax charge of
$143 million
for a partial impairment of the Company’s investment in AFSI. See Note
8
for additional information.
|
6.
|
Includes a charge of
$20 million
for post-closing adjustments on the divestiture of AgroFresh and a gain of
$6 million
for post-closing adjustments on the split-off of the chlorine value chain.
|
7.
|
Pretax charge for environmental remediation activities at a number of the Company's locations, primarily resulting from the culmination of negotiations with regulators and/or final agency approval. See Note
18
for additional information.
|
8.
|
Includes implementation costs associated with the Company's restructuring programs and other productivity actions. Also includes a charge of
$33 million
for a retained litigation matter related to the chlorine value chain.
|
9.
|
Pretax charge related to the Company's termination of a terminal use agreement.
|
2018
|
|
|
|
|
|
||||||||||
In millions, except per share amounts (Unaudited)
|
1st
|
2nd
|
3rd
|
4th
|
Year
|
||||||||||
Net sales
|
$
|
12,237
|
|
$
|
12,789
|
|
$
|
12,634
|
|
$
|
11,944
|
|
$
|
49,604
|
|
Cost of sales
|
$
|
9,980
|
|
$
|
10,540
|
|
$
|
10,456
|
|
$
|
10,098
|
|
$
|
41,074
|
|
Gross margin
|
$
|
2,257
|
|
$
|
2,249
|
|
$
|
2,178
|
|
$
|
1,846
|
|
$
|
8,530
|
|
Restructuring, goodwill impairment and asset related charges - net
1
|
$
|
87
|
|
$
|
40
|
|
$
|
48
|
|
$
|
46
|
|
$
|
221
|
|
Integration and separation costs
|
$
|
224
|
|
$
|
262
|
|
$
|
313
|
|
$
|
380
|
|
$
|
1,179
|
|
Income from continuing operations, net of tax
|
$
|
925
|
|
$
|
810
|
|
$
|
714
|
|
$
|
491
|
|
$
|
2,940
|
|
Income from discontinued operations net of tax
|
$
|
514
|
|
$
|
554
|
|
$
|
335
|
|
$
|
432
|
|
$
|
1,835
|
|
Net income
2
|
$
|
1,439
|
|
$
|
1,364
|
|
$
|
1,049
|
|
$
|
923
|
|
$
|
4,775
|
|
Net income attributable to Dow Inc. and The Dow Chemical Company
|
$
|
1,404
|
|
$
|
1,333
|
|
$
|
1,013
|
|
$
|
891
|
|
$
|
4,641
|
|
Earnings per common share from continuing operations - basic
3
|
$
|
1.21
|
|
$
|
1.05
|
|
$
|
0.91
|
|
$
|
0.63
|
|
$
|
3.80
|
|
Earnings per common share from continuing operations -
diluted
3
|
$
|
1.21
|
|
$
|
1.05
|
|
$
|
0.91
|
|
$
|
0.63
|
|
$
|
3.80
|
|
1.
|
See Note
8
for additional information.
|
2.
|
Includes tax adjustments related to The Act, enacted on December 22, 2017. See Note
10
for additional information.
|
3.
|
Earnings per common share amounts relate only to Dow Inc. as TDCC common shares are not publicly traded and are all owned by Dow Inc.
|
2017
|
|
|
|
|
|
||||||||||
In millions, except per share amounts (Unaudited)
|
1st
|
2nd
|
3rd
|
4th
|
Year
|
||||||||||
Net sales
|
$
|
10,124
|
|
$
|
10,554
|
|
$
|
10,991
|
|
$
|
12,061
|
|
$
|
43,730
|
|
Cost of sales
|
$
|
8,346
|
|
$
|
8,703
|
|
$
|
8,979
|
|
$
|
10,322
|
|
$
|
36,350
|
|
Gross margin
|
$
|
1,778
|
|
$
|
1,851
|
|
$
|
2,012
|
|
$
|
1,739
|
|
$
|
7,380
|
|
Restructuring, goodwill impairment and asset related charges (credits) - net
1
|
$
|
—
|
|
$
|
(12
|
)
|
$
|
117
|
|
$
|
2,634
|
|
$
|
2,739
|
|
Integration and separation costs
|
$
|
109
|
|
$
|
136
|
|
$
|
290
|
|
$
|
263
|
|
$
|
798
|
|
Income (loss) from continuing operations, net of tax
|
$
|
614
|
|
$
|
812
|
|
$
|
505
|
|
$
|
(3,218
|
)
|
$
|
(1,287
|
)
|
Income from discontinued operations, net of tax
|
$
|
301
|
|
$
|
548
|
|
$
|
296
|
|
$
|
737
|
|
$
|
1,882
|
|
Net income (loss)
2
|
$
|
915
|
|
$
|
1,360
|
|
$
|
801
|
|
$
|
(2,481
|
)
|
$
|
595
|
|
Net income (loss) attributable to Dow Inc. and The Dow Chemical Company
|
$
|
888
|
|
$
|
1,322
|
|
$
|
779
|
|
$
|
(2,524
|
)
|
$
|
465
|
|
Earnings (loss) per common share from continuing operations - basic
3
|
$
|
0.81
|
|
$
|
1.04
|
|
$
|
0.64
|
|
$
|
(4.36
|
)
|
$
|
(1.88
|
)
|
Earnings (loss) per common share from continuing operations - diluted
3
|
$
|
0.80
|
|
$
|
1.03
|
|
$
|
0.64
|
|
$
|
(4.36
|
)
|
$
|
(1.88
|
)
|
1.
|
See Note
8
for additional information.
|
2.
|
See Notes
7
,
9
,
10
,
18
and
21
for additional information on items materially impacting "Net income (loss)." The fourth quarter of 2017 included: tax adjustments related to The Act, enacted on December 22, 2017, and a charge related to payment of plan obligations to certain participants of a U.S. non-qualified pension plan. The third quarter of 2017 included a gain related to the sale of the Company's EAA Business. The second quarter of 2017 included a gain related to the Nova patent infringement award.
|
3.
|
Earnings per common share amounts relate only to Dow Inc. as TDCC common shares are not publicly traded and are all owned by Dow Inc.
|
|
Dow Inc. and Subsidiaries
The Dow Chemical Company and Subsidiaries
|
|
(a)
|
The following documents are filed as part of this report:
|
(1)
|
The Company’s
2018
Consolidated Financial Statements and the Report of Independent Registered Public Accounting Firm are included in Part II, Item 8. Financial Statements and Supplementary Data.
|
(2)
|
Financial Statement Schedules – The following Financial Statement Schedule should be read in conjunction with the Consolidated Financial Statements and Report of Independent Registered Public Accounting Firm included in Part II, Item 8. Financial Statements and Supplementary Data:
|
Schedule II
|
Valuation and Qualifying Accounts
|
Schedule II - Valuation and Qualifying Accounts
|
|
|
|
||||||
(In millions) For the years ended Dec 31,
|
2018
|
2017
|
2016
|
||||||
Accounts Receivable - Allowance for Doubtful Receivables
|
|
|
|
||||||
Balance at beginning of year
|
$
|
59
|
|
$
|
51
|
|
$
|
48
|
|
Additions charged to expenses
|
10
|
|
23
|
|
13
|
|
|||
Additions charged to other accounts
1
|
4
|
|
2
|
|
—
|
|
|||
Deductions from reserves
2
|
(31
|
)
|
(17
|
)
|
(10
|
)
|
|||
Balance at end of year
|
$
|
42
|
|
$
|
59
|
|
$
|
51
|
|
Inventory - Obsolescence Reserve
|
|
|
|
||||||
Balance at beginning of year
|
$
|
18
|
|
$
|
34
|
|
$
|
14
|
|
Additions charged to expenses
|
7
|
|
5
|
|
26
|
|
|||
Deductions from reserves
3
|
(2
|
)
|
(21
|
)
|
(6
|
)
|
|||
Balance at end of year
|
$
|
23
|
|
$
|
18
|
|
$
|
34
|
|
Reserves for Other Investments and Noncurrent Receivables
|
|
|
|
||||||
Balance at beginning of year
|
$
|
430
|
|
$
|
350
|
|
$
|
487
|
|
Additions charged to expenses
4
|
44
|
|
83
|
|
152
|
|
|||
Deductions from reserves
5
|
(14
|
)
|
(3
|
)
|
(289
|
)
|
|||
Balance at end of year
|
$
|
460
|
|
$
|
430
|
|
$
|
350
|
|
Deferred Tax Assets - Valuation Allowance
|
|
|
|
||||||
Balance at beginning of year
|
$
|
1,255
|
|
$
|
936
|
|
$
|
868
|
|
Additions charged to expenses
|
152
|
|
369
|
|
140
|
|
|||
Deductions from reserves
|
(182
|
)
|
(50
|
)
|
(72
|
)
|
|||
Balance at end of year
|
$
|
1,225
|
|
$
|
1,255
|
|
$
|
936
|
|
1.
|
Additions to allowance for doubtful accounts charged to other accounts were classified as "Accounts and notes receivable - Other" in the consolidated balance sheets. These reserves relate to the Company's sale of trade accounts receivable. Anticipated credit losses in the portfolio of receivables sold were used to fair value the Company's interests held in trade accounts receivable conduits. See Notes
16
and
24
to the Consolidated Financial Statements for further information.
|
2.
|
Deductions include write-offs, recoveries, currency translation adjustment and other miscellaneous items.
|
3.
|
Deductions include disposals and currency translation adjustments.
|
4.
|
In 2016, additions to reserves for "Other investments and noncurrent receivables" charged to costs and expenses include
$143 million
related to the Company's investment in AgroFresh Solutions, Inc. See Note
8
to the Consolidated Financial Statements for further information.
|
5.
|
In 2016, deductions from reserves for "Other investments and noncurrent receivables" include
$237 million
related to the Dow Silicones ownership restructure. See Note
6
to the Consolidated Financial Statements for further information on the Dow Silicones ownership restructure.
|
The Dow Chemical Company and Subsidiaries
|
Trademark Listing
|